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Summary 
Neurons are highly polarized cells with two structurally and functionally distinct 
compartments, axons and dendrites. This dichotomy is the basis for unidirectional 
signal propagation, the quintessential function of neurons. During neuronal 
development, the formation of the axon is the initial step in breaking cellular 
symmetry and the establishment of neuronal polarity. Although a number of polarity 
regulators involved in this process have been identified, our understanding of the 
intracellular mechanisms underlying neuronal polarization still remains fragmentary. 
 
In my studies, I addressed the role of microtubule dynamics in initial neuronal 
polarization. To this end I aimed to investigate the following issues: 1) How do 
microtubule dynamics and stability change during initial neuronal development? 2) 
Do microtubules play an instructive role in axon formation? 3) What are possible 
regulators mediating changes in microtubule dynamics during axon formation? 
 
Using hippocampal neurons in culture as a model system for neuronal polarization 
I  first addressed the dynamics of microtubules in early developmental stages of 
neurons. Assessing posttranslational modifications of tubulin which serve as markers 
of microtubule turnover I  found that microtubule stability is increased in a single 
neurite already before axon formation and in the axon of morphologically polarized 
cells. This polarized distribution of microtubule stability was confirmed by testing the 
resistance of neuronal microtubules to pharmacologically induced depolymerization. 
The axon of polarized neurons and a single neurite in morphologically unpolarized 
cells showed increased microtubule stability. Thus, I  established a correlation 
between the identity of a process and its microtubule stability. 
 
By manipulating specific regulators of neuronal polarity, SAD kinases and GSK-3β, 
I  analyzed a possible relation between a polarization of microtubule stability and 
neuronal polarity. I found that a loss of polarity correlated with a loss of polarized 
microtubule stability in neurons defective for SAD A and SAD B kinases. In marked 
contrast, the formation of multiple axons, induced by the inhibition of GSK-3β, was 
associated with increased microtubule stability in these supernumerary axons. These     Summary 
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results suggested that SAD kinases and GSK-3β regulate neuronal polarization –at 
least in part– by modulating microtubule dynamics. 
 
To establish a possible causal relation between microtubule dynamics and axon 
formation I  assessed the effects of specific pharmacological alterations of 
microtubule dynamics on neuronal polarization. I found that application of low doses 
of the microtubule destabilizing drug nocodazole selectively reduced the formation of 
future dendrites. Conversely, low doses of the microtubule stabilizing drug taxol led 
to the formation of multiple axons. I  also studied microtubule dynamics in living 
neurons transfected with GFP-tagged EB3, a protein binding specifically to 
polymerizing microtubule plus ends. In line with my previous observations I found 
that microtubules are stabilized along the shaft of the growing axons while dynamic 
microtubules enrich at the tip of the growing process, suggesting that a well- 
balanced shift of microtubule dynamics towards more stable microtubules is 
necessary to induce axon formation. By uncaging a photoactivatable analog of taxol I 
induced a local stabilization of microtubules at the neurite tip of an unpolarized 
neuron which was sufficient to favor the site of axon formation. This indicates that a 
transient stabilization of microtubules is sufficient to trigger axon formation. 
 
In summary, my data allow the following conclusions: 1) Microtubule stability 
correlates with the identity of a neuronal process. 2) Microtubule stabilization causes 
axon formation. 3) Microtubule stabilization precedes axon formation. I  therefore 
deduce that microtubules are actively involved in the process of axon formation and 
that local microtubule stabilization in one neuronal process is a physiological signal 
specifying neuronal polarization. 
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1. Introduction 
Neurons are highly polarized cells, a characteristic that enables them to form the 
cellular basis of neuronal networks, one of the most refined structures found in 
nature. Typically, mature neurons have one thin, long process to transmit 
information, the axon, and several tapered, shorter processes to receive information, 
the dendrites. Newly generated neurons gradually develop these clear-cut polar 
structures, thereby laying the foundation for unidirectional signal propagation. The 
formation of the axon is a crucial hallmark of this process of neuronal polarization, as 
it marks the first break in symmetry during neuronal development. Accommodating 
the importance of neuronal polarization for the function of nerve cells, one of the key 
questions of neurobiology is how a neuron acquires and maintains its polarity. 
 
1.1 Neuronal  polarity 
The polarity of nerve cells takes shape in three different levels: Morphology, 
molecular composition and function. Eye-catching, axons and dendrites differ at the 
level of morphology. Axons are usually long and slender, in contrast to the shorter, 
tapered, highly branched morphology of dendrites. On the level of molecular 
composition, neuronal polarity is reflected in the distinct machinery of axons and 
dendrites for signal transmission and reception, respectively (Bear et al., 2007). 
Axons are equipped to actively conduct electrical signals in the form of action 
potentials —generated at their initial segment, the so-called ‘axon hillock’ (reviewed 
in Catterall, 2000)— down to their terminals (see Figure 1-1 A; Bear et al., 2007). 
 
When an action potential reaches the presynaptic axon terminal it promotes the 
release of neurotransmitters into the synaptic cleft (see Figure  1-1  B). By this 
mechanism an electrical signal (the action potential) is converted to a chemical signal 
and passed on via a (chemical) synapse to a postsynaptic cell, e.g. an adjacent 
neuron or other target tissues like muscles or secretory glands. [Signal transmission 
via electrical synapses is described in (Bennett and Zukin, 2004).] In contrast to 
axons, dendrites are fitted to receive signals (Bear et al., 2007). Receptors in their 
postsynaptic membrane bind the neurotransmitter molecules released by the axon     Introduction 
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which evokes or modulates postsynaptic potentials (PSPs; reviewed in Südhof, 
2008). Depending on the type of receptor, PSPs may be excitatory or inhibitory; they 
are summarized in the dendrites and the cell body and may in turn generate a new 
action potential at the axon hillock of the receiving cell (Bear et al., 2007). 
 
Selective targeting and retention establishes the compartmentalized distribution of 
axonal (Gu et al., 2003; Sampo et al., 2003; Stowell and Craig, 1999; Wisco et al., 
2003; Yap et al., 2008) and dendritic (Rosales et al., 2005; Stowell and Craig, 1999; 
 
Figure 1-1: Neuronal polarity and function 
Neurons generate action potentials at the initial segment of the axon (the axon hillock) which are 
subsequently conducted down the axon to the axon terminals (A). There the action potentials trigger 
the release of neurotransmitter molecules from presynaptic vesicles into the synaptic cleft (B). 
Neurotransmitters bind to postsynaptic receptors (B) and thereby evoke or modulate postsynaptic 
potentials (PSPs) which are integrated in dendrites and the cell body (A). If the summarized PSPs 
exceed a certain threshold in the receiving neuron they stimulate voltage-gated sodium channels at 
the axon hillock to induce a new action potential. Image from http://www.nia.nih.gov/ (National 
Institute of Ageing). 
     Introduction 
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West et al., 1997) proteins. Once set up, a membrane diffusion barrier at the axonal 
initial segment maintains this polarity by preventing the diffusional mixing of axonal 
and somatodendritic membrane proteins (Nakada et al., 2003). 
 
In summary, the morphological and molecular polarity of neurons reflects the 
different functions of axons and dendrites, with the axon transmitting signals over 
long distances and the extensively branched dendrites receiving and integrating 
signals. 
 
 
1.2 Primary  neuronal  cultures 
Given the complexity of neuronal development, a molecular understanding of 
neuronal polarization requires studying at least part of the process in vitro, where, in 
principle, one can both control the cellular environment and manipulate individual 
neurons. 
 
1.2.1 Characteristics  of  in vitro neuronal cultures 
Several in vitro cell culture techniques have been successfully employed to address 
specific cell biological or functional questions and provide a common means to 
systematically study the complex nervous system (Harry et al., 1998; Saneto and de 
Vellis, 1987; Shahar et al., 1989). Although not considered absolute alternatives to 
in vivo experiments, in vitro methods are invaluable to address specific issues of 
neuronal development in a more isolated context under controlled conditions. In 
principle, the simplification of the culture system allows the dissection and analysis of 
individual aspects of developmental processes which as a whole are too complex to 
scrutinize. 
 
Importantly,  in vitro cultures of embryonic neural tissues such as organotypic 
cultures, re-aggregate cultures, and dissociated primary cell cultures recapitulate 
many aspects of the neural in vivo development, including polarization (Dotti et al., 
1988), maturation (Bartlett and Banker, 1984a; Mains and Patterson, 1973; Seeds 
and Haffke, 1978; Trapp et al., 1979) and synaptogenesis (Bartlett and Banker,     Introduction 
6   Ph.D. Thesis Harald Witte 
1984b; Bornshein and Model, 1972; Trenkner and Sidman, 1977; Yavin and Yavin, 
1977). Moreover, the time course of their development often parallels the one 
displayed by neurons in situ (Kozak, 1977; Mains and Patterson, 1973; Spitzer and 
Lamborghini, 1976; Yavin and Yavin, 1977). 
 
Primary cultures make individual living neurons more easily accessible to both 
manipulation and observation. For instance, neurons can be readily transfected at 
different developmental stages (Kaech and Banker, 2006; Zeitelhofer et al., 2007). 
By this means it is possible to overexpress certain proteins or to knock down the 
expression of specific genes (reviewed in Zeringue and Constantine-Paton, 2004) to 
study their function. Moreover, fluorescently tagged proteins can be introduced to 
explore the subcellular localization and trafficking of proteins inside living neurons 
(Jacobson et al., 2006; Stepanova et al., 2003) or as reporters for intracellular 
processes (Heim et al., 2007; Hüttelmaier et al., 2005). The analysis of neuronal 
cultures prepared from knockout animals in addition offers the possibility to analyze 
the effects of specific gene disruptions. Furthermore, it allows investigating postnatal 
aspects of neural development of knockout animals that die at or shortly after birth 
from systemic defects. 
 
 
1.2.2  Dissociated hippocampal neurons in culture 
Dissociated hippocampal neurons are among the best-characterized model systems 
to study neuronal polarity (Dotti et al., 1988). Since the first description of this system 
by Banker and Cowan (Banker and Cowan, 1977) it has been considerably refined 
(de Hoop et al., 1997; Goslin and Banker, 1991). Dissociated hippocampal neurons 
grow and mature under controlled growth conditions, mainly free of unspecified 
external cues. Although this on the one hand deprives them of their in vivo 
environment it offers on the other hand the chance to study their cell-autonomous 
polarization program. Such insights in turn provide entry points to analyze which 
extracellular signals regulate the intracellular mechanisms underlying polarization. 
Several particularities account for the widespread popularity of dissociated 
hippocampal neurons as a model system. Firstly, the population of nerve cells in the 
hippocampus is relatively homogeneous, with pyramidal cells accounting for     Introduction 
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approximately 90 % of the neurons and interneurons making up the rest (Benson et 
al., 1994). Since hippocampal cultures are routinely prepared from late-stage rodent 
embryos the tissue also contains relatively few ‘contaminating’ glial cells and is easy 
to dissociate. 
 
Secondly, cultured hippocampal neurons reliably polarize in vitro forming one axon 
and several dendrites. Later in development they also mature and form synaptic 
contacts (Bartlett and Banker, 1984a; Bartlett and Banker, 1984b), just like their 
in vivo counterparts. The polarization of cultured hippocampal neurons follows a 
highly stereotyped sequence of developmental events which can be divided into five 
stages (Dotti et al., 1988 see Figure  1-2). Shortly after plating in serum-
supplemented medium, hippocampal neurons attach to the substrate and start to 
form lamellipodia, dynamic membrane ruffles, around their cell body (stage  1). 
Subsequently, after 6-18  hours in culture, the lamellipodia condense to 4-5  short 
processes, the so-called ‘minor neurites’ (stage  2). By this time, the neurons are 
transferred to serum-free medium in culture dishes containing an astrocyte feeder 
layer to promote growth and differentiation (de Hoop et al., 1997). Towards the end 
of stage 2 membrane organelles as well as cytosolic proteins become concentrated 
 
Figure 1-2: Development of dissociated hippocampal neurons in culture 
Dissociated hippocampal neurons develop in culture in a stereotyped manner, recapitulating neuronal 
polarization and maturation. For details see text. Scheme modified from Dotti et al., 1988 and Arimura 
and Kaibuchi, 2007. 
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in one of the – seemingly identical – minor neurites (Bradke and Dotti, 1997). This 
process then starts to grow out quickly to become the axon (stage 3; after 1-1.5 days 
in culture). This first morphological sign of axon formation is a crucial hallmark of 
neuronal polarization, as it marks the initial break in symmetry during neuronal 
development (Craig and Banker, 1994). The remaining processes start to elongate 
with a delay of several days and also grow at a much slower rate to form the cell’s 
dendrites (stage  4; after ~4  days in culture). Axonal and dendritic proteins are 
segregated in stage  4 (Bradke and Dotti, 2000a), indicating the molecular 
polarization of axons and dendrites. By stage 5 (>7 days in culture) the neurons have 
formed functional synaptic contacts and generate electric currents (Bartlett and 
Banker, 1984b; Segal, 1983) – they have now reached functional polarization. 
 
To summarize, preparations of dissociated hippocampal neurons recapitulate 
neuronal polarization in vitro. The decisive step in this process is the formation of the 
axon since it represents the cornerstone for all further polarization events. 
 
 
1.3  Polarity regulation and the neuronal cytoskeleton 
During the last years various molecular regulators of neuronal polarization have been 
identified (reviewed in Arimura and Kaibuchi, 2007). Although these studies have 
largely improved our knowledge about the specific signaling pathways mediating 
neuronal polarity, our understanding of most of the intracellular mechanisms 
underlying neuronal polarization has remained fragmentary. The next sections will 
provide an overview of polarity regulators, their complex interconnections and their 
relation to the neuronal cytoskeleton, a cellular structure crucial for neuronal 
polarization. 
 
1.3.1  Signaling pathways involved in the specification of neuronal polarity 
Phosphoinositide 3-kinase (PI3K) has recently been shown to be a central player in 
the establishment of neuronal polarity (Menager et al., 2004; Shi et al., 2003). PI3K is 
activated by upstream regulators such as Ras (Huang and Reichardt, 2003; Oinuma 
et al., 2007; Yoshimura et al., 2006) or insulin receptor substrate-1 (IRS-1; Yamada     Introduction 
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et al., 1997) in response to stimulation by neurotrophic factors. Active PI3K produces 
the phospholipid phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) at the plasma 
membrane which was reported to promote neurite outgrowth and axon specification 
(Menager et al., 2004). Phosphatase and tensin homologue deleted on 
chromosome  10 (PTEN), in contrast, represents an antagonist of PI3K which 
decreases PIP3 levels at the leading edge of neurites and disrupts the development 
of polarity (Shi et al., 2003). Proteins with pleckstrin homology (PH) domains bind 
PIP3 with high affinity (reviewed in Saraste and Hyvonen, 1995), hence active PI3K 
recruits such factors to the plasma membrane. 
 
For example, the membrane localization of phosphoinositide-dependent protein 
kinase 1 (PDK1; Alessi et al., 1997), integrin-linked kinase (ILK; Oinuma et al., 2007) 
and their target Akt kinase (also called protein kinase B/PKB; reviewed in Cantley, 
2002; Lawlor and Alessi, 2001) depends on PIP3. Elevated PIP3-levels bring Akt, 
PDK1 and ILK into close proximity at the plasma membrane which facilitates 
phosphorylation and thereby activation of Akt (reviewed in Cantley, 2002; Lawlor and 
Alessi, 2001). The expression of constitutively active forms of PI3K or Akt induces the 
formation of multiple axons in cultured hippocampal neurons (Yoshimura et al., 
2006), likely because Akt regulates another key player of neuronal polarization, the 
constitutively active glycogen synthase kinase-3β (GSK-3β). When phosphorylated 
by Akt, GSK-3β is inactivated (Cross et al., 1995). 
 
GSK-3β is implicated in the regulation of neuronal polarization but also a multitude of 
other processes, including the control of metabolism, gene expression, cytoskeletal 
dynamics, intracellular vesicular transport and apoptosis. This variety of functional 
implications reflects its broad spectrum of targets which includes metabolic, signaling, 
and structural proteins (reviewed in Doble and Woodgett, 2003; Grimes and Jope, 
2001; Zhou and Snider, 2005). It is not yet fully understood how a seemingly 
‘promiscuous’ enzyme that has as many proposed substrates as GSK-3β can confer 
signal-dependent specificity. Possible regulatory mechanisms include selective 
activation and inhibition through specific tyrosine and serine phosphorylations, 
binding to scaffolding proteins to facilitate substrate interaction, and targeting of 
GSK-3β to different subcellular localizations (Doble and Woodgett, 2003). Moreover,     Introduction 
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targets of GSK-3β vary in their requirement for pre-phosphorylation by other kinases 
at a ‘priming’ residue to allow phosphorylation by GSK-3β (Fiol et al., 1987). Active 
GSK-3β mainly inhibits its targets (Doble and Woodgett, 2003). During neuronal 
polarization GSK-3β therefore needs to be inactivated (Jiang et al., 2005; Yoshimura 
et al., 2005). Together with adenomatous polyposis coli protein (APC), GSK-3β is 
implicated in targeting partitioning defective 3 (Par-3) to the nascent axon (Shi et al., 
2004). Par-3 is part of the Par-3 / Par-6 / atypical protein kinase C (aPKC) polarity 
complex which provides a link between GSK-3β and Rho GTPases (see below). 
 
Rho GTPases (in full small GTPases of the Rho family) and their effectors are among 
the best-studied regulators of the actin cytoskeleton (reviewed in Govek et al., 2005; 
Witte and Bradke, 2005; see Figure  1-3). They have been implicated in the 
establishment of neuronal polarity (reviewed in Arimura and Kaibuchi, 2007; Govek 
et al., 2005) and a broad variety of other processes, including polarization of other 
cell types, microtubule dynamics, gene transcription, cell cycle progression, and 
vesicle transport (reviewed in Etienne-Manneville and Hall, 2002). 
 
Figure 1-3:  Rho  GTPase 
effectors and cyto-
skeletal dynamics 
Rho GTPases control a 
multitude of effectors to 
modulate the dynamics of 
the actin cytoskeleton and 
microtubules. 
They regulate the 
nucleation and assembly 
of actin filaments, the 
contractility of actomyosin 
and the stabilization of 
microtubules. 
Scheme from Govek et al., 
2005. 
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Rho GTPases cycle between an active GTP-bound and an inactive GDP-bound state 
(Nobes and Hall, 1995); their activity is mainly controlled by guanine nucleotide 
exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine 
nucleotide exchange inhibitors (GDIs; see Figure 1-4). 
 
 
At present more than 20 Rho GTPase have been identified, with RhoA (ras homolog 
gene family, member  A), Cdc42 (cell division cycle  42) and Rac1 (ras-related C3 
botulinum toxin substrate 1) being the most extensively characterized members. In 
neuroblastoma cells, the activation of Cdc42 or Rac1 enhances neurite elongation, 
whereas the activation of RhoA is associated with the inhibition of neurite formation 
(Kozma et al., 1997). In morphologically unpolarized hippocampal neurons, Cdc42 
and another small GTPase, Ras-related protein  1B (Rap1B) localize to a single 
neurite during development, most likely promoting the specification of the future axon 
(Schwamborn and Püschel, 2004). Interestingly, their function depends on PIP3, with 
Rap1B acting upstream of Cdc42, presumably via activating a Cdc42-GEF 
(Schwamborn and Püschel, 2004). The restriction of Rap1B to a single neurite of 
unpolarized cells is mediated by ubiquitin/proteasome-dependent degradation of 
inactive Rap1B in all but one neurite (Schwamborn et al., 2007). Strikingly, 
neurotrophin receptor TrkA (tyrosine receptor kinase A) which is activated at the tip of 
 
Figure 1-4: Regulation of Rho GTPases 
Rho GTPases cycle between an inactive (GDP-bound) and an active (GTP-bound) state (Nobes and 
Hall, 1995) in which they interact with their target proteins (effectors). The Rho GTPase cycle is tightly 
controlled by three types of regulators: (1) Guanine nucleotide exchange factors (GEFs) activate Rho 
GTPases by catalyzing the nucleotide exchange of GDP to GTP. (2) GTPase-activating proteins 
(GAPs) inactivate Rho GTPases by stimulating GTP hydrolysis. (3) Guanine nucleotide exchange 
inhibitors (GDIs) are involved in subcellular targeting of inactive GTPases and controlling the access 
to GEFs and GAPs. All Rho GTPases are essentially prenylated at their C-terminus. Scheme from 
Etienne-Manneville and Hall, 2002.     Introduction 
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growing axons (Da Silva et al., 2005) recruits guanine nucleotide exchange factors of 
Rap1 (York et al., 1998). Rap1 activated in this way may escape the destruction by 
the ubiquitin/proteasome-system and promote axon formation. 
 
Cdc42 also interacts with Par-3 in the aforementioned Par-3 / Par-6 / aPKC polarity 
complex. In this context, Cdc42 mediates the activation of Rac via its guanine 
nucleotide exchange factors STEF/Tiam1 (Nishimura et al., 2005). Active Rac1 
seems able to stimulate PI3K (Keely et al., 1997; Tolias et al., 1995) which closes a 
positive feedback loop consisting of PI3K, PIP3, Rap1B, Cdc42, Par-3 / Par-6 / aPKC 
and Rac1. Such a feedback loop may be able to drive continuous axon outgrowth 
(reviewed in Arimura and Kaibuchi, 2007). An “exit” for such a circle may be provided 
by the PIP3–degrading PTEN or specific GTPase-activating proteins which could 
inactivate either Cdc42 or Rac1. The localized distribution of Rap1B may restrict the 
axon-inducing effect of a positive feedback loop to a single neurite. Consequently, 
overexpression of constitutively active Rap1B or a hyperactivated form of Cdc42 
which overrides the restricted localization induces the formation of multiple axons 
(Schwamborn and Püschel, 2004). 
 
Recent work has shown that also activated c-Jun N-terminal kinase (JNK), so far 
known to be implicated in the regulation of gene transcription, cell death and survival 
(reviewed in Krens et al., 2006), plays a decisive role in axon formation (Oliva et al., 
2006). JNK targets a wide variety of nuclear and cytoplasmic proteins, including 
transcription factors and proteins that regulate the dynamics of actin or microtubules 
(Bjorkblom et al., 2005; Chang et al., 2003; Reynolds et al., 2000; Ricos et al., 1999; 
Yoshida et al., 2004). Interestingly, the JNK pathway seems to interact with several 
other signaling cascades involved in neuronal polarization. JNK, for instance, 
mediates the inhibition of GSK-3β together with Dishevelled, a scaffold protein of the 
Wingless /  INT (WNT)-signaling pathway (Ciani et al., 2004; Ciani and Salinas, 
2007), thus forming a connection to GSK-3β- and WNT-signaling. Along those lines, 
JNK interacting protein 1 (JIP1) associates with p190rhoGEF, an activator of RhoA 
signaling (Meyer et al., 1999), thereby linking JNK and Rho GTPase signaling. 
 
This brief overview already gives an idea about how complex and interconnected the 
signaling network is that regulators of neuronal polarity form. Moreover, the     Introduction 
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described signaling pathways can trigger a multitude of intracellular events, quite 
likely not all of which are involved in axon formation. In this respect, local instability of 
the actin cytoskeleton and enhanced membrane traffic into one minor neurite are 
known to play pivotal roles in axon formation (Bradke and Dotti, 1997; Bradke and 
Dotti, 1999; Jareb and Banker, 1997). As a consequence, efforts have mainly 
focused to establish connections between polarity regulators and the regulation of 
actin dynamics. 
 
 
1.3.2 The  actin  cytoskeleton 
Actin microfilaments consist of two helically twisted strands of filamentous actin 
(F-actin; see Figure 1-5 A, page 14) and are with a diameter of approximately 7 nm 
the thinnest fibers of the cytoskeleton. Regulators of the actin cytoskeleton modulate 
various processes, including ‘de novo’ nucleation of filaments, crosslinking/bundling, 
severing, depolymerization and ADP/ATP exchange to fine-tune the dynamic 
properties of the actin cytoskeleton (Figure 1-5 B; (reviewed in Pollard and Borisy, 
2003). Due to their polar structure actin microfilaments serve as tracks for myosin 
motor proteins which mediate directed transport of organelles and macromolecules 
(reviewed in Krendel and Mooseker, 2005). Myosin motors also drive the transport of 
actin filaments centripetally from the leading edge towards the center of the growth 
cones where actin bundles are depolymerized, a phenomenon called retrograde flow 
(Forscher and Smith, 1988; Lin et al., 1996). 
 
One hallmark of the future axonal growth cone in unpolarized hippocampal neurons 
is a reduced stability of its actin cytoskeleton which may cause a reduction in 
outgrowth obstruction (Bradke and Dotti, 1999). Such local actin instability manifests 
itself in a higher susceptibility of the actin cytoskeleton to extraction using detergents 
(Bradke and Dotti, 1999) and increased dynamics of the growth cone (Bradke and 
Dotti, 1997; Bradke and Dotti, 1999). Regulators of actin dynamics –which may 
mediate such actin instability–are the effectors of several signaling pathways 
involved in axon formation. For instance, neurons treated with toxin B, an inhibitor of 
Rho GTPases (Just et al., 1995) form multiple axons instead of one (Bradke and 
Dotti, 1999), a phenotype that is equally observed upon treatment of neurons with     Introduction 
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cytochalasin  D, an actin destabilizing drug (Bradke and Dotti, 1999; Schwamborn 
and Püschel, 2004). Correspondingly, the active form of actin-depolymerizing factor 
cofilin (see Figure 1-5 B) is enriched in axonal growth cones of hippocampal neurons 
 
Figure 1-5: Actin - Structure and dynamics 
(A) Actin microfilaments consist of two helically intertwined strands of F-actin which is itself composed of 
polymerized subunits of globular actin (G-actin). G-actin subunits are arranged head-to-tail in the actin 
filament which creates two ends with distinct dynamic properties. At the so-called plus- or ‘barbed’ end 
addition of G-actin prevails (i.e. polymerization), making it the faster-growing end. At the minus- or ‘pointed’ 
end loss of subunits, i.e. depolymerization, dominates, it thus grows slowly. Polymerizing G-actin is 
associated with ATP (white subunits) which is then hydrolyzed upon ageing in the filament (yellow 
subunits). Inorganic phosphate (Pi) is released slowly from G-actin (red subunits). 
(B) Simplified actin cycle. Extracellular signaling leads to the activation of WASp/Scar proteins which in turn 
induce actin nucleation and branching by the Arp2/3 complex. Capping proteins terminate polymerization at 
the barbed end of the filament. Formins, in contrast, favor actin polymerization by protecting barbed ends 
from capping proteins. ADF/cofilin –which may be inhibited by PAK and LIM kinase– promotes dissociation 
of the inorganic phosphate, severs ADP-actin filaments and promotes dissociation of ADP-actin from 
filament ends. Profilin catalyzes the ADP/ATP exchange of actin, thereby reconverting ADP-associated 
G-actin to the ATP-bound form. Moreover, profilin sequesters ATP-actin to rapidly release it just upon 
stimulation by WASP/Scar proteins. Scheme modified from Pollard and Borisy, 2003.     Introduction 
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which may account for a local actin instability (Garvalov et al., 2007). Interestingly, 
neurons derived from mice deficient in the Rho GTPase Cdc42 show an increased 
inactivation of cofilin, which thus seems to be a physiological downstream effector of 
Cdc42 in the process of neuronal polarization (Garvalov et al., 2007). Cdc42 itself is 
likely to be regulated by Rap1B (Schwamborn and Püschel, 2004; see section 1.3.1 
above). 
 
Suggesting an involvement of Rac1 in the establishment of neuronal polarity, 
overexpression of T-lymphoma and metastasis 1 (Tiam1) protein, a GEF activating 
Rac1, induces the formation of several axon-like neurites in hippocampal neurons 
(Kunda et al., 2001). Suppression of Tiam1, in contrast, prevents axon formation, 
presumably since neurons fail to reorganize the actin cytoskeleton. This in turn 
blocks the invasion of microtubules into selected growth cones to drive neurite 
outgrowth. Pharmacological destabilization of the actin cytoskeleton can rescue this 
inability, leading to the formation of multiple axons in cells lacking Tiam1 (Kunda et 
al., 2001). 
 
Along those lines, the actin regulator profilin is also involved in the establishment of 
neuronal polarization. Profilin stimulates the ADP/ATP exchange of G-actin (see 
Figure  1-5  B), thus refilling the pool of ATP-associated G-actin which in turn 
promotes actin polymerization (Goldschmidt-Clermont et al., 1992; Kang et al., 
1999). In hippocampal neurons, the brain-specific profilin  IIa mediates actin 
stabilization and inhibits neurite sprouting (Da Silva et al., 2003). Normal neuronal 
polarity can be rescued by actin destabilizing using cytochalasin D (Da Silva et al., 
2003). During neuronal polarization, the inhibition of profilin  IIa via RhoA and its 
downstream effector Rho kinase (ROCK) indirectly promotes such a destabilization of 
the actin cytoskeleton (Da Silva et al., 2003) which allows neurite formation. 
 
In spite of its importance for initial neuronal polarization, the regulation of actin 
dynamics does not seem to be the primary target of all signaling pathways involved 
in axon formation. Several recently discovered pathways, although modulating 
numerous cellular events, seem to have another common denominator: 
The regulation of microtubule dynamics. 
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1.3.3  Microtubules – More than just supporting actors? 
Microtubules are hollow cylinders (about 25  nm in diameter) composed of stable 
heterodimers of α- and β-tubulin (Weisenberg et al., 1968; Figure  1-6  A). These 
α/β-tubulin heterodimers polymerize in a head-to-tail fashion to form polar 
protofilaments (Amos and Klug, 1974), 13 of which form the helical microtubule wall 
(Evans et al., 1985). The two ends of a microtubule show different polymerization 
rates; the faster growing end is designated the plus-end while the slower growing end 
is called the minus-end (Allen and Borisy, 1974; Figure 1-6 B). In most non-neuronal 
cells microtubules are oriented radially with the plus ends extending out from a 
central microtubule organizing center (MTOC) during interphase (Piehl and 
Cassimeris, 2003). However, in neurons the situation is somewhat different: In 
axons, microtubules have been reported to be all oriented with the plus ends 
outward, while microtubules in dendrites may have a mixed polarity (Baas et al., 
1989; Baas et al., 1988). Microtubule ends alternate between prolonged phases of 
polymerization and depolymerization, a phenomenon called ‘dynamic instability’ 
(Mitchison and Kirschner, 1984). The transition from polymerization to 
depolymerization is referred to as ‘catastrophe’, whereas the opposite transition from 
depolymerization to polymerization is referred to as ‘rescue’ (Walker et al., 1991; 
Figure 1-6 C). 
 
The assembly, dynamics and organization of microtubules is regulated by a variety of 
microtubule-associated proteins (MAPs; for detailed review see Cassimeris and 
Spittle, 2001). Specific MAPs stabilize microtubules, for instance by stimulating the 
addition of tubulin subunits to the microtubule polymer, by blocking catastrophes, or 
by promoting rescue events. Stabilization is also achieved by cross-linking 
protofilaments (Chapin and Bulinski, 1992; Gustke et al., 1994) or bundling of 
microtubules (Kanai et al., 1992; Masson and Kreis, 1993; Preuss et al., 1997). On 
the other hand, some MAPs destabilize microtubules by promoting catastrophes and 
inhibiting rescues, by severing microtubules, sequestering tubulin subunits and 
weakening lateral interactions between protofilaments (see Cassimeris and Spittle, 
2001). Most MAPs are rendered inactivate by phosphorylation, e.g. by 
MAP/microtubule affinity regulating kinases (MARKs; Trinczek et al., 1995), GSK-3β 
(Zumbrunn et al., 2001) or JNK (Yoshida et al., 2004).     Introduction 
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α/β-tubulin heterodimers are subject to various post-translational modifications 
including acetylation/deacetylation, tyrosination/detyrosination, generation of Δ2-
tubulin, polyglutamylation, polyglycylation, palmitoylation and phosphorylation 
(reviewed in Westermann and Weber, 2003). Mainly, the carboxy-terminal tails of 
tubulin are modified. As yet, the functions of most posttranslational tubulin 
modifications have remained rather elusive. Some modifications are used as markers 
for microtubule longevity (reviewed in Westermann and Weber, 2003). For instance, 
 
Figure 1-6: Microtubules – Structure and dynamics 
(A) Heterodimers of α- and β-tubulin are the building blocks of microtubules. Both α- and β-tubulin 
bind one molecule of guanine nucleotide (Weisenberg et al., 1968). α-tubulin is associated with GTP 
which is neither exchanged nor hydrolyzed. The helical microtubule wall typically consists of 
13 parallel protofilaments (A) with each turn of the helix spanning 3 tubulin monomers (B, see Desai 
and Mitchison, 1997; Mandelkow et al., 1986). This arrangement results in a lattice seam on one side 
of the microtubule wall (B, red dashed line). Presumably, the structure of the microtubule is 
determined by the γ-tubulin ring complex (γ-TURC) at the MTOC. Microtubules are nucleated by the 
binding of α/β-tubulin heterodimers to the γ-tubulin ring complex and start elongating by the addition of 
dimers at the plus-end (for review see Raynaud-Messina and Merdes, 2007). The binding, hydrolysis 
and exchange of GDP/GTP on the β-tubulin monomer is the driving force for switching between 
polymerization (assembly) and depolymerization (disassembly) of microtubules (C), yet it is not 
required for microtubule assembly itself (Hyman et al., 1992). Scheme modified from Akhmanova and 
Steinmetz, 2008. 
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acetylation of α−tubulin or enzymatic removal of its C-terminal tyrosine residue 
(detyrosination) gradually occurs in the microtubule polymer and is therefore found in 
long-lived, stable microtubules, i.e. microtubules with a low turnover which undergo 
few catastrophic events. In contrast, the presence of tyrosinated α−tubulin in 
microtubules which has not undergone detyrosination yet, denotes a recent 
assembly, i.e. tyrosinated α−tubulin is found in dynamic microtubules with a high 
turnover. 
 
The intrinsic polarity of microtubules qualifies them as well-suited tracks for directed 
intracellular transport. Using various microtubule-dependent motor proteins of the 
kinesin and dynein superfamilies, cells specifically transport macromolecules, 
vesicles and organelles along microtubules (reviewed in Goldstein and Yang, 2000; 
Vale, 2003). Apart from few exceptions, most kinesins move toward the plus-ends of 
microtubules. By contrast, all dyneins discovered so far target microtubule minus-
ends. It is still not fully understood how neurons achieve compartment-specific 
transport to axons and dendrites, but selective delivery, retention and vesicle fusion 
(reviewed in Tang, 2001), target-specific motor proteins (Setou et al., 2000) and 
posttranslational modifications of microtubules (Reed et al., 2006) seem to be 
involved in regulating this process. 
 
In the context of neuronal polarization, microtubules have drawn little attention only. 
That is somewhat surprising since microtubules are necessary for process formation 
in neuronal and non-neuronal cells (Daniels, 1972; Edson et al., 1993; Joshi et al., 
1985), growth cone steering (Buck and Zheng, 2002; Suter et al., 1998) as well as 
migration of neuronal (Rakic et al., 1996) and non-neuronal cells (Kole et al., 2005; 
Liao et al., 1995). Microtubules have mostly been considered to be passive players 
controlled by actin restraint (Forscher and Smith, 1988; Suter et al., 1998; Waterman-
Storer and Salmon, 1997; also see section 1.3.2 above). 
 
Recently, a growing number of studies has identified polarity regulators that appear 
to act through processes independent of actin dynamics, including synapses of 
amphids defective (SAD) kinases (Kishi et al., 2005), collapsin response mediator 
protein 2 (CRMP-2; Inagaki et al., 2001) and GSK-3β (Jiang et al., 2005; Yoshimura     Introduction 
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et al., 2005). This underscores the notion that additional intracellular mechanisms 
underlie neuronal polarization. Although these non-actin regulating proteins are 
involved in multiple processes, one common denominator appears to be their direct 
or indirect involvement in the control of microtubule dynamics. GSK-3β, for example, 
a multitarget protein kinase regulating many metabolic, signaling, and structural 
proteins (reviewed in Doble and Woodgett, 2003) is involved in the establishment 
and maintenance of neuronal polarity (Jiang et al., 2005; Yoshimura et al., 2005). 
Among its many functions GSK-3β also modulates microtubule dynamics, e.g. by 
phosphorylating MAPs (Doble and Woodgett, 2003; Goold et al., 1999), whose 
binding to microtubules is essential for neurite formation (Caceres and Kosik, 1990). 
It is worth noting that some MAPs, including adenomatous polyposis coli protein 
(APC), are inhibited by GSK-3β phosphorylation while others, including MAP1B, are 
activated (Doble and Woodgett, 2003; Goold et al., 1999). Consistent with the 
complex effects on MAPs, GSK-3β can either support or inhibit axonal growth 
depending on the extent of its inhibition (Kim et al., 2006). Overexpression of 
CRMP-2, another target of GSK-3β implicated in the regulation of microtubule 
dynamics and endocytosis, induces multiple axons in later developmental stages, 
suggesting a role for CRMP-2 in axon formation and maintenance (Inagaki et al., 
2001). Another example are the SAD kinases, homologs of the conserved Par-1 
serine/threonine kinase which acts in a variety of polarity events in species ranging 
from nematodes and flies to mammals (reviewed in Wodarz, 2002). SAD kinases are 
required for neuronal polarization (Kishi et al., 2005) and modulate presynaptic 
vesicle clustering (Crump et al., 2001) but also phosphorylate MAPs (Kishi et al., 
2005). Recent work also suggests a role for activated JNK, so far known to be 
implicated in the regulation of gene transcription, cell death and survival (reviewed in 
Bogoyevitch and Kobe, 2006) in axon formation (Oliva et al., 2006). JNK target 
microtubule associated proteins —among a wide variety of other nuclear and 
cytoplasmic proteins, including transcription factors and actin regulating proteins 
(Bjorkblom et al., 2005; Chang et al., 2003; Reynolds et al., 2000; Ricos et al., 1999; 
Yoshida et al., 2004). 
 
In summary, several identified regulators of neuronal polarity appear to indirectly or 
directly act on microtubules. Therefore the possibility arises that, in addition to the     Introduction 
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well-established function of the actin cytoskeleton, microtubules may play a pivotal 
role in axon formation. 
 
 
1.4  Objectives of this study 
Despite the wealth of polarity regulators identified in the past years our knowledge 
regarding the intracellular mechanisms that establish neuronal polarization has 
remained fragmentary. While efforts so far mainly have focused on the role of the 
actin cytoskeleton in axon formation, the task of microtubules in the establishment of 
neuronal polarity has remained unclear and is still poorly understood. The work 
presented in this thesis therefore aims to characterize the role of microtubules in 
neuronal polarization. To this end I addressed the following issues: 1) How do 
microtubule dynamics and stability change during initial neuronal development? 2) 
Do microtubules play an instructive role in axon formation? 3) What are possible 
regulators mediating changes in microtubule dynamics during axon formation? 
I report here that the future axon has more stable microtubules in its shaft, and that 
stabilization of microtubules is sufficient to induce axon formation. The data shows 
that microtubules and the regulation of their stability play an instructive role in the 
initial polarization of neuronal cells. 
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2. Results 
2.1  Microtubule turnover in neuronal cells 
Previous studies have yielded divergent results concerning the distribution of long-
lived, stable microtubules in developing neuronal cells (Arregui et al., 1991; Dotti and 
Banker, 1991), leaving it unclear whether microtubule turnover was different in axons 
and minor neurites. As an entry point to study the role of microtubules in initial 
neuronal polarization the differential distribution of microtubule turnover in neurons 
was reanalyzed. To that end cultured rodent hippocampal neurons (Dotti et al., 1988) 
were used as a model system. 
 
Some posttranslational modifications of α−tubulin are a good read-out for turnover of 
microtubules (see section 1.3.3 on page 17), therefore acetylation and tyrosination 
levels of α−tubulin were used as markers for stable and dynamic microtubules, 
respectively (reviewed in Westermann and Weber, 2003). While acetylated α−tubulin 
is confined to microtubules, tyrosinated α−tubulin is found both polymerized in 
microtubules and unpolymerized in the cytoplasm. To remove unpolymerized tubulin 
subunits, i.e. to assess polymerized microtubules only, cells were extracted during 
fixation. Thereafter, cells were stained for different posttranslational modifications of 
α−tubulin and their distribution evaluated. 
 
 
2.1.1  Microtubule turnover is decreased in axons 
To examine potential differences in the microtubule turnover of axons and minor 
neurites, morphologically polarized neurons (stage 3) were scrutinized. Expectedly, 
tyrosinated microtubules were predominant in the growth cones of all processes 
regardless of their identity, reflecting their dynamic state required for steering and 
extension (Tanaka et al., 1995; Figure 2-1 C, D). 
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When we analyzed fluorescence recovery after photo-bleaching (FRAP) using 
neurons transfected with α-tubulin fused to GFP, we found that the GFP signal 
recovered faster in the growth cone compared to the axonal shaft. This reinforces the 
concept of a high turnover of microtubules in the growth cones (Figure 2-2). 
 
The axonal shaft of stage 3 neurons (Figure 2-1 A), however, showed an enrichment 
of stable acetylated microtubules compared to the shafts of minor neurites in 
83.5±1.0% of the cases (mean±SEM; n=709 neurons from 3 independent 
experiments; Figure 2-1 B, D). On average of all stage 3 neurons, the axonal shaft 
showed a 3.2-fold ±0.5 ratio increase of the fluorescence intensities of acetylated 
versus tyrosinated microtubules compared to the shafts of minor neurites 
(Figure  2-1  I; n=106 neurons from 3 independent experiments; p-value<0.001 by 
t-test). 
 
 
 
 
Figure  2-1: Differential distribution of acetylated and tyrosinated microtubules in polarized 
hippocampal neurons 
(A-D) Polarized stage  3 rat hippocampal neurons stained for acetylated (B) and tyrosinated (C) 
α−tubulin (arrow, axon; arrowheads, minor neurites). Cells were permeabilized during fixation to 
remove unpolymerized tubulin subunits, therefore only tubulin incorporated in microtubules is 
assessed. In stage  3 neurons, a high ratio of acetylated to tyrosinated α-tubulin is found in 
microtubules in the axonal shaft (D, arrow) in comparison to microtubules of minor neurites (D, 
arrowheads, and E). Scale bar: 20 µm. 
(E) Ratio quantification of fluorescence intensities of acetylated and tyrosinated α-tubulin in 
microtubules of stage  3 neurons (mean±SEM; n>105 neurons from 3 independent experiments; 
***, p-value<0.001 by t-test). Values are normalized to the mean of non-axonal processes.     Results 
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2.1.2  A reduction of microtubule turnover precedes axon formation 
The above analysis had shown a correlation between axonal identity and reduced 
microtubule turnover in the axon. The next question was when this change in 
microtubule dynamics occurs: Is it a consequence of axon formation itself or does it 
happen already before the establishment of the axon? 
 
For detailed analysis of the microtubule turnover in stage 2 neurons (Figure 2-3 A), 
the ratios of acetylated to tyrosinated α−tubulin in the medial part of all neurites of a 
cell were measured and compared using the Hampel outlier test. In 35.0±6.1% of all 
stage 2 neurons one neurite had singled out and exhibited a significantly higher ratio 
of acetylated to tyrosinated α−tubulin than the remaining neurites (Figure 2-3 B-D, 
arrowhead with asterisk; F, arrow; G; p-value<0.05 by Hampel outlier test, n=107 
Figure  2-2: Growth cones display 
higher microtubule turnover than 
neurite shafts 
(A) Rat hippocampal neuron (2 days 
in vitro), transfected with α−tubulin-
GFP. 
(B) Panels  1 to 4 show a higher 
magnification of the area boxed in 
(A). The signal of α-tubulin GFP was 
simultaneously bleached in two 
regions in the growth cone and the 
neurite shaft (arrows) and 
fluorescence recovery was followed 
afterwards. 
Scale bars: 20 µm (A); 5 µm (B). 
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neurons from 3 independent experiments). On average of all stage 2 neurons, the 
ratio of acetylated vs. tyrosinated α−tubulin was increased 1.9-fold ±0.3 in the minor 
neurite with the highest ratio compared to the average of the other neurites 
(p-value<0.001 by t-test; Figure 2-3 E) and also significantly different from the neurite 
with the second-highest ratio alone (p-value<0.001 by t-test). The increase of the 
 
Figure 2-3: Differential distribution of acetylated and tyrosinated microtubules in unpolarized 
hippocampal neurons 
(A-D) Morphologically unpolarized stage 2 rat hippocampal neurons stained for acetylated (B) and 
tyrosinated (C) α-tubulin (compare Figure  2-1; arrowheads, minor neurites). In 35.0±6.1% of 
morphologically unpolarized stage 2 neurons, the ratio acetylated/tyrosinated α-tubulin is significantly 
increased in one of the minor neurites (D, white arrowhead with asterisk) (p<0.05 by Hampel outlier 
test). The areas boxed in (D) are shown in higher magnification in panels (F) and (G). Scale bars: 
20 µm. 
(E) Ratio quantification of fluorescence intensities of acetylated and tyrosinated α-tubulin in 
microtubules of stage  2 neurons (mean±SEM; n>105 neurons from 3 independent experiments; 
***, p-value<0.001 by t-test). Values are normalized to the mean of non-maximal processes. 
(F-I) Higher magnification (F, G) and profiles of immunofluorescence intensity (arbitrary units) (H, I) of 
acetylated (green channel) and tyrosinated (red channel) α-tubulin of the neurites marked in (D). Scale 
bars: 10 µm. 
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ratio was due to a relative increase of acetylated α−tubulin over tyrosinated or total 
α−tubulin within the process (Figure  2-3  H, I) and indicates that microtubule 
stabilization in one neurite precedes axon formation in morphologically still 
unpolarized cells. 
 
 
2.1.3  Differences in posttranslational modifications reflect an actual stability 
difference of microtubules 
Posttranslational modifications of microtubules are widely used as markers for 
microtubule dynamics and stability (reviewed in Westermann and Weber, 2003). 
Altered microtubule dynamics, however, are not a result of the modifications 
themselves (Khawaja et al., 1988). Therefore the next step was to address whether 
the observed differential distribution of posttranslational modifications reflects an 
actual stability difference of microtubules in axons and minor neurites. 
To assess their stability microtubules were partially depolymerized by treatment with 
the microtubule destabilizing drug nocodazole (Hoebeke et al., 1976) and their 
retraction at the distal end of processes was examined. To this end unpolarized cells 
(stage 2;  1 day  in vitro (DIV)) and polarized cells (stage  3; 2  DIV) grown on a 
coverslip containing a relocation grid were located, imaged (Figure 2-4 A,C,E,G) and 
treated with 3.3-5µM  nocodazole for 5  mins. Subsequently, cells were fixed and 
simultaneously extracted to remove tubulin monomers. Then α-tubulin was labeled to 
assess microtubules and F-actin to better visualize the outline of the cells. 
 
In 81.8±5.9% (n=119 neurons from 5 independent experiments) of polarized neurons 
(stage 3), briefly treated with nocodazole for 5 min, microtubules of minor neurites 
retracted more than axonal microtubules (Figure  2-4  C, D, I;  7.6±0.9 µM  and 
11.9±0.8 µM in axons and minor neurites, respectively; p <0.001 by t-test). Treatment 
with vehicle (DMSO; Figure 2-4 A, B, E, F) showed no effect, microtubules extended 
close to the distal end of all processes (Figure  2-4  B, F). Thus, the differential 
distribution of posttranslational modifications also reflects an actual stability 
difference of microtubules in axons compared to minor neurites. 
 
     Results 
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(I and J) Microtubule retraction after nocodazole treatment in polarized stage 3 (I) and morphologically 
unpolarized stage 2 (J) neurons (mean±SEM; n=119 and 50 neurons from five and three independent 
experiments, respectively; ***, P<0.001 by t-test). 
 
Similar to polarized neurons, morphologically unpolarized neurons (stage 2) showed 
a distinct difference between microtubule retraction in one neurite compared to the 
remaining neurites (3.1±0.7 µM and 9.9±1.0 µM, respectively; n=50 neurons from 3 
independent experiments; p-value<0.001 by t-test; Figure 2-4 G, H, J; compare with 
control neurons in Figure 2-4 E, F), thus suggesting an early polarization of stabilized 
microtubules during neuronal development. 
 
Doublestaining for acetylated and tyrosinated α-tubulin revealed that microtubules 
which resisted depolymerization were acetylated (Figure  2-5  A, B, D), whereas 
tyrosinated microtubules had vanished after nocodazole treatment (Figure 2-5 A, C, 
D). This is in agreement with previous studies (e.g. Baas and Black, 1990) and 
Figure 2-4: Stable microtubules are enriched in axons 
(A-H) To consider actual differences in microtubule stability 
only, microtubules (green) were partially depolymerized by 
treatment with nocodazole and their retraction from the distal 
end of the processes toward the cell body was examined (see 
I and J). Arrows, axons; arrowheads, minor neurites. F-actin 
(red) outlining the neuron was used as a reference point for 
measuring microtubule retraction. In DMSO-treated control 
cells, microtubules reach close to the distal end of both axon 
(B, arrow) and minor neurites (B and F, arrowheads). In 
nocodazole-treated cells, microtubules of minor neurites 
retract toward the cell body (D and H, arrowheads). 
Microtubules in the axon of stage 3 cells (D, arrow) and in one 
of the minor neurites of stage  2 cells (H, arrowhead with 
asterisk) are more resistant to depolymerization.     Results 
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confirms that acetylation and tyrosination of microtubules are indeed markers for 
microtubule stability. The ratio of acetylated to tyrosinated microtubules was 
subsequently used to rate microtubule stability. 
Taken together, these results indicate that the axon of stage  3 neurons and one 
minor neurite of a subpopulation of stage  2 neurons show markers of lower 
microtubule turnover. Moreover, these differences in posttranslational modifications 
reflect a stability difference of microtubules in morphologically polarized and 
unpolarized neurons. 
 
 
2.2  Microtubule turnover is changed in neurons whose polarity is 
affected by manipulation of polarity regulators 
In recent years a number of molecular players has been identified which are involved 
in the regulation of neuronal polarity (reviewed in Arimura and Kaibuchi, 2007). To 
assess whether such regulators potentially affect microtubule turnover in polarizing 
 
Figure 2-5: Microtubule stability and posttranslational modifications of α-tubulin 
Polarized rat hippocampal neurons with one axon (arrow) and several minor neurites (arrowheads) 
after 2 DIV before (A) and after (B-D) treatment with nocodazole (5 µM for 5 min). Tyrosinated (C; D, 
red channel) and acetylated (B; D, green channel) microtubules are assessed. Scale bar: 20 µm. 
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neurons two examples with opposing polarity phenotypes –formation of multiple 
axons and loss of polarity– were analyzed. 
 
2.2.1  Microtubule turnover is reduced in supernumerary axons induced by 
inhibition of GSK-3β 
First, the relation of microtubule turnover and GSK-3β, one of the central regulators 
of neuronal polarity, was investigated. Inhibition of GSK-3β has been reported to 
induce the formation of multiple axons (Jiang et al., 2005; Yoshimura et al., 2005) 
and therefore provided a means to analyze a multiple axon-phenotype. In this study, 
the GSK-3β inhibitor SB415286 (Meijer et al., 2004 and references therein) was 
used. 
 
Figure 2-6: Supernumerary axons induced by inhibition of GSK-3β show increased microtubule 
stability 
(A, B) Rat hippocampal neurons grown in the presence of GSK-3β inhibitor SB 415286 for 72h (A) 
and 24h (B) (arrow, axon; arrowheads, minor neurites; arrowheads with asterisk, neurite with 
increased microtubule stability). Scale bars: 20 µm 
(C) Ratio quantification of fluorescence intensities of acetylated and tyrosinated α−tubulin in 
microtubules of unpolarized stage 2 neurons. The normalized average ratio of the 5 longest neurites is 
shown (mean±SEM; n>50 neurons per condition and time point from 3  independent experiments; 
*, p<0.05 by t-test). 
(D) Rat hippocampal neurons (3  DIV) treated with the GSK-3β inhibitor SB  415286 (10-20  µM; 
treatment 6-8  hours after plating) formed 2.1±0.1 axons on average. These supernumerary axons 
show an increased ratio of acetylated to tyrosinated α−tubulin, equal (p>0.35 by t-test) to that of the 
single axon of stage 3 control neurons (treatment 0.04% DMSO) (mean±SEM; n>35 neurons from 
3 independent experiments).     Results 
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After 3 DIV, rat hippocampal neurons grown in the presence of SB415286 (10-20 µM; 
applied 6-8 h after plating), had developed 2.1±0.1 axons, based on morphology and 
the presence of the axonal marker Tau-1. The stability of microtubules in the 
supernumerary axons was assessed by measuring the ratio of stable versus dynamic 
microtubules. Interestingly, additional axons induced by inhibition of GSK-3β showed 
an enrichment of acetylated microtubules similar to wild type axons (Figure 2-6 A, D; 
compare to Figure 2-1 D). 
These data indicate that inhibition of GSK-3β causes an increase of microtubule 
stability along with the formation of multiple axons. 
 
 
2.2.2 Inhibition of GSK-3β leads to microtubule stabilization before axon 
formation 
The next question was now whether this increase in microtubule stability occurred 
before or as a consequence of the axon formation induced by inhibition of GSK-3β. 
To address this issue a time-course experiment was conducted. Cells grown in the 
presence of SB415286 were fixed at certain time points after applying the GSK-3β 
inhibitor and their microtubule stability was assessed. An increase in microtubule 
acetylation in several minor neurites (Figure 2-6 B,  arrowheads  with  asterisk) 
preceded the formation of multiple axons in morphologically still unpolarized stage 2 
neurons treated with SB415286. To quantify this effect, the ratio of stable versus 
dynamic microtubules was determined for all processes; then the average of the five 
longest processes was formed since the analyzed neurons (stage 2) had not formed 
an axon yet (Figure  2-6  B). Approximately 5h after treatment with SB  415286, 
stage  2 neurons showed a trend towards increased microtubule acetylation 
(+23.0±10.6%), indicating a raise in microtubule stability (Figure 2-6 C). This increase 
was significant after ~8h (+47.4±8.7%; mean±SEM; p<0.05 by t-test). 
 
Taken together, these data suggest that GSK-3β affects microtubule turnover in 
polarizing neurons. Moreover, an induction of microtubule stabilization by inhibition of 
GSK-3β seems to occur already in stage 2 neurons before axon formation. 
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2.2.3  Polarization of microtubule stability is lost in SAD A / SAD B knockout 
neurons 
For comparison to a multi-axonal phenotype neurons from mice deficient in the 
PAR-1 homologs sad-a and sad-b ( sad-a
-/-;  sad-b
-/-, further on called SAD  A/B
-/-) 
were analyzed. SAD A/B knockout neurons show a polarity defect and lack a mature 
axons. In contrast, they generate multiple processes of similar length that are without 
a clear identity, containing both the dendritic marker MAP2 as well as the axonal 
marker Tau-1 (Kishi et al., 2005). 
 
Figure 2-7: Loss of neuronal polarity in SAD A/B knockout neurons is associated with loss of 
polarized microtubule stability 
(A, B) Hippocampal neurons (3 DIV) derived from mice deficient for SAD A and SAD B kinase show 
disturbed polarity, lacking a defined axon. Instead, SAD  A/B knockout neurons form multiple 
processes of similar length and uniform tubulin acetylation levels (see (C)), yet a high cell-to-cell 
variability. Scale bars: 20 µm 
(C)  Ratio quantification of fluorescence intensities of acetylated and tyrosinated α−tubulin in 
microtubules. Processes of SAD  A
-/-B
-/- neurons are short of the specific enrichment of acetylated 
microtubules in one process found in wild type neurons as well as littermate control neurons 
(SAD A
+/+B
+/-) (mean±SEM; n=66 and 27 neurons from 3 independent experiments for SAD A
-/- SAD 
B
-/- and control, respectively). Note that the acetylation/tyrosination ratio varies slightly in control cells 
between species (rat vs. mouse) (C, D). 
(D) Ratio of the acetylation/tyrosination ratios of the longest versus second longest process per cell for 
SAD A
-/-B
-/- and control neurons (mean±SEM; ***, p<0.001 by t-test).     Results 
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SAD A/B kinase double knockout neurons lacked the specific enrichment of stable, 
acetylated microtubules in a single process found in wild type neurons as well as 
littermate control cultures (Figure 2-7 A-C), indicating a loss of polarized microtubule 
stability. Some of these neurons have neurites with microtubules acetylated to a 
similar extent as in axons, whereas the majority has an acetylation level that 
resembles minor neurites. Despite this cell-to-cell variation (Figure  2-7  A, B), 
however, acetylation levels were mostly uniform within a given cell. The 
acetylation/tyrosination ratio of the longest versus the second longest neurite per cell 
was not significantly different in SAD  A
-/- B
-/- neurons (1.09±0.03; p-value>0.25 by 
t-test) while control neurons show a clear distinction (2.06±0.05; p-value<0.01 by 
t-test; Figure  2-7  D). Thus, specific alterations of neuronal polarity, including the 
formation of supernumerary axons or a loss of polarity, correlate with characteristic 
changes in microtubule stability. 
 
In summary, these results show that specific alterations of neuronal polarity correlate 
with characteristic changes in microtubule turnover. Moreover, they suggest that the 
analyzed polarity regulators act via the modulation of microtubule stability. 
 
 
2.3  Moderate microtubule destabilization selectively reduces the 
formation of minor neurites 
SAD kinases and GSK-3β can act upstream of microtubule dynamics by controlling 
the affinity of microtubule-associated proteins (Jiang et al., 2005; Kishi et al., 2005; 
Yoshimura et al., 2005) that are known microtubule stability modulators, yet they 
have various other cellular functions including the regulation of metabolism, 
signaling, gene transcription and endocytosis (Crump et al., 2001; Grimes and Jope, 
2001). This abundance of putative regulatory mechanisms raised the question 
whether the observed differences in microtubule turnover between axons and minor 
neurites play a direct role in polarization. If microtubule stability is critical in 
distinguishing future axonal and dendritic fate, manipulations of microtubule 
dynamics should affect polarization. 
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To test this assumption neurons were cultured in the presence of the microtubule 
destabilizing drug nocodazole (Hoebeke et al., 1976) at low concentrations (15-
75 nM) which moderately increase the catastrophe rate of microtubules (Vasquez et 
al., 1997). Nocodazole was added to the medium after 1 DIV and cells were further 
cultured in the presence of the drug. After 3 DIV, cells were fixed and stained for the 
axonal marker Tau-1. 
 
 
Figure 2-8:  Moderate microtubule destabilization selectively blocks the formation of minor 
neurites 
(A-D) Rat hippocampal neurons (3  DIV) cultured in the presence of various low concentrations of 
nocodazole or 0.02% DMSO (treatment after 1 DIV), stained for Tau-1 (B, D). Scale bars: 20 µm. 
(A, B) Control neurons have formed one axon (A, arrow) with the typical Tau-1 gradient towards its 
distal part (B, arrow) and several Tau-1-negative minor neurites (arrowheads). 
(C, D) The number of minor neurites (arrowheads) is reduced under growth conditions which slightly 
destabilize microtubules, however, neurons are still able to form an axon (arrow). 
(E) Nocodazole reduces the number of minor neurites formed in a concentration-dependent manner 
(neurites per cell: 4.0±0.1, 3.6±0.1, 2.6±0.1, and 2.2±0.2 for 0.02%  DMSO, 15, 45 and 75  nM 
nocodazole, respectively; p-value<0.001 by ANOVA; n>750 neurons from 3 independent experiments 
per condition). 
(F) Neurite extension is not blocked by low concentrations of nocodazole. Total neurite length 
increased from day 1 to day 3 under all conditions (n>275 neurons per condition from 3 independent 
experiments; p-value<0.001 by t-test). Data is presented as mean±SEM.     Results 
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In control cells, the average number of processes almost doubled from day  1 
(2.2±0.2 processes per cell) to day  3 in vitro  (4.0±0.1 processes per cell; 
p-value<0.001 by ANOVA; Figure  2-8  E), reflecting the formation of an axon and 
several minor neurites (Figure  2-8  A,  B). Cells grown in the presence of low 
concentrations of nocodazole were able to form and extend an axon likewise 
(Figure 2-8 C, D, arrow). The number of minor neurites, however, was significantly 
reduced in nocodazole-treated neurons (Figure 2-8 C, D,  arrowhead;  E).  This 
reduction was not due to a general growth inhibition by nocodazole (Figure 2-8 F) but 
caused by the development of many neurons with just one or two processes 
(Figure 2-8 C-E).  Total  neurite length increased from day 1 to day  3 under all 
conditions (p-value<0.001 by t-test), however, to a lesser extent when treated with 45 
or 75  nM nocodazole (increase from 57.5±7.8 µm  to  255.8±9.7 µm,  209.3±8.6 µm 
and 130.3±3.6 µm for 0.02% DMSO, 45 or 75 nM nocodazole, respectively; n>275 
neurons per condition from 3 independent experiments). Interestingly, the extension 
of the axon was not impaired in contrast to minor neurites (132.1±6.1  µm and 
134.0±14.7  µm for 0.02%  DMSO and 45  nM nocodazole, respectively; p>0.5 by 
t-test;  Figure 2-8 F).  Expectedly,  higher  concentrations of nocodazole started to 
inhibit axonal outgrowth as well (Figure 2-8 F). Taken together, the data suggest that 
the future axon is able to overcome moderate microtubule destabilizing conditions 
while the outgrowth of minor neurites is impaired. 
 
 
2.4  Microtubule stabilization is sufficient to induce axon formation 
Since increased microtubule stability seemed to allow the axon to overcome 
microtubule destabilizing conditions it was interesting to assess whether microtubule 
stabilization itself is sufficient to induce axon formation. To address this question 
hippocampal neurons were treated after 1 DIV with the microtubule-stabilizing drug 
taxol (Schiff et al., 1979; Schiff and Horwitz, 1980) for various durations. Previous 
studies (e.g. Dehmelt et al., 2003; Schwamborn and Püschel, 2004) had used high 
concentrations of taxol (>100 nM) which render microtubules completely static and 
result in a block of neurite formation. In contrast, this study used low concentrations 
of taxol (3-10 nM) that favor microtubule polymerization (Derry et al., 1995) yet do not 
completely block microtubule dynamics.     Results 
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2.4.1 Microtubule  stabilization promotes neurite outgrowth 
Taxol-treated neurons showed a drastic increase in neurite outgrowth 
(Figure 2-9 A, E; Figure 2-10 A). The number of processes per cell exceeding 60 µm, 
a morphological characteristic of early axons, had increased more than 2-fold in the 
presence of low concentrations of taxol (3-10 nM) for 2 days in comparison to control 
neurons (Figure 2-9 A, C, E). 
Taxol-induced processes showed a high ratio of acetylated to tyrosinated α−tubulin 
resembling axonal characteristics (Figure 2-10 B; compare to Figure 2-1 D) and were 
 
Figure 2-9: Taxol-induced microtubule stabilization triggers the formation of multiple axons 
(A-D) Rat hippocampal neurons (3 DIV) grown in the presence of low concentrations of taxol (3 nM) 
or DMSO (treatment after 1 DIV), stained for the axonal marker Tau-1. 
Taxol induces the formation of multiple elongated processes (A, arrows) positive for Tau-1 
(B, arrows). Control neurons (C, D) have formed one axon (arrow) and several minor neurites 
(arrowheads). Scale bars: 20 µm. 
(E) The number of neurites longer than 60  µm is increased after 2 days of taxol-treatment 
(mean±SEM; p-value<0.001 by t-test; n>170 neurons per condition from 3 independent experiments 
per condition). DMSO (0.02%): vehicle; Cyto.D (1 µM Cytochalasin D): positive control (Bradke and 
Dotti, 1999). 
(F) The number of cells with two or more Tau-1-positive processes increases in a concentration-
dependent manner in taxol-treated neurons (mean±SEM; p-value<0.001 by ANOVA; n>800 neurons 
per condition from at least 3 independent experiments). 
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indistinguishable from axons in terms of their microtubule stability (Figure 2-10 C-F; 
compare to Figure 2-4). 
 
Still, with the low taxol concentrations used tyrosinated microtubules prevailed in the 
growth cones of these processes (Figure 2-10 B),  indicating  that  microtubule 
dynamics were not completely abolished. In contrast, higher taxol concentrations 
blocked microtubule dynamics and axonal growth completely (Dehmelt et al., 2003). 
 
 
 
Figure 2-10:  Taxol induces the formation of axon-like processes with reduced microtubule 
turnover and increased stability 
(A, B) Taxol-treated rat hippocampal neurons (3 DIV, treatment with 3 nM taxol after 1 DIV). Taxol-
induced processes (A, arrows) show an increased ratio of acetylated (green channel) to tyrosinated 
(red channel) α-tubulin like axons (B, arrows; compare to Figure 2-1 D). Scale bar: 50 µm. 
(C-F) Taxol-treated rat hippocampal neurons (2 DIV, treatment with 10 nM taxol after 1 DIV). On day 2 
in vitro, cells had formed multiple axon-like processes (A-D, arrows). Microtubule stability was 
assessed as before by partial depolymerization using nocodazole (see Figure 2-4 and section 5.2.1.5 
in Materials and Methods). Only little retraction of microtubules (D, F, green channel) with respect to 
the actin cytoskeleton (E, F, red channel) occurred in the taxol-induced processes as observed in the 
overlay (F, arrows) (7.5±1.8µm; n=67 neurons from 3  independent experiments). This retraction 
distance did not differ significantly from the one seen for axons (7.6±0.9 µm; p-value>0.1 by t-test) but 
was significantly shorter than the distance of retraction displayed by minor neurites (11.9±0.9 µm; 
p-value<0.001 by t-test). Scale bars: 20 µm. 
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2.4.2  Taxol-induced processes show axonal characteristics 
Taxol-induced processes also showed other typical axonal features. After 3 DIV the 
number of cells with two or more processes positive for the axonal marker Tau-1 was 
increased 4-fold in taxol-treated neurons compared to control neurons (Figure 2-9 B, 
D, F, page 34). At later stages of development when axonal and dendritic proteins 
become segregated (Craig and Banker, 1994), the taxol-induced Tau-1 positive 
processes also showed the restriction of the dendritic marker MAP2 to the proximal 
part of the process as in control axons (Figure 2-11, open arrowheads). In addition to 
the supernumerary axons most of the cells had at least one or two dendrites. 
 
The taxol-induced processes also clustered the presynaptic marker Synapsin 1 later 
in development (10-12 DIV; Figure 2-12) which was not observed in dendrites, further 
 
Figure 2-11: Taxol-induced processes show axonal characteristics 
Rat hippocampal neurons (5 DIV) grown in the presence of taxol (3 nM; A, B) or DMSO (0.02%; C, D) 
(treatment after 1 DIV), stained for Tau-1 (B, D, red channel) and the dendritic marker MAP2 (B, D, 
green channel). 
DMSO-treated neurons have formed one axon (arrow) and several dendrites (black arrowheads) (C). 
Taxol-induced processes (A, arrows) show a proximal-distal gradient of Tau-1 (B, arrows) like control 
axons (D, arrow). MAP2-signal is restricted to dendrites (D, white arrowheads) and the proximal part 
of axons and Taxol-induced processes (B, D, open arrowheads). Scale bars: 25 µm. 
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confirming their axonal character. These results therefore indicate that microtubule 
stabilization causes the formation of multiple axons. 
 
 
 
 
Figure 2-12: Multiaxonal neurons mature and form neuronal networks 
Maturation of taxol-treated neurons. To unequivocally identify the origin of axons in the dense 
neuronal network neurons establish we used cultures of mouse hippocampal neurons in which a 
subset of cells expressed enhanced green fluorescent protein (eGFP) under the control of a 
ubiquitously active promoter (Okabe et al., 1997). Mixed WT/GFP cultures containing 1-3% of neurons 
expressing GFP allow following individual neurons in dense networks (A, B). Taxol (3 nM) was added 
to the medium of the mixed culture after 1 DIV, neurons were further grown in the presence of the 
drug, fixed after 11 DIV and immunostained for GFP (green channel) and the presynaptic marker 
Synapsin 1 (blue channel). 
(A, B) Taxol-treated neurons have formed multiple axons (arrows) in 81.3±2.2% of the cases (n>120 
neurons). 
(C-E) Higher magnifications of the regions marked in (A) and (B). The multiaxonal GFP-positive 
neurons cluster the presynaptic marker Synapsin 1 in their axons. Magnifications of the regions boxed 
in (C-E) are shown as insets to better visualize the localization of Synapsin 1 on GFP-positive axons 
(arrows). Scale bars: 100 µm (A, B), 20 µm (C-E).     Results 
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2.4.3  Microtubule acetylation alone is not sufficient to induce axon formation 
The application of taxol resulted in the stabilization of microtubules 
(Figure  2-10  C-D), however, it also induced acetylation of microtubules 
(Figure 2-10 B). Microtubule acetylation was recently reported to promote kinesin-1-
mediated cargo transport to specific neurites (Reed et al., 2006). Such directed 
transport in turn might trigger axon formation from a specific neurite. In principle, the 
axon-inducing effect of taxol could be related to its microtubule stabilizing function or 
the consecutive acetylation of microtubules. To address this point acetylation of 
microtubules was indirectly increased by inhibiting their deacetylation. Since 
posttranslational modifications themselves are a result but not the cause of altered 
microtubule dynamics (Khawaja et al., 1988) this provided a means to assess the 
effect of increased microtubule acetylation independently of microtubule stabilization. 
Deacetylase inhibitors were added to the culture medium ~12 h after plating, cells 
were further cultured in the presence of the drug and fixed after 2 to 4 days. 
 
Figure 2-13: Acetylation of microtubules alone is not sufficient to induce axon formation. 
(A–D) Hippocampal neurons grown in the presence of 0.02% ethanol (control; A, B) or deacetylase 
inhibitors TSA (2 nM; C, D) or tubacin (not depicted), fixed after 2 DIV (treatment ~12 h after plating). 
Control neurons (A, B) show a high ratio of acetylated (green channel) versus tyrosinated (red channel) 
microtubules in the axon (B, arrow) in comparison to minor neurites (B, arrowheads). Neurons treated 
with TSA (2 nM; C, D) feature an increased level of microtubule acetylation in the minor neurites (D), yet 
show normal polarization with one axon (arrow) and several minor neurites (arrowheads). 
Scale bars: 20 µm. 
(E) Quantification of axon numbers (assessed by Tau-1 staining) in neurons treated with deacetylase 
inhibitors (TSA or tubacin) and control neurons (treated with ethanol or DMSO). 
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Posttranslational modifications of microtubules and the distribution of microtubule-
associated proteins were scrutinized by immunostaining. This experiment was carried 
out together with Dorothee Neukirchen. 
 
Neurons treated with the deacetylase inhibitors tubacin (1  µM) and trichostatin  A 
(TSA; 2 nM) featured a clear increase of microtubule acetylation in minor neurites 
similar to that of axons (Figure  2-13  A-D). In spite of this elevated microtubule 
acetylation, polarity was not altered in these neurons and they showed no increase in 
supernumerary axons compared to control neurons (Figure 2-13 E). Moreover, the 
distribution of several microtubule-associated proteins (MAP2 and dephosphorylated 
Tau, recognized by Tau-1 antibody) was indistinguishable from control cells 
(Figure  2-14). Thus, the axon-inducing effect of taxol appears to be linked to 
microtubule stabilization itself. Increasing acetylation of microtubules per se, 
however, does not affect neuronal polarity. 
 
 
 
Figure 2-14: Treatment with deacetylase inhibitors does not alter the distribution of specific 
microtubule associated proteins. 
Hippocampal neurons grown in the presence of 0.02% ethanol (control; A, B) or deacetylase inhibitor 
TSA (2 nM; C, D), fixed after 4 DIV (treatment ~12 h after plating). The distribution of Tau-1 (B, D; red 
channel) and MAP2 (B, D; green channel) is not altered in neurons treated with deacetylase inhibitors. 
Scale bars: 20 µm. 
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2.5 Taxol application rapidly stabilizes microtubules and shifts 
dynamic microtubules to the tips of processes 
After having established that microtubule stabilization causes the formation of 
multiple axons the mechanism by which taxol acts was further analyzed. To assess 
microtubule dynamics in living neurons during axon formation, neurons were 
transfected with the GFP-tagged microtubule plus end binding protein  3 (EB3; 
Stepanova et al., 2003). EB3 belongs to a family of proteins which specifically bind to 
polymerizing microtubule plus ends, the microtubule plus-end-tracking proteins 
(reviewed in Akhmanova and Hoogenraad, 2005). Microtubule dynamics in living 
neurons were monitored at different developmental stages and after addition of taxol 
using time lapse fluorescence microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2-15: Taxol induces the 
protrusion of polymerizing 
dynamic microtubules to the 
growth cone periphery 
Figure  2-15: Taxol induces the 
protrusion of polymerizing 
dynamic microtubules to the 
growth cone periphery 
Legend see page 41     Results 
Ph.D. Thesis Harald Witte   41 
 
Overall, the application of low concentrations of taxol (10 nM) reduced the dynamicity 
of microtubules (Figure 2-15). We observed a reduction of moving EB3-GFP particles 
in neurites to 51.0% of controls (≥500 moving EB3-particles of at least 5 neurons per 
condition quantified). Low concentrations of taxol, however, did not completely 
abolish microtubule dynamics like higher taxol concentrations (>100  nM) used in 
earlier studies (Figure 2-16, Stepanova et al., 2003). 
 
 
 
 
 
 
Figure 2-15: Taxol induces the protrusion of polymerizing dynamic microtubules to the growth 
cone periphery 
(A-F) An unpolarized neuron (1 DIV) expressing the microtubule plus end binding protein EB3 tagged 
with GFP. Phase and fluorescent images of the untreated neuron (A, B) were acquired every 
10 seconds. Dynamic microtubules marked by EB3-GFP are present along the whole length of all 
processes (labeled with a-d in panel  B; higher magnification in panel  C). Subsequently, taxol was 
added to the medium to a final concentration of 10 nM (D-F) and imaging was continued. Dynamic 
microtubules become localized to the tips of the processes upon taxol addition (E; higher 
magnification in F, arrows). Scale bars: 20 µm. 
(G) Kymographs showing the movement of EB3-GFP along the process allow to follow taxol-induced 
changes in distribution and dynamics of GFP-tagged EB3. The horizontal axis represents time, the 
vertical axis distance. In all panels the top represents the distal part of the region of interest while the 
bottom corresponds to the proximal part. EB3-GFP diagonal streaks directed to the upper right 
therefore represent dynamic microtubules facing the growth cone with their plus ends, while diagonal 
streaks aiming at the lower right stand for dynamic microtubules facing the cell body with their plus 
ends. Briefly after addition of taxol, practically all dynamic microtubules face the growth cones with 
their plus ends (EB3-GFP streaks directed to the upper right) (panels a, c, d). Upon taxol addition, 
dynamic microtubules become localized to the tips of the processes (panels a-d) and rapid neurite 
outgrowth begins (panels a, c, d). 
Figure 2-16: High concentrations 
of taxol abolish microtubule 
dynamics 
Hippocampal neuron (1  DIV) 
expressing GFP-tagged EB3 (A). 
Taxol was added to a final 
concentration of 100  nM at t=0 
(after panel  B). Neurons were 
continuously imaged before and 
after addition of the drug. Dynamic 
microtubules start to disappear 
several minutes after taxol addition 
(D) and are virtually gone in the 
later course of the experiment (E, 
F). Scale bar: 20 µm.     Results 
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Figure  2-17: Taxol directs 
growing microtubule plus ends 
toward the tips of processes. 
(A–D) After 1  DIV, unpolarized 
neurons transfected with EB3-GFP 
(A) were subjected to low doses of 
taxol. The effect on microtubule 
dynamics was examined 30  min 
after treatment by monitoring the 
distribution of EB3-GFP (B–D). n = 
52 neurons from eight independent 
experiments. 
(C) Higher magnification of the 
growth cones marked in A and B. 
EB3-GFP is mainly localized at the 
tips of neurites after a 30-min 
treatment with 10 nM taxol (a’–d’) in 
comparison to a more even 
distribution before treatment (a–d). 
(D) Profiles of EB3-GFP 
immunofluorescence intensity 
(arbitrary units) of a representative 
neurite (neurite “c” ) before (red) 
and after (green) taxol treatment. 
Scale bars: (A, B) 20 µm; (C) 5 µm. 
 
Instead, low doses of taxol caused an accumulation of EB3-GFP at the tips of all 
minor neurites after taxol application in 84.6±12.0% of the cases (Figure  2-17; 
Figure  2-15). This directional shift towards the tip indicates the protrusion of 
polymerizing dynamic microtubules to the growth cone periphery and was 
accompanied by neurite outgrowth Figure 2-15). 
 
Interestingly, in polarizing control neurons (Figure 2-18 A, B) we observed in 64±12% 
of the cases an enrichment of EB3-GFP in the presumptive future axonal growth 
cone, which was identified by its size and dynamics (Bradke and Dotti, 1997; Bradke 
and Dotti, 1999; Figure 2-18 B, C, neurite I, asterisk). Such enrichment was not seen 
in the growth cones of other neurites (Figure 2-18 C) and indicates a shift of dynamic 
microtubules to the process tip by stabilization along the shaft. 
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In conclusion, manipulations of microtubule stability cause drastic changes in 
neuronal polarity. Stabilizing microtubules using taxol promotes polymerization at 
their plus ends, leading to an accumulation of dynamic microtubule plus ends at the 
neurite tips which results in outgrowth of multiple axons. 
 
 
2.6  Local microtubule stabilization is sufficient to bias the site of 
axon formation 
Initial neuronal polarization has been described as a “tug of war” (Craig and Banker, 
1994) in which each neurite has the potential to become the axon, but only one 
neurite is singled out to acquire axonal fate. It has been postulated that a positive 
feedback loop triggers this selection when a critical threshold is transiently reached in 
one minor neurite which then allows sustained growth of the future axon (Andersen 
and Bi, 2000; Arimura and Kaibuchi, 2007; Bradke and Dotti, 2000b). If microtubule 
Figure 2-18: Dynamic microtubules 
in polarizing neurons 
(A-C) Dynamic microtubule plus ends 
in polarizing neurons (1  DIV), 
visualized by transfection with 
EB3-GFP. 
(C) Higher magnification of the growth 
cones marked in (B). The growth cone 
of the future axon (B, C, asterisk) 
harbors a high amount of dynamic 
microtubules in comparison to the 
growth cones of the remaining minor 
neurites in 64±12% of the cases 
(n=14  neurons from more than five 
independent experiments). Scale 
bars: (A, B) 20 µm; (C) 5 µm. 
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stabilization is part of such a proposed feedback loop, transient microtubule 
stabilization in one neurite should be sufficient to trigger axon formation. 
 
To test this hypothesis, one minor neurite of individual, unpolarized neurons (stage 2, 
1 DIV) was randomly chosen and a membrane-permeant photoactivatable (caged) 
form of taxol (1-10  nM Paclitaxel,2′-(4,5-dimethoxy-2-nitrobenzyl)carbonate; Buck 
and Zheng, 2002) was locally activated by applying UV pulses to the selected growth 
cone or the region directly adjacent to it (Figure 2-19 A, neurite VI, white circle) for 10 
to 15 min (Figure 2-19 B). Neurons were further cultured in plain medium, reimaged 
two days after uncaging (Figure 2-19 E), fixed and stained for Tau-1 and MAP2 to 
unambiguously identify the site of axon formation (Figure 2-19 F). 
 
 
 
Figure 2-19: Local microtubule stabilization promotes axon formation 
(A, B) Rat hippocampal neuron (1 DIV) before (A) and after (B) UV-mediated photoactivation (circle) 
of caged taxol at the tip of one randomly chosen minor neurite. 
(C, D) Photoactivation did not interfere with the overall growth cone dynamics; most growth cones, 
including the pulsed one (arrow), are active. 
(E, F) 2  days after uncaging, the pulsed process had become the axon (arrow), which is Tau-1-
positive (red) and MAP2-negative (green, F). 
(G) Probability of axon formation in the targeted area doubles after local activation of caged taxol 
compared with that expected by random chance (mean±SEM; **, P<0.01 by Chi-square test). Control 
treatment (DMSO and UV) does not influence randomized axon formation (P>0.8 by Chi-square test). 
Scale bars: (A, B) 20 µm; (C, D) 5 µm; (E, F) 50 µm. 
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In terms of activity, local uncaging did not interfere with growth cone dynamics 
(Figure 2-19 C, D).  Most  growth  cones  of the neurons including the pulsed one 
(arrow) remain active during the uncaging procedure. To quantify the extent of site-
directed axon formation caused by local activation of caged taxol the deviation of the 
site of axon formation from the pulsed area was measured two days after uncaging. 
From 56  cells that underwent focal taxol activation 6  died and 9  did not develop 
further within the next 48  hours; therefore they were excluded from the analysis. 
From the remaining 41  cells 38  formed a single axon, only the other 3  neurons 
formed multiple axons. 68.3±7.5% of the developing neurons formed an axon from 
the pulsed neurite or close by (within a sector deviating less than 30° from the pulsed 
area), in comparison to 32.9±1.9% expected by random chance (p-value<0.01 by 
Chi-square test; 12 independent experiments; Figure 2-19 G). In contrast, in vehicle 
(DMSO)-treated cells UV-pulses did not influence randomized axon formation 
(32.1±7.8% observed versus 34.9±1.7% expected; p-value>0.8 by Chi-square test; 
n=28 neurons from 9 independent experiments). For calculation of the probability of 
random axon formation the number of growth cones within the sector in question was 
divided by the total number of the cells’ growth cones. 
 
The outcome of local uncaging in terms of site-directed axon formation was 
independent of the size of the growth cone and the length of the neurite receiving the 
UV-pulses. Pulsed neurites could become the axon even if the neuron had other 
longer neurites with bigger growth cones which have a higher probability to form the 
axon (Bradke and Dotti, 1997; Bradke and Dotti, 1999; Goslin and Banker, 1989; 
Figure 2-19 A), a phenomenon hardly observed in vehicle control experiments. Thus, 
already a short trigger (10-15 min) of microtubule stabilization is enough to bias the 
site of axon formation. 
 
The immediate effects of local uncaging were visualized by performing the uncaging 
experiment with EB3-GFP transfected neurons. Caged taxol was activated in a 
restricted area at the tip of a non-growing process (Figure 2-20 A, B, white circle) with 
limited microtubule dynamics (visualized by the absence of EB3-GFP; Figure 2-20 E, 
panel  1). Photoactivation of caged taxol promoted the protrusion of polymerizing 
microtubules to the distal part of the process  (Figure 2-20 D; E,  panels 2  and  3, 
arrow). This effect persisted after withdrawal of the trigger, i.e. after uncaging, and     Results 
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resulted in process outgrowth (Figure 2-20 A; C; E, panel 4 and 5). Local microtubule 
stabilization could also initiate outgrowth of a process when the cell had another 
rapidly growing process already (Figure  2-20  A, C, arrowhead). In conclusion, 
transient local stabilization of microtubules seems sufficient to induce axon formation 
from this site. 
 
 
 
Figure 2-20: Local microtubule stabilization shifts dynamic microtubules to the growth cone 
periphery 
Caged taxol was locally activated at the tip of a non-growing neurite (A and B, circle) of an EB3-GFP-
transfected neuron at 1 DIV. Before uncaging, the chosen neurite does not grow and shows little 
microtubule dynamics (A and B, arrow; E, panel 1), whereas another neurite is rapidly growing (A and 
B, arrowhead; also see C and D). During uncaging (E, panels  2 and 3), the process becomes 
activated, visualized by enrichment of EB3-GFP at its tip (E, panel  3, arrow). After uncaging, the 
pulsed neurite shows increased thickness (C, D). Dynamic microtubules keep protruding to the 
peripheral part of the process, promoting its outgrowth (D and E, panels 4 and 5, arrow). The asterisk 
in A and C indicates the initial position of the neurite tip in A. Scale bars: (A-D) 20 µm; (E) 10 µm.  
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3. Discussion 
In recent years, a rapidly growing number of molecules involved in neuronal 
polarization have been identified. Most studies have focused on polarity regulators 
and the control of their activity during axon formation which has led to a better 
understanding of the specific signaling pathways mediating neuronal polarity 
(reviewed in Arimura and Kaibuchi, 2007; da Silva and Dotti, 2002). In contrast, the 
intracellular mechanisms which actually underlie axon formation have drawn 
relatively little attention. Various mechanisms downstream of polarity regulators have 
been suggested to play a role in neuronal polarization yet have not been evaluated. 
In this respect the actin cytoskeleton and the regulation of its dynamics are an 
exception since a substantial share of research has so far concentrated on its role in 
axon formation. The goal of this study was to investigate which fundamental process, 
besides actin dynamics, could regulate neuronal polarization. 
 
My data shows that microtubule stabilization plays an active role during the 
specification of axonal fate in early neuronal development. Axon formation correlates 
with increased microtubule stability, and interfering with the function of specific 
polarity regulators leads to alterations in both neuronal polarization and microtubule 
dynamics. Establishing a causal relation, I  show that destabilizing microtubules 
selectively reduces the formation of future dendrites while stabilizing microtubules is 
sufficient to induce axon formation. 
 
In summary, I present evidence how molecules and pathways that act independent of 
actin dynamics can govern neuronal polarization – by selective alteration of 
microtubule stability. 
 
     Discussion 
48   Ph.D. Thesis Harald Witte 
3.1 Microtubule stability correlates with the identity of neuronal 
processes 
3.1.1  Axonal microtubules show increased stability 
Previous studies analyzing the microtubule network in developing neuronal cells 
have yielded conflicting results. In 1991 Arregui et al. had reported stable 
microtubules to be restricted to the axon of cerebellar macroneurons (Arregui et al., 
1991). Another study from the same year, however, could not confirm the 
confinement of stable acetylated microtubules to the axon in hippocampal neurons 
and concluded that microtubule stability “does not play a major role in determining 
which of the processes initially extended by hippocampal neurons becomes the 
definitive axon” (Dotti and Banker, 1991). It is conceivable that this contradiction in 
data within such a short period of time prevented further analysis of the role of 
microtubules in early neuronal polarization. 
In my study I assessed the ratio of stable versus dynamic microtubules in neuronal 
processes, instead of individual posttranslational modifications of tubulin alone which 
allowed me to reevaluate microtubule stability in developing neurons. I found that 
stable microtubules are indeed not restricted to the axon, but nevertheless 
predominate in the axonal shaft in comparison to minor neurites, bringing together 
the results of the aforementioned studies (Arregui et al., 1991; Dotti and Banker, 
1991). The higher resistance of axonal microtubules to depolymerization, which 
I  observed, confirmed an increase in microtubule stability in axons. My results 
therefore suggest a correlation between axonal identity and increased microtubule 
stability. 
 
3.1.2 Interfering with regulators of neuronal polarity results in altered 
microtubule stability 
Changes in the distinct morphology of neurons are often used as a readout when 
regulators of neuronal polarity are experimentally altered. For instance, loss of 
polarity or the formation of supernumerary axons are frequently the result of modified 
activity of specific polarity regulators, e.g. PI3K (Menager et al., 2004; Shi et al., 
2003), Akt kinase (Jiang et al., 2005) or CRMP-2 (Inagaki et al., 2001) [for detailed 
record see Arimura and Kaibuchi, 2007]. If microtubules and their dynamics are a     Discussion 
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final target of at least some polarity regulators it is conceivable that an analysis of 
neurons with altered polarity should allow to further substantiate the correlation 
between polarized microtubule stability and neuronal polarity. 
First I examined microtubule turnover in neurons deficient in the PAR-1 homologs 
SAD A and SAD B which have been reported to lose polarity (Kishi et al., 2005). 
Interestingly, I found this loss of neuronal polarity to be accompanied by a loss of 
polarization of microtubule stability. In contrast, when I induced multiple axons by 
inhibition of GSK-3β (Jiang et al., 2005; Yoshimura et al., 2005) I found that the 
supernumerary axons exhibit a prevalence of stable microtubules like normal axons. 
SAD kinases and GSK-3β control various processes, yet one of their common 
denominators is the regulation of the affinity of MAPs to microtubules (Goold et al., 
1999; Kishi et al., 2005). MAPs, in turn, control the dynamics and stability of 
microtubules. Moderate inhibition of GSK-3β, for example, reduces phosphorylation-
dependent inactivation of specific MAPs (reviewed in Doble and Woodgett, 2003; 
Zhou and Snider, 2005) eventually leading to increased microtubule stability and 
polymerization (see section  3.3.2 for further discussion). My data show that 
polarization of microtubule stability and neuronal polarization are parallel events. 
Moreover, interfering with the regulation of microtubule stability disrupts proper 
establishment of neuronal polarity. 
 
 
3.2  Microtubule stabilization causes axon formation 
3.2.1  Global pharmacological microtubule stabilization induces the formation 
of multiple axons 
To investigate a potential causal relation between microtubule stability and axon 
formation I pharmacologically increased microtubule stability in neurons and 
analyzed the effect on neuronal polarity. To this end I altered microtubule dynamics 
using the microtubule stabilizing drug taxol (Schiff et al., 1979; Schiff and Horwitz, 
1980) at low concentrations which favor microtubule polymerization, yet do not block 
microtubule dynamics completely (Derry et al., 1995). Interestingly, I found that 
microtubule stabilization itself is sufficient to induce axon formation. Taxol-treated 
neurons formed multiple axons with increased axon-like microtubule stability. In line     Discussion 
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with previous studies (e.g. Dehmelt et al., 2003; Schwamborn and Püschel, 2004), 
high concentrations of taxol resulted in a block of neurite formation as microtubules 
are hyperstabilized and thus rendered completely static. This indicates that a slight, 
balanced shift of microtubule dynamics towards more stable microtubules is 
necessary to induce axon formation. 
 
3.2.2  MAPs, microtubule stabilization and axon formation 
Importantly, the pharmacological microtubule stabilization found to induce axon 
formation has various physiological counterparts. The regulation of assembly 
dynamics, organization and stability of microtubules is tightly controlled by a 
multitude of MAPs which are in turn the effectors of various signaling pathways (see 
section 3.3.2 for further discussion). 
 
The binding of MAPs to microtubules and hence microtubule stability is regulated by 
several kinases, including SAD kinases (Kishi et al., 2005), microtubule/MAP-affinity 
regulating kinases (Drewes et al., 1998), GSK-3β (Sperber et al., 1995; Trivedi et al., 
2005; Yoshimura et al., 2005), or JNK (Chang et al., 2003). The activity of most 
MAPs, including Tau, MAP2, APC and CRMP-2 is decreased upon phosphorylation 
(Murthy and Flavin, 1983; Yoshida et al., 2004; Yoshimura et al., 2005; Zumbrunn et 
al., 2001), resulting in reduced microtubule stabilization or polymerization. In 
contrast, MAP1B is activated by phosphorylation and impedes the conversion of 
dynamic to stable microtubules; phosphorylation of MAP1B therefore results in 
increased microtubule dynamics (Goold and Gordon-Weeks, 2005; Goold et al., 
1999; Trivedi et al., 2005). 
 
Given the diversity of proteins regulating microtubule dynamics, it is not surprising 
that several different mechanisms may promote the selective alteration of 
microtubule dynamics in polarizing neurons. Three possibilities will be discussed in 
more detail: active microtubule stabilization, increased polymerization and a 
reduction of microtubule destabilization. 
 
One way of actively increasing the stability of microtubules is to lower their 
catastrophe rate, i.e. the frequency at which microtubules switch from a growing to a     Discussion 
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depolymerizing state. Tau (Drechsel et al., 1992; Xie et al., 1998) and MAP2 
(Kowalski and Williams, 1993), for instance, alter microtubule dynamics via this 
process. Consistently, both MAPs are necessary for the formation of polar neuronal 
structures: Suppression of MAP2 using antisense oligonucleotides in cultured 
cerebellar macroneurons prevents the establishment of neurites in general (Caceres 
et al., 1992), thereby blocking the establishment of neuronal polarity. Knockdown of 
Tau, instead, did not interfere with the formation of neurites on the whole but 
precludes axon formation (Caceres and Kosik, 1990; Caceres et al., 1991), 
proposing different roles for Tau and MAP2 during neuronal polarization. 
 
Interestingly, stabilization does not necessarily have to occur along the length of a 
microtubule. APC, for example, stabilizes microtubules by binding to their plus ends 
(Zumbrunn et al., 2001). APC is enriched at the tip of the axon in polarized 
hippocampal neurons (Votin et al., 2005), suggesting a role for APC in the regulation 
of axonal microtubule dynamics. Other localized microtubule stabilizing factors 
including EB1, EB3, CLASPs and mDia (Akhmanova et al., 2001; Nakagawa et al., 
2000; Votin et al., 2005; Wen et al., 2004) may regulate the dynamics of microtubule 
plus ends the same way to accomplish local microtubule stabilization. When I 
assessed the dynamics of microtubules in living neurons expressing EB3-GFP I 
found EB3 to be enriched at the tip of the future axon. It is possible that it may 
function there, together with other regulators, as a localized microtubule stabilizing 
factor. 
 
In addition to direct stabilization, the regulation of microtubule polymerization is also 
likely to play a role in axon formation. Tau, for example, is able to increase the 
polymerization rate of tubulin in vitro (Drechsel et al., 1992), which may lead to a 
greater microtubule polymer mass in neurons. Similarly, CRMP-2 which binds to 
tubulin heterodimers promotes microtubule assembly and increased polymerization 
in vitro and in hippocampal neurons (Fukata et al., 2002). Such increased 
polymerization may promote microtubule advance in growth cones and thereby 
stimulate axon growth. Consequently, overexpression of CRMP-2 causes the 
formation of multiple axons (Inagaki et al., 2001). A comparable mechanism may 
apply to regulator of G-protein signaling 2 (RGS2) which promotes the formation of 
neurites in PC12 cells by stimulating microtubule polymerization (Heo et al., 2006).     Discussion 
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Like CRMP-2, RGS2 directly interacts with tubulin subunits (Heo et al., 2006). 
Overexpression of RGS2 enhances the nerve growth factor-induced neurite 
outgrowth, while it is suppressed by specific knock-down of endogenous RGS2 (Heo 
et al., 2006). 
 
Microtubule stabilization can also be indirectly achieved by a reduction of active 
depolymerization. For instance, overexpression of the Rac activator dedicator of 
cytokinesis 7 (DOCK7), induces multiple axons which may be caused by DOCK7-
mediated downregulation of the microtubule depolymerizing activity of stathmin 
(Watabe-Uchida et al., 2006). Like APC, stathmin acts on the plus-ends of 
microtubules, and its inactivation has the same outcome as active microtubule 
stabilization, a reduced catastrophe rate. Inactivation of MAP1B –which increases 
microtubule dynamics in its active state (Trivedi et al., 2005)– likewise leads to 
enhanced microtubule stability in axons (Goold and Gordon-Weeks, 2005; Goold et 
al., 1999). Comparably, increased activity of the neuron-specific microtubule 
destabilizing factor SCG10 (Riederer et al., 1997; Stein et al., 1988) which is 
controlled by JNK during neuronal polarization leads to reduced process outgrowth 
(Tararuk et al., 2006). Knockdown of SCG10, however, also suppresses neurite 
outgrowth indicating that dynamic microtubules are to some extent necessary for 
neurite formation (Morii et al., 2006), consistent with the results of my taxol 
experiments and earlier studies (Tanaka et al., 1995). Consequently, a moderate 
increase of SCG10 levels increases neurite growth (Morii et al., 2006), possibly by 
increasing the amount of free tubulin at growth cones. My hypothesis that a well-
balanced control of microtubule dynamics is necessary to induce axon formation (see 
section 3.2.1) is consistent with these results. 
 
In summary, neurons possess a broad repertoire of mechanisms to achieve 
microtubule stabilization during polarization. Pharmacologically induced microtubule 
stabilization, e.g. by taxol application, mimics these mechanisms to induce axon 
formation. I propose that the fundamental process the different signaling pathways 
converge on is increased microtubule stability in the axon, no matter whether it is 
accomplished by active microtubule stabilization, increased polymerization or a 
reduction of microtubule destabilization. The increased stability and polymerization     Discussion 
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allows microtubules to protrude with their dynamic ends more distally, thereby 
promoting axon formation. 
 
 
3.3  Microtubule stabilization precedes axon formation 
3.3.1  Microtubule stabilization and axon formation - Sequential events 
During initial neuronal development one out of several seemingly equal neurites is 
singled out to become the axon. My data suggest that microtubule stabilization in this 
neurite precedes morphological polarization, based on the following observations: 
1)  Microtubule stability is increased in one neurite of a subpopulation of 
morphologically unpolarized neurons, as shown using markers for microtubule 
turnover and assessing microtubule stability by partial depolymerization. 2) Neurons 
grown under mild microtubule destabilizing conditions are able to form an axon, while 
formation of minor neurites is impaired, suggesting that only one minor neurite is able 
to overcome the destabilizing environment. 3) Local microtubule stabilization in one 
minor neurite by focal activation of a caged form of taxol strongly biases the site of 
axon formation. Consistent with my findings, the overexpressed kinesin-1 motor 
domain, which preferably binds to microtubules containing markers of lower turnover 
(Reed et al., 2006), accumulates in the future axon before morphological polarization 
occurs (Jacobson et al., 2006; see section  3.3.3 for further discussion). Taken 
together, my data argue that changes in microtubule dynamics govern neuronal 
polarization and that microtubule stabilization precedes axon formation. 
 
3.3.2  Regulation of microtubule stabilization during neuronal polarization 
How could local microtubule stabilization be achieved during axon formation? 
Presumably, both an environmental cue (Adler et al., 2006) or an internal signal like 
centrosome localization (de Anda et al., 2005; Zmuda and Rivas, 1998) could initiate 
a local imbalance inside the microtubule network. In the following sections I will 
discuss putative external signals including guidance cues, neurotrophins and other 
signaling pathways involved in axon specification with respect to their ability to 
regulate microtubule dynamics.     Discussion 
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In the nematode C. elegans, directional netrin cues define the site of axon initiation of 
a subtype of motor neurons by promoting a PI3K signaling-dependent asymmetric 
distribution of the actin-regulator MIG-10/lamellipodin (Adler et al., 2006). 
Interestingly, asymmetric PI3K-signaling itself plays an important role in neuronal 
polarization (Menager et al., 2004) and promotes microtubule stabilization in 
migrating fibroblasts via Akt and GSK-3β (Onishi et al., 2007). Similarly, netrin-
induced activation of Rac (Li et al., 2002) may promote microtubule stabilization via 
reducing the microtubule depolymerizing activity of stathmin (Watabe-Uchida et al., 
2006; see section 3.2.2 above). Thus, netrin-induced axon formation may function, at 
least in part, via regulation of microtubule dynamics, in line with the netrin turning 
response depending on microtubules (Buck and Zheng, 2002) and the GSK-3β target 
MAP1B (Del Rio et al., 2004). 
 
Interestingly, semaphorin 3A, another repulsive guidance cue, is also involved in the 
specification of neuronal polarity (reviewed in Whitford et al., 2002). In cortical 
neurons, semaphorin  3A regulates the oriented growth of axons toward the white 
matter (Polleux et al., 1998). This function may be mediated to some extent by the 
modulation of microtubule dynamics since semaphorin 3A signaling was reported to 
influence the activity of GSK-3β (Eickholt et al., 2002) and CRMP-2 (Mitsui et al., 
2002). It seems therefore conceivable that axon guidance cues do not only direct the 
growing axon but also stimulate and orient the asymmetrical growth of neurites 
before axon specification. 
 
Similarly, WNT-signaling has been reported to determine the polarity of a subset of 
mechanosensory neurons along the anterior–posterior body axis in C. elegans 
(Hilliard and Bargmann, 2006; Prasad and Clark, 2006). WNT-signaling is known to 
control various polarity-related developmental processes, including asymmetric cell 
division, cell fate determination and tissue polarity (reviewed in Logan and Nusse, 
2004). Downstream of the WNT-receptor Frizzled, the scaffold protein Dishevelled 
mediates the inhibition of GSK-3β together with JNK (Ciani et al., 2004; Ciani and 
Salinas, 2007). Given the fact that WNT-signaling is able to induce microtubule 
stabilization (Ciani et al., 2004; Krylova et al., 2000), the regulation of microtubule     Discussion 
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dynamics is likely to be involved in WNT-mediated axon specification. The 
modulation of MAP1B-activity, for instance, seems to be part of such WNT-induced 
microtubule stabilization during axon formation (Lucas et al., 1998). In summary, the 
regulation of microtubule dynamics by WNT-signaling likely plays a role during axon 
formation. 
 
Neurotrophic factors, including nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF) and neurotrophin 3 (NT3) are putative extracellular cues to determine 
neuronal polarity as well. NT3, for instance, has been reported to accelerate neuronal 
polarization by enhancing axon growth (Morfini et al., 1994). The receptors of 
neurotrophins are tyrosine receptor kinases (Trks; reviewed in Huang and Reichardt, 
2003) which allow them to access a broad variety of downstream effectors. PI3K, for 
example, signals downstream of Trks and regulates neuronal polarization (Menager 
et al., 2004) and microtubule stabilization (Onishi et al., 2007), presumably by 
inactivation of GSK-3β via PI3K and Akt-kinase (Jiang et al., 2005; Zhou et al., 2004; 
compare section 1.3.1). Taking into account the central role of GSK-3β in several 
pathways governing neuronal polarization and my findings that microtubule 
stabilization precedes axon formation, local inactivation of GSK-3β is probably of 
special interest in initial neuronal polarization. It may induce axon outgrowth, for 
instance by MAP-mediated microtubule stabilization (Kim et al., 2006; Zhou et al., 
2004) or enhanced polymerization via CRMP-2 (Yoshimura et al., 2006). 
Interestingly, the small GTPase R-Ras which is selectively localized to a single 
neurite of unpolarized hippocampal neurons (Oinuma et al., 2007) is activated by 
Trks upon neurotrophin stimulation (reviewed in Reichardt, 2006). Since R-Ras can 
inhibit GSK-3β via PI3K and Akt-kinase it might account for local GSK-3β inactivation 
in response to neurotrophic factors. Similarly, the ganglioside-converting enzyme 
plasma membrane ganglioside sialidase (PMGS) which promotes the activation of 
TrkA at the tips of neurites, accumulates in a single immature neurite during stage 2 
(Da Silva et al., 2005). This local TrkA-activation by PMGS leads to activation of PI3K 
which in turn provides a link to a localized regulation of microtubule dynamics. In 
hippocampal neurons, BDNF has been reported to promote axon differentiation 
(Shelly et al., 2007). It has also been shown to induce an increase in cellular cAMP 
levels by inhibition of phosphodiesterase-4 in cerebellar neurons (Gao et al., 2003)     Discussion 
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that leads to activation of LKB1 via cAMP-dependent protein kinase (PKA; Shelly et 
al., 2007). Active LKB1 in turn phosphorylates and thereby activates SAD  A and 
SAD B kinases (Barnes et al., 2007), providing a link to the regulation of microtubule 
dynamics. Interestingly, LKB1 is also linked to WNT-signaling (Ossipova et al., 2003), 
suggesting that different extracellular cues like WNT and neurotrophins cooperate to 
control neuronal polarization. 
 
In addition to diffusible factors, the extracellular matrix and cell adhesion molecules 
are possible initiators of neuronal polarization. When hippocampal neurons are 
plated on substrates patterned with stripes of poly-L-lysine and either laminin or 
neuron–glia cell adhesion molecule (NgCAM), axons formed preferentially from 
undifferentiated neurites that have contact with laminin or NgCAM (Esch et al., 1999). 
Similarly, the contact of individual neurites with laminin-coated beads caused a rapid 
elongation, suggesting this neurite to become the axon (Menager et al., 2004). The 
increased outgrowth was marked by an accumulation of PIP3, the lipid product of 
PI3K, at the tip of the growing neurite (Menager et al., 2004). Elevated PIP3-levels 
indicate a high PI3K-activity which links microtubule stabilization (e.g. via the 
PI3K/Akt/GSK-3β pathway) and axon specification. Extracellular signals may 
therefore trigger both neurite outgrowth and the specification of a process to acquire 
axonal fate by regulation of microtubule dynamics. 
 
Intracellular signals pose an alternative explanation to extracellular signals specifying 
axon formation. During early developmental stages, the centrosome and the Golgi 
apparatus cluster close to the area where neurons form their first neurite, which will 
later become the axon (de Anda et al., 2005; Zmuda and Rivas, 1998). The 
localization of the centrosome may therefore be responsible for an early bias of 
microtubule stability between different neurites which could account for axon 
specification. In a study from 2001, Palazzo et al. show that the orientation of the 
centrosome and microtubule stabilization are independent events in migrating 
fibroblasts (Palazzo et al., 2001b). In the light of these results, an instructive role for 
the centrosome in local microtubule stabilization during neuronal polarization seems 
unlikely. Moreover, the centrosome position itself is controlled by PI3K and Cdc42 
(reviewed in Etienne-Manneville and Hall, 2003), it may therefore not be the cause 
for local microtubule stabilization but rather a result of axon-inducing signaling     Discussion 
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(Arimura and Kaibuchi, 2007; Siegrist and Doe, 2006). An alternative explanation for 
an early bias of microtubule stabilization comes from CLIP-associated protein 
(CLASP)-mediated nucleation of non-centrosomal microtubules at the Golgi network 
(Efimov et al., 2007). Since Golgi network and centrosome are often in close 
proximity, microtubules emanating from the Golgi apparatus might be one 
explanation for the supposed correlation between centrosome position and the site of 
axon formation. 
 
Currently, it seems most likely that extracellular signals determine the site of axon 
formation. The signaling pathways I have discussed are all connected to the 
regulation of microtubule dynamics and may thus trigger neuronal polarization by 
inducing a local stabilization of microtubules. 
 
 
3.3.3  Microtubule stability, posttranslational modifications and axonal 
transport 
Local microtubule stabilization as a promoter for axon formation in morphologically 
unpolarized neurons offers an explanation for the increased membrane traffic which 
precedes axon formation (Bradke and Dotti, 1997). Microtubule-dependent motor 
proteins show a higher affinity towards stabilized microtubules (Liao and Gundersen, 
1998; Reed et al., 2006), which is in line with enhanced vesicle transport on stable 
microtubules (Lin et al., 2002; Nakata and Hirokawa, 2003). Increased microtubule 
stability in the future axon may therefore lead to polarized membrane flow, 
contributing to determining the site of axon formation. The inhibition of membrane 
trafficking, in contrast, prevents the development of polarity and axonal growth (Jareb 
and Banker, 1997). Interestingly, a recent study from Horiguchi et al. has shown that 
guanylate kinase-associated kinesin (GAKIN) mediates the transport of PIP3 itself or 
factors that stimulate the production of PIP3 (Horiguchi et al., 2006). The 
accumulation of PIP3 at the tip of one neurite precedes axon specification in 
hippocampal neurons (Shi et al., 2003); such enrichment might be mediated by 
increased GAKIN-binding to locally stabilized microtubules. Whether GAKIN actually 
prefers binding to stable microtubules, however, remains to be shown. 
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A recent study from Reed et al. proposes microtubule acetylation to be key to control 
motor-protein trafficking. Kinesin-1 shows reduced binding to microtubules isolated 
from the ciliate Tetrahymena when microtubule acetylation is abolished (Reed et al., 
2006). Similarly, in stage 2 hippocampal neurons with pharmacologically increased 
microtubule acetylation the selective localization of the kinesin-1 cargo JNK-
interacting protein  1 (JIP1) to only a subset of neurites is lost, JIP1 rather 
accumulates at the tips of nearly all neurites under such conditions (Reed et al., 
2006), suggesting that microtubule acetylation controls directed transport to neurites 
during axon formation. My data, in contrast, argue that the acetylation of 
microtubules alone is not sufficient to induce initial axon formation. Neurons treated 
with the same deacetylase inhibitors as used in the study from Reed et al. did not 
show altered polarity, suggesting normal axonal transport. It has to be considered, 
however, that in my study low concentrations of the deacetylase inhibitor TSA were 
used. These low concentrations were necessary to avoid cell death during the 
extended incubation time which is required to assess neuronal polarization but were 
nevertheless sufficient to induce hyperacetylation of microtubules (compare 
Figure 2-13 D). Reed et al., on the other hand, assessed only the first few hours after 
addition of the deacetylase inhibitors, using ~60-fold more TSA than in my study 
which may have additional side effects. My data argue that changes in microtubule 
dynamics but not acetylation of microtubules alone are the primary cause of axon 
formation. This is in line with recent results from Zhang et al. which show that mice 
deficient for histone deacetylase  6 (HDAC  6) are viable and fertile (Zhang et al., 
2008). Importantly, the development of most tissues including the nervous system is 
normal in these mice although microtubules show increased acetylation levels 
(Zhang et al., 2008). 
 
Possibly, other posttranslational modifications of tubulin, including polyglycylation or 
polyglutamylation, might play a role in neuronal polarization. For instance, tubulin 
polyglutamylation seems to influence MAP/microtubule interactions. In vitro, Tau, 
MAP1B, and MAP2 preferentially bind to moderately polyglutamylated tubulins 
(~3 glutamyl units; Bonnet et al., 2001; Boucher et al., 1994) whereas MAP1A shows 
optimal affinity for tubulins with a high level of modification (~6 glutamyl units; Bonnet 
et al., 2001). Since glutamylation levels of tubulin change during neuronal 
development (Audebert et al., 1994) they might control developmental transitions in     Discussion 
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binding of different MAPs (Bonnet et al., 2001). A loss of polyglutamylation also 
affects binding of microtubule-dependent motor proteins (Ikegami et al., 2007; Reed 
et al., 2006), leading to abnormal trafficking. Hippocampal neurons derived from mice 
deficient in tubulin-tyrosine-ligase, the enzyme retyrosinating α-tubulin, showed high 
levels of Δ2-tubulin in microtubules with increased stability (Erck et al., 2005). 
Interestingly, these neurons showed accelerated neurite outgrowth and a premature 
axonal differentiation. Moreover, they had a tendency to form multiple axons, similar 
to the phenotype observed in my experiments with pharmacological microtubule 
stabilization. The results from Erck et al. are in line with a putative instructive role for 
microtubule stability during neuronal polarization proposed by my work. Future 
studies may address in more detail which role in neuronal polarization the enzymes 
play that mediate posttranslational modifications of microtubules. It will be interesting 
to see whether posttranslational modifications other than acetylation are the cause 
for or the consequence of axon formation. 
 
 
3.3.4  Local microtubule stabilization and feedback loops 
In the context of initial neuronal polarization a system of intracellular feedback loops 
has been proposed to determine the site of axon formation (Andersen and Bi, 2000; 
Bradke and Dotti, 2000b). Initially, all neurites are assumed to be equal, competing to 
become the axon. It was postulated that on the one hand a positive feedback loop 
promotes outgrowth of one neurite to acquire axonal fate while on the other hand 
negative feedback loops inhibit outgrowth of the remaining neurites (Andersen and 
Bi, 2000; Bradke and Dotti, 2000b). Increased microtubule stability in one neurite 
would allow to induce intracellular events such as increased microtubule-dependent 
transport (Liao and Gundersen, 1998; Lin et al., 2002) that, again, could reinforce 
microtubule stability, thereby creating a positive feedback loop. A recent study on the 
selective enrichment of the Kif5 kinesin motor domain in the growing axon postulated 
that microtubules in the axon should biochemically differ from the minor neurites’ 
microtubules (Jacobson et al., 2006). My work directly shows such distinct 
characteristics between the microtubules of axons and minor neurites –their different 
stability– that could specifically enhance membrane traffic in the growing axon. 
Polarized transport may lead to a selective enrichment of microtubule-stabilizing     Discussion 
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factors during neuronal polarization. These factors may stabilize microtubules at their 
target, thereby further driving the aforementioned positive feedback loop. 
 
My results support the idea that microtubule stabilization plays a role in a putative 
positive feedback loop triggering axon specification. When I  locally stabilized 
microtubules at the tip of one process of an unpolarized neuron by photoactivation of 
caged taxol I  observed increased microtubule polymerization, visualized by EB3-
GFP, and neurite outgrowth (see section  2.6, page  46). Although the trigger was 
short (~15 min), local microtubule stabilization was sufficient to strongly bias the site 
of axon formation (see section  2.6, page  44). Likely, a short pulse of microtubule 
stabilization activates a cascade of events leading to a positive feedback loop which 
is able to promote sustained axonal outgrowth. For instance, CRMP-2, which 
promotes microtubule polymerization, is a cargo of kinesin-1 (Kimura et al., 2005). 
Local microtubule stabilization might enhance kinesin-dependent transport (Lin et al., 
2002; Nakata and Hirokawa, 2003) and therefore lead to an enrichment of CRMP-2 
at the growth cone of one neurite. This could then promote further microtubule 
stabilization and sustained axonal outgrowth. Since CRMP-2 additionally mediates 
the interaction of kinesin-1 with the Sra-1/WAVE1 complex (Kawano et al., 2005) 
which is involved in actin reorganization (Steffen et al., 2004) it provides a link 
between actin and microtubule dynamics. The enrichment of PIP3 at the tip of the 
future axon (Shi et al., 2003) might trigger a positive feedback loop as well. PIP3 
could on the one hand set off microtubule stabilization via the Akt/GSK-3β pathway 
and increased MAP binding to microtubules (see sections 1.3.1 and 3.2.2). This in 
turn might contribute to further transport of PIP3 to the tip of the future axon via the 
kinesin-like motor protein GAKIN (Horiguchi et al., 2006). Moreover, additional PIP3 
would be generated by the feedback loop of PI3K, Rho GTPases and the 
Par-3 / Par-6 / aPKC polarity complex (see section 1.3.1 and Arimura and Kaibuchi, 
2007; Weiner et al., 2002) which would again cause more microtubule stabilization. 
 
More experimental evidence for a role of feedback loops controlling axon 
specification comes from the observation that an individual neurite accumulates PIP3 
at its tip and commences rapid outgrowth when touched with a laminin-coated bead 
(Menager et al., 2004), in line with the proposed positive feedback loop. When a 
second neurite contacts a laminin-coated bead, however, the first neurite stops     Discussion 
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growing, suggesting a suppression of its outgrowth by a negative feedback loop 
induced by the second neurite (Menager et al., 2004). Although the exact nature of 
these feedback signals remains to be determined, local microtubule stabilization 
evoked by PIP3–signaling may be involved and offers an explanation how to drive 
sustained axon outgrowth. 
 
Interestingly, microtubule-dependent transport also provides a link between the 
dynamics of microtubules and the actin cytoskeleton. For instance, the RhoA 
activator p190RhoGEF (van Horck et al., 2001) presumably interacts with kinesin via 
the JIP1 scaffold protein (Meyer et al., 1999; Verhey et al., 2001). RhoA regulates 
actin dynamics via ROCK (Leung et al., 1996; reviewed in Riento and Ridley, 2003) 
but was more recently also discovered to control microtubule stabilization via mDia 
(Palazzo et al., 2001a) and its downstream effectors. Transport of p190RhoGEF to 
specific neurites mediated by increased microtubule stability might therefore on the 
one hand forward additional microtubule stabilization. On the other hand, RhoA may 
modulate retrograde actin flow (Amano et al., 1996; Delorme et al., 2007; Kimura et 
al., 1996; Sumi et al., 2001) which can promote neurite outgrowth (Rösner et al., 
2007). The Cdc42-specific GEFs Asef1 and 2 (Hamann et al., 2007) use a similar 
means as p190RhoGEF to reach microtubule ends. Asef is activated by binding to 
APC (Hamann et al., 2007) which concentrates at growing microtubule plus ends 
(Mimori-Kiyosue et al., 2000), presumably via an indirect interaction with the plus-
end-directed motor proteins KIF3A and KIF3B (Jimbo et al., 2002). Thus, APC might 
deliver Asef to neurite tips where it could specifically activate Cdc42. The localization 
of TrioGEF1, a specific activator of RhoG, also depends on an intact microtubule 
cytoskeleton (Blangy et al., 2000; Gauthier-Rouviere et al., 1998) and probably 
kinesin (Gauthier-Rouviere et al., 1998; Vignal et al., 2001). RhoG itself can activate 
both Rac1 and Cdc42 (Blangy et al., 2000; Gauthier-Rouviere et al., 1998). 
Increased Rac1 activity may lead to further microtubule stabilization via inactivation 
of stathmin (Watabe-Uchida et al., 2006; see section 3.2.2 above) and could drive a 
positive feedback loop in the future axon for the kinesin-dependent delivery of 
TrioGEF1. In such a scenario the RhoG-activated Cdc42 could render the actin 
cytoskeleton more dynamic, e.g. via cofilin (Garvalov et al., 2007), which would 
release restraint to microtubule-driven axon outgrowth. Interestingly, both active 
Cdc42 and Rac1 activate p21-activated kinase 5 (PAK5; Cau et al., 2001; Dan et al.,     Discussion 
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2002), thereby providing another link to cytoskeletal dynamics. PAK5 has recently 
been reported to suppress the activity of MARK2 (Matenia et al., 2005), a regulator of 
MAP/microtubule interaction (Biernat et al., 2002). MARK2 phosphorylation causes 
the detachment of MAPs like Tau from microtubules, hence its inactivation leads to 
microtubule stabilization. Additionally, PAK5 causes a destabilization of the actin 
cytoskeleton via as yet unknown effectors (Matenia et al., 2005), and might thus 
further link TrioGEF1, RhoG, Cdc24 and Rac1 to cytoskeletal dynamics. To review, 
the microtubule-dependent intracellular distribution of Rho-GEFs likely contributes to 
orchestrate the regulation of both actin and microtubule dynamics during initial 
neuronal polarization.  
Ph.D. Thesis Harald Witte   63 
4. Outlook 
In summary, I present here for the first time direct evidence that microtubule stability 
is an active determinant of neuronal polarization. Recent work has shown that actin 
and microtubules mutually influence each other (Basu and Chang, 2007). Taking into 
account my findings about the instructive role of microtubules in neuronal 
polarization, I hypothesize that the initial trigger for axon formation could derive from 
both actin and microtubules. Their reciprocal regulation in turn may drive a positive 
feedback loop which sustains axonal growth. The next challenge beyond the scope 
of this study will be to characterize this molecular interplay of microtubules and the 
actin cytoskeleton during neuronal polarization. Moreover, molecules involved in the 
regulation of microtubule dynamics in processes like cell migration or axon guidance 
should be reassessed for a potential role in neuronal polarization. Interestingly, it was 
recently shown that microtubule organization is a crucial factor for the formation of 
the two distinct structures following axonal lesion – actively protruding growth cones 
and non-growing retraction bulbs (Ertürk et al., 2007). It might therefore also be worth 
to explore the ability of taxol to convert a non-growing minor neurite into a growing 
axon in situations where process growth is restrained, e.g. in the context of central 
nervous system lesions. 
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5. Materials and Methods 
5.1 Materials 
5.1.1 Chemicals 
High-purity chemicals were purchased from Biomol, Invitrogen, Merck, Roth, and Sigma-Aldrich. 
Water used to prepare solutions was filtered with the “Milli-Q-Synthesis A-10” system from Millipore. 
 
Table 1: Chemicals used in this study 
Chemical Supplier  Product  number 
Agarose Biomol  01280 
Apo-transferrin, human  Sigma  T-2252 
Borax Sigma  B-9876 
Boric acid  Merck  1.00165 
Bovine serum albumin, powder  Sigma  A-7906 
Copper (II) sulfate pentahydrate (CuSO4*5H2O) Merck  1.02790 
Dimethyl sulfoxide (DMSO)  Roth  A994 
EDTA (Ethylenediamine-tetraacetic acid)  Sigma  E-5134 
EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
 tetraacetic  acid)  Sigma E-3889 
Ethanol absolute (≥99.8%) Sigma  32205 
Fetal bovine serum  Invitrogen  10500-064 
Fish gelatin  Sigma  G-7765 
Gelmount mounting medium  Sigma  G-0918 
D(+)Glucose monohydrate  Merck  1.08342 
L-Glutamine 200mM (100x)  Invitrogen  25030 
Hank’s balanced salt solution (HBSS) with Calcium and 
Magnesium  Invitrogen 14025 
HEPES (N-2-Hydroxyethylpiperazine-N'-2- ethane sulfonic acid)  Biomol  05288 
Horse Serum  Sigma  H-1270 
Hydrochloric acid (HCl; 1 M)  Merck  1.09057 
Hydrochloric acid, fuming (HCl; 37%)  Merck  1.00317 
Insulin Sigma  I-5500 
Magnesium chloride hexahydrate (MgCl2*6H2O) Merck  1.05833 
MEM 10x  Invitrogen  21430 
MEM essential amino acids 50x  Invitrogen  11130 
MEM non-essential amino acids 100x  Invitrogen  11140 
Nitric acid (HNO3; ≥65%) Roth  4989 
Ovalbumin (albumin from chicken egg white)  Sigma  A-5503     Materials and Methods 
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Chemical Supplier  Product  number 
Paraffin (non-caking, solidification  point 57-60°C)  Merck 1.07158 
Paraformaldehyde Merck  1.04005 
PIPES (1,4-Piperazinediethanesulfonic acid)  Sigma  P-1851 
Poly-L-lysine Sigma  P-2636 
Progesteron Sigma  P-8783 
Putrescine-dihydrochloride Sigma  P-5780 
Pyruvate (piruvic acid)  Sigma  P-2256 
Selenium-dioxide Sigma  325473 
Sodiumhydrogencarbonate (NaHCO3) Merck  1.06329 
Sodium hydroxide (NaOH)  Merck  1.06482 
Sucrose Merck  1.07651 
Tris(hydroxymethyl)-aminomethane Merck  1.08382 
Triton X (TX)-100  Roth  6683 
Trypsin-EDTA (1x; 0.05% Trypsin, 0.53 mM EDTA•4Na)  Invitrogen  25300 
 
 
5.1.2 Drugs 
Table 2: Drugs used in this study 
Drug Stock  [mM]  Solvent  Supplier  Function 
taxol  5  DMSO  Sigma or LC laboratories  microtubule stabilization 
cytochalasin D  10  DMSO  Sigma destabilization  of  F-actin 
nocodazole 6.67  DMSO  Sigma  microtubule  destabilization 
SB 415286  25  DMSO  Tocris Bioscience  GSK-3β inhibitor 
tubacin 20  DMSO  gift from Ralph Mazitschek 
and Stuart Schreiber  deacetylase inhibitor 
trichostatin A  4  ethanol  Cell Signaling Technology  deacetylase inhibitor 
 
Single-use aliquots of the drug stock solutions were kept at -20°C. 
 
 
5.1.3 Commercial  kits 
Table 3: Commercial kits 
Name  Supplier & Product number 
EndoFree Plasmid Maxi Kit  Qiagen, #12326 
Rat Neuron Nucleofector Kit  Amaxa, #VPG-1003 
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5.1.4  Enzymes and DNA markers 
Table 4: Enzymes and DNA markers 
Name  Supplier & Product number 
Taq DNA Polymerase (5 U/µl)  Invitrogen, #18038-026 
100 bp ladder (500 ng/µl)  New England Biolabs, # N3231 
1 kb ladder (500 ng/µl)  New England Biolabs, # N3232 
 
Fragments of the 100bp ladder [bp]:  1.517, 1.200, 1.000, 900, 800, 700, 600, 517/500, 400, 300, 200, 100 
The 100 bp-ladder has bands with increased intensity at 1000 bp and 500/517 bp. 
 
Fragments of the 1 kb ladder [bp]:  10.002, 8.001, 6.001, 5.001, 4.001, 3.001, 2.000, 1.500, 1.000, 517, 500 
The 1 kb-ladder has a band with increased intensity at 3.000 bp. 
 
 
5.1.5 Equipment 
Table 5: Equipment 
Equipment Model  Supplier 
Lab equipment 
Bunsen burner, mobile  Fireboy eco / Fireboy plus  Integra Biosciences 
Centrifuges  Universal 30F  Hettich 
5810 Eppendorf 
Table centrifuges: 5415 C and 5415 R  Eppendorf 
Mini centrifuge GMC-060  Laboratory & Medical Supplies Co. 
Electroporator Nucleofector™  II  Amaxa 
Hemocytometer  Neubauer improved 
(depth 0.100 mm, 0.0025 mm
2)  Optik Labor 
Ice machine  AF 100  Scotsman 
Incubator (for bacteria)  B 6200  Heraeus 
Incubator (with CO2)  HERAcell® 240  Kendro 
Incubator shaker  innova 4000  New Brunswick Scientific 
Magnetic hot plate stirrer  IKAMAG RET or RCT  IKA Labortechnik 
Microwave NN-T251W  Panasonic 
Mixing rotor  Mixing rotor variospeed  Renner GmbH 
Mood enhancer, CD-based  Micro Component High Fidelity System 
UX-S1  JVC 
Multi pipette  Multipette® plus  Eppendorf 
PCR machines  T3000 Thermocycler  Biometra / Whatman 
T Gradient  Biometra / Whatman 
Mastercycler Gradient  Eppendorf 
pH meter  inoLab pH Level 1  WTW GmbH & Co. KG     Materials and Methods 
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Equipment Model  Supplier 
Pipettes  P2 / P20 / P200 / P1000  Gilson 
Pipetting aid  pipetus®  Hirschmann Laborgeräte 
Power supplies 
(electrophoresis) 
Standard Power Pack P25  Biometra / Whatman 
LKB GPS 200/400  Pharmacia 
Racks for glass coverslips  porcelain staining racks, no. 8542-E40  Thomas Scientific 
Scales  PC 2000  Mettler 
Scout ™ Pro SPU 2001  Ohaus Corp. 
AT261 DeltaRange® (precision scale)  Mettler 
Spectrophotometer Ultrospec  3000 Amersham  Biosciences 
Sterilizing oven  T 5050 E  Heraeus 
Thermo mixer  Thermomixer comfort  Eppendorf 
Vacuum aspiration system  PC 2004 vario  Vacuubrand, Inc. 
Vortexer  K-550-GE / Vortex Genie 2  Scientific Industries 
Water baths  Lauda Ecoline E-100 / bath 025  Brinkmann Instruments 
C-58 / 3  Julabo Labortechnik 
  
Gel documentation system 
Gel documentation system  IP-CF01.SD incl. digital camera  Peqlab 
UV transilluminator  ECX-20.M incl. CN-08 setup  Peqlab 
Hoods  SterilGARD Hood, Class II Type A/B3  The Baker Company, Inc 
LaminAir HA 2448 GS  Heraeus 
Laminar air flow hoods 
(for dissection) 
HERAguard® HPH15  Kendro 
EdgeGARD Hood EG-3252  The Baker Company, Inc. 
Thermo printer  P93  Mitsubishi 
    
Dissection 
Dissection lamp   KL 1500 LCD / KL 200  Schott 
Dissection 
stereomicroscope  Stemi SV 6  Zeiss 
Forceps  Straight forceps Dumont #5, 11 cm, Biologie tips 
(#11252-20)  Fine Science Tools 
Curved forceps Dumont #7, 11.5 cm, Biologie tips 
(#11297-10)  Fine Science Tools 
Scissors  Vannas-Tübingen spring scissors, 8.5 cm, straight tips 
(#15003-08)  Fine Science Tools 
Hardened fine iris scissor, 11 cm, straight tips 
(#14090-11)  Fine Science Tools 
Extra fine scissors, model “Bonn”, 8.5 cm, straight tips 
(#14084-08)  Fine Science Tools 
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Equipment Model  Supplier 
Microscopy and time lapse imaging 
CCD camera  4912-5000 or 4912-5100  Cohu 
Camera control panel  C 2741  Hamamatsu 
Image acquisition 
hardware for PC  LG3 image grabber  Scion Corp. 
Inverted epifluorescence 
microscopes 
Axiovert 135TV  Zeiss 
AxioObserver.D1 Zeiss 
Inverted bright field 
microscope  Wilovert® Will 
Mechanical microscope 
shutters 
Uniblitz-Shutter for phase light (incl. adapter) 
VS25S 2 ZM 0 – 21  Vincent Associates 
Uniblitz-Shutter for fluorescence light (incl. adapter) 
VS25S 2 ZM 0 R1 – 21 (with high temperature 
modification) 
Vincent Associates 
Shutter driver  VMM-D1 or VCM-D1  Vincent Associates 
 
 
5.1.6 Consumables 
Table 6: Consumables 
Material Type  Supplier 
Disinfection, cleaning and sterilization 
Cleaning concentrate for 
glassware and instruments  Deconex® 11 Universal  Borer Chemie AG 
Disinfectant for hands  Sterillium®  Bode Chemie 
Sterilizing bags  MELAfol 1502 (for instruments) MELAG 
Polypropylene 200x300 mm  Roth 
Wipes  TORK® facial tissues, extra soft  SCA 
Precision wipes KIMTECH Science  Kimberly-Clark 
    
Filtration systems 
Bottle top filters  Steritop™ bottle top filter 250 ml / 
500 ml (0.22 µm)  Millipore 
Filtration systems  Stericup™ filter unit 250 ml / 500 ml 
(0.22 µm)  Millipore 
Filter system 250 ml / 500 ml (0.22 µm)  Corning Inc. 
Syringe driven filter units  Millex®-GV, 0.22 µm (sterilization) or 
Millex®-HA, 0.45 µm (clarification)  Millipore 
    
Microscopy and immunohistochemistry 
Cover glasses for microscopy  No. 1, Ø 15 mm  Marienfeld 
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Material Type  Supplier 
Cover glasses with relocation grid  CELLocate® glass coverslips, square size 
55 µm  Eppendorf 
Custom-made glass coverslips with 
4 x 4 mm relocation grid  Laserzentrum Hannover 
Glass bottom dishes 
(for live-cell imaging) 
3 cm (#P35G-1.5-14-C; 14mm hole size) 
3 cm (#P35G-1.5-20-C; 20 mm hole size)  MatTek 
High pressure metal halide arc 
lamp (for AxioObserver)  X-CITE 120, 120 Watt  EXFO Photonic Solutions 
Mercury short arc bulb 
(for Axiovert)  103W/2 Osram 
Microscope slides  76 x 26 mm, with frosted end  Menzel 
    
Pipettes and accessories 
Combitips for multi pipette  0.1 ml / 0.2 ml / 0.5 ml / 1 ml / 2.5 ml / 
50 ml  Eppendorf 
Pasteur pipettes, glass  150 mm or 230 mm, unplugged  Poulten & Graf 
150 mm or 230 mm with cotton plugs  VWR International 
Pipette tips  2 µl / 20 µl / 200 µl / 1000 µl  Peske 
Plastic pipettes  5 ml or 25 ml Costar® Stripette®  Corning Inc. 
Falcon® serological pipette 10 ml  Becton Dickinson 
    
Reaction tubes 
PCR reaction tubes  PCR softstrips 0.2 ml, with attached cap 
strip (#711690)  Biozym 
Reaction tubes  Safelock 1.5 ml or 2 ml  Eppendorf 
Tubes (conical bottom, screw-top)  15 ml or 50 ml tubes  Becton Dickinson 
(Falcon®) or Corning 
    
Tissue culture 
Tissue culture flasks  Nunclon™ Delta surface, 75 cm
2
 
(#153732)  Nunc 
Tissue culture plastic dishes  Nunclon™ Ø 3 cm or 6 cm  Nunc 
Falcon® Ø 10 cm  Becton Dickinson 
    
Miscellaneous  
Ear tags for mice  Four digit ear tags (#73850)  Hauptner & Herberholz 
Gloves, powder-free, disposable  Semperguard, latex or nitrile  Semperit Technische 
Produkte GmbH 
Injection needles, disposable  20G / 22G / 23G / 26G / 27G  Braun, Terumo or Becton 
Dickinson 
Plastic laboratory film  Parafilm “M” 38 m x 10 cm (#PM-996)  Pechiney Plastic Packaging 
Syringes  1 ml / 5 ml / 10 ml / 50 ml  Becton Dickinson 
Thermal recording paper  KP61B-CE  Mitsubishi 
All other consumable materials are mentioned in the methods section. 
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5.1.7  Media and standard solutions 
5.1.7.1  Buffers and standard solutions 
Table 7: Buffers and standard solutions 
Solution  Ingredients and preparation 
10× Agarose gel-
loading buffer 
50% (v/v) 
1x 
glycerol 
TBE buffer 
Mix 5.75 ml of 87% glycerol, 1 ml of 10x TBE buffer 
and distilled water to final volume of 10  ml and add 
saturated Bromphenol blue solution for dark blue color 
(approximately 50 µl). Store in aliquots at 4°C. 
Borate buffer, 
pH 8.5 
1.24 g 
1.90 g 
Boric acid 
Borax 
Dissolve in 390 ml of distilled water. pH should be 8.5, 
adjust with 1  M HCl or NaOH if necessary. Adjust 
volume to 400 ml and filter-sterilize. Store at RT. 
0.5 M EDTA, 
pH 8.0 
186.1  g  EDTA  Add EDTA (disodium salt dihydrate) to 800  ml of 
distilled water. Adjust to pH  8.0: Add about 15  g of 
NaOH pellets while stirring, then carefully add 5  N 
NaOH to bring the pH to 8.0. The EDTA won't dissolve 
completely until pH≈8.0. Adjust volume to 1  l with 
distilled water. Clear solution with 0.45  µm filter and 
sterilize by autoclaving. Store at RT. 
1 M MgCl2  Dissolve 20.33 g MgCl2*6 H2O in 100 ml of distilled water and filter-sterilize. Store in 
small aliquots at RT since MgCl2 is hygroscopic. 
5M NaCl  Dissolve 292.2 g of NaCl in 1 l of distilled water. Autoclave and store at RT. 
5 N NaOH  Dissolve 200 g NaOH in 1 l distilled water. 
16% PFA / Sucrose  16% (w/v) 
16% (w/v) 
PFA 
Sucrose 
PFA should be handled under fume hood. Heat 650 ml 
water to approximately 60°C, add ~3  pellets of NaOH 
and 160 g PFA powder. Close the beaker well to prevent 
evaporation of PFA. The solution should start clearing up 
within ~30 min. Continue heating and stirring until the 
PFA is fully dissolved. Add 160 g sucrose, keep stirring 
until fully dissolved. Add 100 ml 10x PBS. 
Adjust pH to 7.4 with 37% HCl if necessary and adjust 
volume to 1 l with 1x PBS. Filter solution through paper 
filter. Store as aliquots of 50 ml at -20°C. 
 
5x PHEM buffer, 
pH 6,9 
 
300 mM 
125 mM 
50 mM 
10mM 
 
PIPES 
HEPES 
EGTA 
MgCl2 
for 250 ml 
4,54 g PIPES powder 
1,49 g HEPES powder 
5 ml EGTA (500mM) 
0,5 ml MgCl2 (1M) 
      Dissolve all ingredients in 200  ml of distilled water. 
Adjust the pH to 6,9 with ~1/10 of the final volume of 
5 N NaOH. The PIPES will not dissolve until the pH is 
adjusted. Adjust volume to 250 ml with distilled water 
and check pH again. Filter solution through 0.45  µm 
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Solution  Ingredients and preparation 
 
Phosphate-buffered 
saline (PBS) 
 
137 mM 
2.7 mM 
8 mM 
1.5 mM 
 
NaCl 
KCl 
Na2HPO4 
KH2PO4 
for 1 l 
8 g NaCl 
0.2 g KCl 
1.15 g Na2HPO4 
0.24 g KH2PO4 
      Dissolve all ingredients in 800  ml of distilled water. 
Adjust to pH 7.4 with HCl and adjust volume to 1 l with 
distilled water. Sterilize by autoclaving and store at RT. 
For 10x  PBS use the 10-fold amount of salts in 1 l of 
distilled water. 
1M Tris-HCl, 
pH 7.4 or 8.0 
Dissolve 121.1 g Tris base in 800 ml of distilled water. Adjust pH to the desired value 
by adding 37% HCl (~70 ml for pH 7.4; ~ 42 ml for pH 8.0). Adjust volume to 1 l. 
Sterilize by autoclaving and store at RT. 
Tris-EDTA (TE) 
buffer, pH 8.0 
10 mM 
1 mM 
Tris-HCl 
EDTA 
Mix 1 ml 1 M Tris-HCl pH 8.0 and 200 µl 0.5 M EDTA 
pH 8.0 in 90 ml distilled water, check pH and adjust to 
8.0 by adding 37% HCl if necessary. Add distilled water 
to final volume of 100 ml. Sterilize by autoclaving and 
store at RT. 
50× Tris-acetate-
EDTA (TAE) 
electrophoresis 
buffer 
242 g 
57.1 ml 
 
100 ml 
Tris base 
glacial acetic 
acid 
0.5 M EDTA 
(pH 8.0) 
Add distilled water to 1 l. May be autoclaved. Store at 
RT. 
Dilute the concentrated stock buffer to 1x prior to use 
and prepare both gel solution and electrophoresis 
buffer from the diluted buffer. 
10× Tris-borate-
EDTA (TBE) 
electrophoresis 
buffer 
108 g 
55 g 
40 ml 
Tris base 
boric acid 
0.5 M EDTA 
(pH 8.0) 
Add distilled water to 1 l. May be autoclaved. Store at 
RT. 
Dilute the concentrated stock buffer to 0.5-1x prior to 
use and prepare both gel solution and electrophoresis 
buffer from the diluted buffer. 
 
 
5.1.7.2  Media and supplements for primary cell culture 
Table 8: Stock solutions 
Solution Ingredients  Preparation 
5.5% (w/v) NaHCO3  27.5 g  NaHCO3 Dissolve  NaHCO3 in distilled water and filter-sterilize. 
Store at 4°C. 
20% (w/v) Glucose  20% (w/v)  D(+)-glucose  Warm up distilled water and add glucose stepwise 
under constant stirring. Do not autoclave but rather 
filter-sterilize. Store at 4°C. 
L-glutamine (100x)  200 mM  glutamine  Dissolve glutamine in warm distilled water. Store 5 ml 
aliquots at -20°C. 
Pyruvate (100x)  1.1 g  pyruvate  Dissolve pyruvate in 100 ml distilled water. Filter-
sterilize and store at 4°C for up to ~3 months. 
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Table 9: N2 supplements 
Supplement Preparation 
Insulin (1.000x)  Dissolve 50mg insulin in 10ml 0.01N HCl, store aliquots at –20°C. 
Progesteron (1.000x)  Dissolve 63 mg Progesteron in 100 ml ethanol, add 1 ml of this solution to 99 ml 
distilled water. Store aliquots at -20°C. 
Putrescine-
dihydrochloride 
(1.000x) 
Dissolve 161 mg putrescine-dihydrochloride in 10 ml distilled water, store aliquots at 
-20°C. 
Selenium-dioxide 
(1.000x) 
Dissolve 33 mg selenium-dioxide in 100 ml distilled water, add 1 ml of this solution 
to 99 ml distilled water. Store aliquots at -20°C. 
N2 supplement stock 
(10x) 
Mix 5 ml of each insulin, progesteron, putrescine-dihydrochloride and selenium-
dioxide 1.000x-stocks with 500 mg human apo-transferrin in a total volume of 
500 ml N-MEM. Store aliquots for up to ~6 months at -20°C. 
 
Table 10: Cell culture media 
MEM-HS 
(Minimal essential medium 
supplemented with 
10% (v/v) horse serum 
300 ml 
50 ml 
20 ml 
15 ml 
5 ml 
10 ml 
10 ml 
50 ml 
distilled water  
10x MEM 
5,5% NaHCO3 
20% (w/v) glucose 
L-glutamine (100x) 
50x MEM essential aminoacids 
100x MEM non-essential aminoacids 
horse-serum 
  Adjust pH to 7.3 with 1M NaOH, add distilled water to 500 ml. 
Filter-sterilize and store at 4°C for up to ~2 weeks. 
N-MEM  50ml 
20 ml 
15 ml 
5 ml 
5 ml 
10xMEM 
5.5% NaHCO3 
20% (w/v) glucose 
L-Glutamine (100x) 
Pyruvate (100x) 
  Mix all ingredients in a total volume of 500 ml distilled water. 
Filter-sterilize and store at 4°C for up to ~2 weeks. 
N2 medium  450 ml 
50 ml 
100 mg 
N-MEM 
N2 supplement stock (10x) 
Ovalbumin 
  Check pH, adjust to 7.3 if necessary. 
Filter-sterilize and store at 4°C for up to ~2 weeks. 
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5.1.7.3  Media and antibiotics for bacterial culture 
Table 11: Bacterial media 
LB (Luria-Bertani-) media  1% (w/v)
0.5% (w/v)
0.5% (w/v)
Bacto-Trypton 
Yeast extract 
NaCl 
  Add distilled water to final volume, adjust pH to 7.5 if necessary. 
Sterilize by autoclaving and store at RT. 
LB-plates  Like LB media, but supplemented with 1.5% Bacto-Agar before autoclaving. 
Store at 4°C. 
 
LB-Agar was cooled to 55°C, LB-media to RT before the addition of antibiotics. After addition of antibiotics 
selection media and plates were stored at 4°C. 
 
Table 12: Antibiotic stocks 
1.000x stock solutions 
Ampicillin  100 mg/ml 
Kanamycin  50 mg/ml 
 
Dissolve antibiotics in distilled water, filter-sterilize and store aliquots at -20°C. 
 
 
5.1.8 Antibodies 
Antibodies were stored in aliquots at -20°C, thawed aliquots were kept at 4°C. 
 
5.1.8.1 Primary  antibodies 
Table 13: Primary antibodies used for immunohistochemistry 
Antibody  Dilution  Type  Supplier & Product number 
anti-acetylated tubulin 
(clone 6-11B-1)  1:50.000  mouse monoclonal, 
ascites fluid  Sigma, #T-6793 
anti-GFP (goat)  1:5.000  goat polyclonal  USBiological, #G8965-05 
anti-GFP (rabbit)  1:2.000 rabbit  polyclonal  RDI Research Diagnostics Inc., 
#RDI-GRNFP4abr 
anti-MAP2 (goat)  1:2.000  goat polyclonal  Santa Cruz, #sc-5357 
anti-MAP2 (mouse)  1:5.000  mouse monoclonal  Sigma, #M-4403 
anti-MAP2 (rabbit)  1:6.000  rabbit polyclonal  Chemicon, #AB5622 
anti-PSD95 
(clone 6G6-1C9)  1:1.000 mouse  monoclonal  ABR Affinity BioReagents, 
#MA1-045 
anti-Synapsin 1  1:200 (blue 
channel)  rabbit polyclonal  Chemicon, #AB1543 
anti-α-tubulin 
(clone B-5-1-2) 
1:20.000  mouse monoclonal  Sigma, #T-5168     Materials and Methods 
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Antibody  Dilution  Type  Supplier & Product number 
anti-tubulin  1:200  rabbit polyclonal  Sigma, #T-3526 
anti-tyrosinated tubulin 
(YL1/2) 
1:40.000 
rat monoclonal 
Abcam, #ab6160 (purified) 
1:200 to 1:3.000  gift from M. Schleicher 
(supernatant of hybridoma cells) 
Tau-1  1:5.000  mouse monoclonal  Chemicon, #MAB 3420 
anti-neuronal Class III 
ß-Tubulin (Tuj-1) 
1:5.000 to 
1:20.000  mouse monoclonal  Covance, # MMS-435P 
anti-neuron specific 
beta III tubulin (Tuj-1) 
1:50-1:100 
(blue channel)  rabbit polyclonal  Abcam, ab18207 
 
 
5.1.8.2 Secondary  antibodies 
All secondary antibodies were purchased from Invitrogen (formerly Molecular Probes). 
The dilution for all secondary antibodies was 1:500. 
Table 14: Secondary antibodies 
Specificity  Host  Fluorochrome  Order number (Invitrogen) 
anti-goat donkey Alexa Fluor 350  A21081 
   Alexa Fluor 488  A11055 
   Alexa Fluor 568  A11057 
anti-mouse donkey  Alexa Fluor 555  A31570 
 goat  Alexa Fluor 350  A31045 
   Alexa Fluor 488  A11029 
   Alexa Fluor 555  A21429 
   Alexa Fluor 568  A11004 
anti-rabbit donkey  Alexa Fluor 488  A21206 
 goat  Alexa Fluor 350  A21068 
   Alexa Fluor 488  A11034 
   Alexa Fluor 555  A21429 
   Alexa Fluor 568  A11036 
anti-rat goat  Alexa Fluor 568  A11077 
   Alexa Fluor 488  A11006 
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5.1.9 Other  dyes 
Table 15: Other dyes 
Dye Fluorochrome  Concentration  Supplier & Product 
number 
Function 
Rhodamine-Phalloidin  TRITC (red)  2 to 4 U/ml  Invitrogen, #R415  visualization of 
F-actin 
Cell Tracker Blue 
CMAC®  CMAC (blue)  5-20 µM  Invitrogen, #C2110  cytoplasmic dye 
 
Rhodamine-Phalloidin was applied together with secondary antibodies during immunostaining. 
Cell Tracker Blue was added to the media of living cells, excess dye was washed out after 30  minutes 
incubation. 
 
 
5.1.10 Bacteria 
For plasmid propagation the E. coli strain DH5α (Hanahan, 1983) was used. 
The relevant genotype of DH5α is: F' / endA1 hsdR17(rK
-mK
+) glnV44 thi-1 recA1 gyrA (Nal
r) relA1 Δ(laclZYA-
argF)U169 deoR (Φ80dlacΔ(lacZ)M15) 
 
 
5.1.11 Plasmids 
Table 16: Plasmids 
Plasmid name  Selection marker  Description  Reference 
pEGFP-N1-EB3 
Kan
R 
(confers resistance to 
30 µg/ml Kanamycin 
to E. coli hosts) 
Contains the full length cDNA of 
human end binding protein 3 (EB3) 
cloned into the SalI- / BamHI-
restriction sites of pEGFP-N1 
Stepanova et al., 2003 
pEGFP-T7/C1-
α-Tubulin 
Contains alpha-tubulin-cDNA cloned 
into the XhoI- / BamHI-restriction sites 
of pEGFP-T7/C1 
 
pEGFP-N1-EB3 was a gift from Vic Small (IMBA, Vienna, Austria) and Anna Akhmanova (Erasmus Medical 
Center, Rotterdam, Netherlands). pEGFP-T7/C1-α-Tubulin was a gift from Susanna Nagel and Erich Nigg (MPI 
of Biochemistry, Martinsried, Germany). 
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5.1.12 Oligonucleotides 
All oligonucleotides were synthesized by Metabion. Desalted Oligonucleotides were used as primers for PCR 
genotyping or sequencing. Primer sequences are shown from their 5’ to their 3’ end. 
pEYFP-N1 for and EGFP N-term rev primers were used as sequencing primers for pEGFP-N vectors. 
pEGFP-C1 for and pEGFP-C1 rev primers were used as sequencing primers for pEGFP-C vectors. 
 
Table 17: Oligonucleotides 
Primer name  Sequence (5’ Æ 3’) 
pEYFP-N1 for  GGG CGG TAG GCG TGT ACG GTG G 
EGFP N-term rev  CGT CGC CGT CCA GCT CGA CCA G 
pEGFP-C1 for  GAT CAC TCT CGG CAT GGA C 
pEGFP-C1 rev  CAT TTT ATG TTT CAG GTT CAG GG 
SAD A common  TGG GAA GGT AAG CAG GGA GGC CAG GTA ACC 
SAD A WT  TGC CCC TGC TCA CCT TAG GTG TCA CCA TG 
SAD B common  AAT GAA GAT GGC TTG ATA GGC TTA CCA C 
SAD B common 4  GGA GGA ATT TTG TAG ATT TAG CAC CCT GCC 
SAD B WT  TGT CTC CTA TAC CTT GAT AGG TAG GCA G 
J25  TGC CAA GTT CTA ATT CCA TCA GAA GCT G 
Fabpi-200 control primer 3’  TAG AGC TTT GCC ACA TCA CAG GTC ATT CAG 
Fabpi-200 control primer 5’  TGG ACA GGA CTG GAC CTC TGC TTT CCT AGA 
Sequences for Fabpi-200 control primers were designed by the Mouse Genetics Core facility, Washington University in 
St. Louis, School of Medicine (publicly available on http://mgc.wustl.edu/protocols/pcr_primer_set.html). 
 
 
5.2 Methods 
5.2.1 Cell  Culture 
5.2.1.1  Primary culture of hippocampal neurons 
Glass coverslips for hippocampal neurons were bathed overnight in nitric acid (≥65%), rinsed 5x in distilled 
water, sterilized at 220°C for 6 h and distributed to 6 cm petri dishes (5-6 coverslips per dish) under sterile 
conditions. Coverslips were then provided with paraffin dots and coated with poly-L-lysine (1 mg/ml in borate 
buffer, pH 8.5) overnight at RT. Coverslips were washed 3x with distilled water to remove excess poly-L-lysine 
and subsequently incubated with MEM-HS overnight. 
Primary hippocampal neurons derived from rat embryos were cultured as described (de Hoop et al., 1997; Goslin 
and Banker, 1991). In brief, the hippocampi of E17 or E18 rats or mice were dissected, trypsinized for 10 min 
with 0.05% Trypsin-EDTA at 36°C and washed 3x in HBSS. Cells were then triturated approximately 10-20x in 
~2 ml HBSS with both a regular and a fire-polished glass pasteur pipette until the suspension was homogeneous. 
The volume of the suspension was then increased to 5 ml with HBSS and cell density was determined using a     Materials and Methods 
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hemocytometer (Neubauer Improved). 1.0–1.3x10
5 cells were plated onto poly-lysine-coated glass coverslips in 
6 cm petri dishes containing minimal essential medium (MEM) and 10% heat-inactivated horse serum. The cells 
were kept in 5% CO2 at 36.5°C. After 6-12 hours, the coverslips were transferred to a 6 cm dish containing 
astrocytes in MEM and N2 supplements. Hippocampal neurons from E18 SAD A SAD B knockout mice were 
cultured as described above, using mouse wild type astrocytes. For mixed wild type/GFP neuronal cultures 
wild type mouse hippocampal neurons were combined with 1-3% of hippocampal neurons isolated from mice 
expressing enhanced green fluorescent protein (eGFP) under control of the ubiquitously active CAG promoter 
(Ikawa et al., 1998; Okabe et al., 1997), a hybrid promoter composed of the cytomegalovirus (CMV) enhancer, a 
fragment of the chicken β-actin promoter and rabbit β-globin exons (Niwa et al., 1991). 
 
 
5.2.1.2  Primary culture of glia cells 
Cerebral hemispheres were collected after removing the meninges during dissection of hippocampi from E17 or 
E18 rats or mice (~4-5 hemispheres for one culture flask or ~4 hemispheres for ~15 dishes for use during the 
next days). The hemispheres could be kept in HBSS at RT during the preparation of the hippocampal neurons. 
Hemispheres were washed 1-2x with HBSS to remove debris and then trypsinized for ~10  min at 36°C 
(8-10  brains in 5 ml 0.05% Trypsin-EDTA containing 10mM HEPES pH 7,25). Subsequently, Trypsin was 
removed and the hemispheres were carefully washed 2-3x with 5 ml HBSS. Hemispheres were then triturated 
approximately 20 times with the help of a regular and a fire-polished glass pasteur pipette, first in 4 ml, then in 
10 ml total volume until the suspension was homogeneous. To pellet big pieces of debris the suspension was 
centrifuged for 5-10 sec at 80 g after tituration. A volume corresponding to 4-5 hemispheres was then added to 
untreated tissue culture flasks containing 15-20  ml pre-warmed MEM-HS. The next day the medium was 
changed completely to remove cell debris. When the cells reached about 70-80% confluency (7-10 days), they 
were trypsinized for 3-4  min with ~2  ml 0.05% Trypsin-EDTA containing 10  mM HEPES pH  7,25 and 
afterwards split to new flasks (at a ratio of 1:3) or 6 cm-dishes (1 confluent flask for ~40 dishes). The astrocyte 
cultures could be passaged up to three times. 
 
 
5.2.1.3 Transfection  of hippocampal neurons 
Neurons were transfected before plating with the Amaxa Nucleofector system using highly purified DNA 
(EndoFree Maxi Prep; Qiagen). Directly after isolation of hippocampal neurons up to 3-7.5µg of plasmid DNA 
was used for electroporation of 500.000 cells according to the manufacturers’ instructions. In brief, cells were 
centrifuged with 80 g for 5 min at RT, subsequently all the supernatant but 50-100 µl was removed. 100 µl 
transfection buffer and the plasmid DNA were then added, the cells were resuspended by gently pipetting up and 
down approximately 10 times with a 200 µl pipette and transferred to an electroporation cuvette. Next, cells 
were electroporated using the Amaxa Nucleofector program O-003 for rat hippocampal neurons. Directly after 
electroporation, 500  µl of pre-warmed MEM-HS was added to the neurons to increase cell survival. 
Subsequently, neurons were plated in one to three 6 cm dishes containing MEM-HS and further cultured as 
described above.     Materials and Methods 
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5.2.1.4 Drug  treatment 
When necessary, drugs were pre-diluted in their solvent to achieve the desired final concentration with the last 
dilution step in media or HBSS. 
Depending on the experiment, 0.3 to 100 nM taxol, 1 µM cytochalasin D, 15 to 225 nM nocodazole, 10-20 µM 
SB415286, 2 nM trichostatin A and 1 µM tubacin were added to culture medium after 6 to 18 hours after plating, 
and cells were further incubated at 36.5°C in the presence of the drug. 
For short term incubation, 10 to 100 nm taxol or 3.3 to 5 µM nocodazole were added to cells in HBSS. Cells 
were then incubated at 36.5°C in the incubator or on the microscope stage in the presence of the drug. 
Nocodazole and SB415286 precipitate in aqueous solutions. To ensure homogenous distribution of these drugs, 
1 ml of the medium or HBSS of the cells to be treated was transferred to a 2 ml Eppendorf tube, the drugs were 
added to the tube and vortexed immediately after addition. After a short spin (~1 sec ) in a table centrifuge to 
collect the liquid, medium or HBSS were transferred back to the dish and mixed by swirling. 
 
 
5.2.1.5  Microtubule stability assay 
Directly before the experiment, solutions of 3.3 to 5 µM nocodazole in HBSS were prepared: Nocodazole was 
added from the stock to the required amount of HBSS in a 50 ml tube which was then vortexed immediately 
after drug addition. The solution was then distributed to 3 cm dishes and warmed up to 36.5°C in the incubator. 
Neurons grown on glass coverslips with a relocation grid were transferred to plain Hepes-buffered HBSS in 
glass bottom dishes, imaged and then transferred (cells facing up) to one of the dishes containing 
3.3-5 µM nocodazole for 5 min. Subsequently, neurons were simultaneously fixed and permeabilized to remove 
α-tubulin not incorporated in microtubules (PHEM-fixation, see 5.2.3.1 on page 82) and immunostained with 
rhodamine-coupled phalloidin and an anti-α-tubulin antibody (Sigma, #T 5168). F-actin outlining the neuron 
was used as a reference point for measuring microtubule retraction. 
 
 
5.2.2 Microscopy 
5.2.2.1 Image  acquisition 
Images were captured using a Zeiss Axiovert 135TV or a Zeiss Axio Observer D1 microscope equipped with a 
CCD camera from the 4912 series (Cohu) at room temperature (fixed samples) or 36°C (living neurons). The 
camera was connected to a Hamamatsu CCD camera C 2741 control panel. Pictures were recorded on a hard disc 
using an LG3 image grabber and Scion Image, version Beta 4.0.2 (both from Scion Corp.). To acquire both 
phase and fluorescence images from the same time point I constructed a dual-control cable which allows the 
simultaneous control of both phase and fluorescence shutters of the microscope setup (Figure 5-1). 
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5.2.2.2  Time lapse imaging (Video microscopy) 
Living neurons were kept at 36°C on the stage of a Zeiss Axiovert 135TV microscope. Glass bottom dishes 
(MatTek Corporation, Ashland, MA) filled with Hepes-buffered HBSS were used for observation with Zeiss 
LD A-Plan 32x (NA 0.4) or Zeiss Plan-Apochromat 40x (NA 1.0) objectives. Alternatively, custom-made cell 
chambers served for live observation of neurons with a Zeiss Plan-Apochromat 63x (NA 1.4) objective. When 
necessary, drugs were diluted to 4x concentration in HBSS and added on stage during the observation. Cells 
were illuminated with 100 W, 12 V halogen light (Osram) or fluorescence light from a 103W/2 mercury short 
arc bulb (Osram). Halogen light was set to minimal intensity to avoid phototoxicity, fluorescence radiation was 
reduced to 5% or 25% with transmission filters to avoid phototoxicity and reduce bleaching.  
 
 
5.2.2.3  Image Analysis and Quantification 
Length and intensity measurements were taken using Scion Image, version Beta 4.0.2 (Scion Corp.) for 
Windows (Microsoft) or ImageJ analysis software (NIH). Plot profiles of fluorescence intensity were created 
with ImageJ. Average neurite length in experiments with long term nocodazole treatment was determined taking 
into account neurons without processes. To analyze movement of fluorescent particles in EB3-GFP-transfected 
neurons, both phase and fluorescent images were acquired in 5-10  sec-intervals during the experiment. 
Subsequently, kymographs from the regions of interest were made from the individual images using Scion Image 
and a purpose-written macro. EB3-particles were only considered for analysis if they could be followed clearly 
for 3 or more frames in the kymographs. The ratio of acetylated versus tyrosinated α-tubulin was determined 
from the average fluorescence intensity of both channels in a square of 3x3 to 5x5 pixels in the medial part of 
each process, after background subtraction with Adobe Photoshop. 
 
 
5.2.2.4  Scion image macros for image acquisition and analysis 
Several macros were written as plug-ins for Scion Image, version Beta 4.0.2 (Scion Corp.) for Windows 
(Microsoft) to facilitate or allow the acquisition and annotation of phase and fluorescence images of multiple 
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channels, time lapse imaging, measurement of fluorescence intensities and ratios, control of irradiation during 
photoactivation of caged substances, and building and analysis of kymographs of moving particles. 
The source codes of the macros are given in the appendix (p. 103). 
 
 
5.2.2.5 Focal  photoactivation of caged taxol 
Near-UV-light (λ=365 nm) was focused on a spot of 20-30 µm in diameter using the fluorescence iris of a Zeiss 
Axiovert 135 equipped with a Zeiss Plan-Apochromat 40x (NA 1.0) oil immersion objective. A sample stained 
with Cell Tracker Blue CMAC (Molecular Probes) was used to determine the exact position of the spot before 
the experiment. For the uncaging experiment with EB3-GFP transfected neurons, a Zeiss Plan-Apochromat 63x 
(NA 1.4) oil immersion objective was used instead and the cells were handled as described above. Under phase 
light, one dynamic growth cone of an unpolarized stage 2 neuron grown on a relocation coverslip was randomly 
chosen. Subsequently, caged taxol or DMSO was added to the neurons on the microscope stage to a final 
concentration of 1-10 nM or 0.02%, respectively. After equilibration, the tip of the selected growth cone or the 
region directly adjacent to it was pulsed for 10-15  min with near-UV-light (pulse duration 50-100  msec; 
frequency 0.2-0.33 Hz). After uncaging, the neurons were incubated in 5% CO2 at 36.5°C.for another 2 days. 
Neurons were then fixed, stained for Tau-1 and MAP2, relocated and the site of axon formation determined. 
Only neurons which had formed an axon during the 48  hours after uncaging were taken into account. For 
analysis the angle between the edge of the uncaged area, the center of the cell body and the site of axon 
formation was measured. 
For calculation of the probability of random axon formation the number of growth cones within the sector in 
question was divided by the total number of the cells’ growth cones. 
 
 
5.2.2.6 Fluorescence  recovery after photo-bleaching (FRAP) 
FRAP experiments were performed with a life cell imaging setup (Deltavision RT; Applied Precision) based on 
an inverted fluorescence microscope (IX71; Olympus) with a UPlanApo 100x (NA 1.35) oil immersion objective 
(Olympus). The setup included a quantifiable laser module (488nm diode laser) for bleaching GFP and an 
incubation chamber (Solent Scientific). Living neurons were imaged in Hepes-buffered HBSS at 36°C. 
Complete bleaching of the signal of GFP-tubulin was achieved by a 1-3 s laser pulse with 50-100% power 
intensity. Images were acquired using a Photometrics CoolSnap HQ camera (Roper Scientific). SoftWoRx 3.5.0 
(Applied Precision) was used for control of bleaching (one spot; alternatively, two spots simultaneously), image 
recording, deconvolution (based on measured point spread function, iteration method: additive) and analysis of 
the FRAP experiments. 
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5.2.3 Immunocytochemistry 
5.2.3.1 Fixation  methods 
PFA-fixation 
For staining of Tau-1, MAP2, GFP or Synapsin 1, cells were fixed with pre-warmed 4% paraformaldehyde / 
4% sucrose in phosphate-buffered saline (PBS) for 15-20 min at RT, washed 3x with PBS and quenched in 
50 mM ammonium chloride in PBS at RT for 15 min to inactivate residual formaldehyde. After quenching cells 
were permeabilized with 0.1% Triton X-100 in PBS for 3-5 min at RT and washed again 3x with PBS. 
 
PHEM-fixation 
Alternatively, to assess acetylated, tyrosinated and total tubulin without unpolymerized tubulin subunits, i.e. to 
analyze only microtubules, cells were simultaneously fixed and permeabilized for 15 min in pre-warmed PHEM 
buffer (60  mM Pipes, 25  mM Hepes, 5  mM EGTA and 1  mM MgCl) containing 0.25%  glutaraldehyde, 
3.7% paraformaldehyde, 3.7% sucrose, and 0.1% Triton X-100 (modified from Smith, 1994), washed 3x with 
PBS, quenched in 50 mM ammonium chloride in PBS at RT for 15 min and washed again 3x with PBS. 
 
 
5.2.3.2 Immunostaining 
For immunostaining quenched coverslips were transferred to a dark moist chamber, cells facing up. Samples 
were blocked for 1 hr at RT with a solution containing 2% fetal bovine serum, 2% bovine serum albumin, and 
0.2%  fish gelatin dissolved in PBS. Subsequently, cells were incubated with primary antibodies diluted in 
10% blocking solution in PBS for at least 1 h at RT or overnight at 4°C. Cells were then washed 4x with PBS 
and incubated with secondary antibodies diluted in 10% blocking solution in PBS for at least 30 min at RT. 
When necessary, rhodamine-phalloidin was applied together with secondary antibodies. If secondary antibodies 
were incompatible in double or triple stainings, they were applied sequentially with 4 wash steps with PBS 
in-between. After incubation with secondary antibodies, cells were washed 3x with PBS and 2x with distilled 
water. Wax dots of the coverslips were then removed manually, coverslips were mounted using Mowiol or 
Gelmount and slides were dried for ~1h in the dark at RT. 
 
 
5.2.4 Molecular  Biology 
5.2.4.1 Culturing  of  E. coli  
E. coli was cultivated at 37°C under aerobic conditions either in liquid LB-media with vigorous shaking 
(220 rpm) or on LB-plates. Cultures were inoculated from single colonies. For plasmid selection, media or plates 
containing appropriate antibiotics were used. 
The density of a bacterial culture was determined photometrically. An optical density (OD) of 1 at λ=600 nm in 
relation to the blank value (pure medium) corresponds to approximately 1x10
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5.2.4.2 Transformation  of  E. coli  
Preparation of competent E. coli cells 
To set up an overnight culture, 6 ml of plain LB medium were inoculated with E. coli (strain DH5α) and grown 
overnight with vigorous shaking. The next day, ~5 ml of the dense overnight culture were used to inoculate 
500 ml of plain LB medium. Cells were then grown at 37°C with vigorous shaking until the culture reached an 
OD600 of 0.5 (within the range of OD600 0.4-0.6). Subsequently, cells were pelleted in 50 ml conical tubes at 
1600 g for 5 min at 4°C, the supernatant was discarded and the pellets resuspended and pooled in 250 ml of cold 
sterile 0.1M CaCl2. Cells were incubated on ice for at least 15-30 minutes (longer incubations do not pose a 
problem). Then cells were pelleted again at 1600 g for 5 min at 4°C, the pellet resuspended in 10 ml of cold 
sterile 0.1M CaCl2 and sterile glycerol was added to a final concentration of 20%. Aliquots of 100 µl were snap-
frozen in liquid nitrogen and stored at -80°C. 
 
Transformation of competent E. coli cells 
10 to 100µl of chemical competent bacteria were gently thawed on ice and mixed with the plasmid to be 
transformed in an 1.5 ml Eppendorf tube. The tube was incubated on ice for 10 min. Bacteria were heat-shocked 
by incubation at 42°C for 1 min and then chilled on ice for 2 min. 1 ml of plain LB medium (pre-warmed to 
37°C) was added to the cells, incubated at 37°C for 60 min with shaking at 225-250 rpm. 50 to 100 µl of the 
transformation were plated on LB agar plates containing the appropriate antibiotic for plasmid selection and 
incubated at 37°C overnight. Alternatively, when few transformants were expected, the transformation was spun 
down at maximum speed for 10 sec in a table top centrifuge and 900 µl of the supernatant discarded. The 
bacterial pellet was resuspended in the remaining liquid, plated and cultured as described above. 
 
 
5.2.4.3  Preparation of plasmid DNA 
Plasmid DNA was purified from small-scale (3  ml, minipreparation) or from large-scale (100  ml, 
maxipreparation) bacterial cultures. LB medium containing 100 µg/ml ampicillin or 50 µg/ml kanamycin was 
inoculated from single colonies of transformed bacteria, starter cultures or bacterial glycerol stocks and 
incubated overnight at 37°C with vigorous shaking. The bacterial suspension was pelleted by centrifugation at 
6.000 g for 5 min at RT and then resuspended in buffer P1 (Qiagen; 50 mM Tris-Cl, pH 8.0; 10mM EDTA; 
100 µg/ml RNase A). Mini- and EndoFree® Maxipreparation of plasmid DNA were carried out according to the 
Qiagen protocol employing alkaline lysis of the cells and binding of the plasmid DNA to an anion exchange 
resin. After washing, elution and precipitation the plasmid DNA was redissolved in a suitable volume of 
TE  buffer (alternatively 10  mM Tris-Cl, pH  8.0), usually 30  µl for minipreparations and 150  µl for 
maxipreparations. After determining the DNA concentration, plasmid DNA was stored at 4°C to avoid strand 
breaks induced by repeated freeze-thaw cycles. 
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5.2.4.4  Handling of nucleic acids 
Measurement of DNA concentration 
DNA concentration was measured in duplicates in a UV photometer at 260 nm. Samples were diluted in distilled 
water. 
At a wavelength of 260 nm and a sample thickness of 1 cm an OD of 1 corresponds to a concentration of 
50  µg/ml for double stranded DNA, 33  µg/ml for single stranded DNA and 40  µg/ml for RNA. The 
concentration of the sample was therefore OD260 × T × dilution factor = X µg/ml, with T being 50 µg/ml for 
double stranded DNA, 33 µg/ml for single stranded DNA and 40 µg/ml for RNA. 
 
Separation of DNA on agarose gels 
Agarose gels (0.8-2% w/v) for non-denaturing gel electrophoresis were prepared by boiling agarose in 0.5x TBE 
or 1x TAE buffer in a microwave oven. After the agarose had cooled to 55°C, ethidium bromide was added to a 
final concentration between 100 to 200 ng/ml and the gel was poured into a gel casting system. The DNA sample 
and 6× DNA loading buffer (one fifth of the sample volume) were mixed, loaded onto the agarose gel in 
0.5x TBE or 1x TAE buffer and run for approximate 30 to 35 min at 100 to 180 V. After electrophoresis the gel 
was analyzed using an ECX-20.M UV-transilluminator and an IP-CF01.SD gel documentation system (both 
from Peqlab). 
 
 
5.2.4.5 Genotyping 
Preparation of genomic DNA from tissue 
Genomic DNA was prepared from mouse tails by alkaline lysis of the tissue. 150 µl of 50 mM NaOH was added 
to a mouse tail of approximately 2 mm length and heated to 95°C for 1 h until the tissue is lysed. During the 
incubation the samples are vortexed approximately every 15 min for ~10 sec at medium intensity to support 
tissue lysis. After lysis, samples are then chilled on ice for 1 to 2  min, neutralized by addition of 50  µl 
1  M  Tris-HCl (pH  7.5) containing 4  mM EDTA, vortexed at medium intensity and centrifuged at 4°C with 
maximum speed in a table top centrifuge for 5 min. Samples were stored at 4°C and could be used as PCR 
templates for more than one year after preparation. 
 
Genotyping using PCR 
For genotyping, 1  µl of the preparation of genomic DNA was used in a 20  µl-hot start reaction for PCR 
amplification (see Table 18 on page 85). Primers specific for the gene encoding the fatty acid binding protein 
(Fabpi primers) were included in each reaction as an internal control since they yield a PCR product independent 
of the SAD A/B genotype of the animal. For primer sequences see section 5.1.12 Oligonucleotides, page 77. 
Final concentrations in the reactions were: 3.5 mM MgCl2; 0.5 mM dNTPs; 1 U Taq Polymerase; 0.5 µM of all 
SAD primers included in the reaction; 0.2 µM of both Fabpi-200 primers. 
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Table 18: PCR mix for SAD A/B genotyping: 
all amounts in [µl]  SAD A combined  SAD-B Wild type  SAD-B Knockout 
DNA  1 
Water  10.60 11.60 11.60 
10xPuffer  2 
MgCl2 (50mM)  1.4 
dNTPs (10mM)  1 
Polymerase 
(Invitrogen; 5U/µl)  0.2 
J25 (10µM)  1 - 1 
SAD A common (10µM)  1 - - 
SAD A wild type (10µM)  1 - - 
SAD B common (10µM)  - 1 - 
SAD B wild type (10µM)  - 1 - 
SAD B common 4 (10µM)  - - 1 
Fabpi-200--3' (10µM)  0.4 
Fabpi-200--5' (10µM)  0.4 
Total 20 
 
19 µl of the mastermix was transferred to PCR strip tubes on ice using an Eppendorf Multipette. 1 µl of the 
genomic DNA was then added to each tube, mixed thoroughly by vortexing and briefly centrifuged to collect the 
liquid. Samples were then placed into the preheated PCR machine and a program using the following PCR 
cycling parameters was started: 
95°C hot start 
95°C 3min   
95°C 30sec   
72°C 45sec  10 cycles, annealing temperature -0.5°C per cycle (Touchdown-PCR) 
72°C 1min   
95°C 30sec   
68°C 45sec  25 cycles 
72°C 1min   
72°C 10min   
4°C hold    
 
PCRs were subsequently mixed with 10× loading buffer and analyzed by gel electrophoresis in a 1.5% agarose 
gel (0.5x TBE). After electrophoresis, gels were analyzed using a UV-transilluminator and a gel documentation 
system (see section 5.2.4.4). 
Expected band sizes for SAD A/B genotyping: 
SAD A wild type  ~480bp  SAB B wild type ~380bp 
SAD A knockout  ~320 bp (+faint band at ~550bp)  SAB B knockout ~330bp 
      
Fabpi 200  194 bp (for all reactions regardless of the SAD A/B genotype) 
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5.2.5 Transgenic  mice 
SAD A/B knockout mice were kept in a C57/Black6 genetic background (C57BL/6NCrlMpi, animal house, 
Max-Planck-Institute of Neurobiology). Mice were separated from their parents at the age of about three weeks, 
males and females were housed separately. Tail biopsies were taken from mice at the age of approximately 
4  weeks when mice were ear tagged using four-digit number ear  tags from Hauptner  &  Herberholz. For all 
experiments, males heterozygous for both SAD  A and SAD  B were crossed with females heterozygous for 
SAD A and homo- or heterozygous for SAD B. For analysis, mice of one litter were compared. Breedings were 
usually set up with a male to female ratio of 1:2, 2:2 or 3:3, depending on the availability of litter mate males. 
Because of the reduced fertility of SAD A/B knockout mice it was necessary to keep males and females together 
for two days. Embryos were taken 18 days after setting up the breeding, i.e. at E16.5 or E17.5. 
 
 
5.2.6 Data  analysis 
For all data sets, the arithmetic average x , the standard deviation s and the standard error of the mean SEM 
were calculated. Computations were performed using Microsoft Excel. 
 
 
 
 
Error bars depict the SEM. The significance of the data was analyzed using suitable statistical tests: Student’s 
T-tests (paired or unpaired), analysis of variance (ANOVA), Hampel outlier test or Chi-square test. Data were 
considered significant with p<0.05 and highly significant with p<0.01. 
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7. Appendix – Source codes of Scion Image macros 
Source codes of Scion image (version Beta 4.0.2) macros 
(see 5.2.2.4 Scion image macros for image acquisition and analysis, p. 80) 
 
7.1  Triple stain image 
acquisition 
{ Global variables } 
var 
mag, barlength: real;  { objective magnification, size of scale bar to 
use (µm) } 
camerapid: integer;  { PID of camera window } 
bgpid: integer;    { background window } 
bgsub: boolean;    { whether to subtract background } 
tsoff: boolean;    { whether to omit timestamp from captured 
images } 
asoff: boolean;    { whether the AutoShutter feature is off } 
shopen: boolean;    { whether we think the shutter is open } 
tlperiod: real;    { timelapse period } 
n:integer;  {Global variable used by integration macros} 
houri,mini,seci:integer; 
timeron:boolean; 
nframes, nframes1, nframes2, nframes3, pframes, pframes2, 
tlframes:integer; 
name, wavelength, wavelength1, wavelength2, wavelength3:integer; 
antigen, antigen1, antigen2, antigen3, annotation, framenumber: string; 
Settings, Settings1, Settings2, Settings3, generalsettings, nophase: 
boolean; 
NumberofStainings, magnification: integer; 
TimelapseSet, annotateon, annotateon2: boolean; 
year,month,day,hour,min,sec,minute,second,DoW:integer; 
roundnumber: integer; 
 
 
 
{ Error(s) issues the error message S and terminates the macro. } 
procedure Error(s:string); 
begin 
  PutMessage(s); exit; 
end; 
 
 
 
procedure ResetTimer 
var 
    
 year,month,day,hour,min,sec,DoW:integer; 
begin 
    
 GetTime(year,month,day,hour,min,sec,DoW); 
      timeron:=True; 
       houri:=hour; 
       mini:=min; 
       seci:=sec; 
end; 
 
procedure Timer; 
var 
 year,month,day,hour,min,sec,hourC,minC,secC,DoW:i
nteger; 
 year2,month2,day2,hour2,min2,sec2,hourC2,minC2,se
cC2,DoW2:integer; 
 l,t,w,h:integer; 
begin 
 GetRoi(l,t,w,h); 
  If (w=0) then Error('Select an ROI First'); 
  If timeron then begin 
   GetTime(year,month,day,hour,min,sec,DoW);   
    if (sec>=secI) then secC:=sec-secI else begin 
     secC:=(sec+60)-secI; 
     min:=min-1; 
     end; 
    if (min>=mini) then minC:=min-mini else begin 
     minC:=min+60-mini; 
     hour:=hour-1; 
     end; 
     hourC:=hour-houri; 
   MoveTo(665,559); 
     SetForegroundColor(0); 
SetFont('Helvetica');SetFontSize(14); 
  
 GetTime(year2,month2,day2,hour2,min2,sec2,D
oW2); 
     write('Time:  ',hour2:2,':'); 
      if  (min2<10)  then 
Write('0',min2:1,':') else Write(min2:2,':'); 
      if  (sec2<10)  then 
Write('0',sec2:1) else Write(sec2:2); 
   MoveTo(665,  547); 
      write('Date: ', year:4, '-'); 
      if  (month<10)  then 
write ('0', month:1, '-') else write (month:2, '-');
     
     i f  
(day<10) then write ('0', day:1) else write (day:2); 
   MoveTo(560,547); 
       Write('Timer: ',hourC:2,':'); 
         if (minC <10) then 
Write('0',minC:1,':') else Write(minC:2,':'); 
      if  (secC<10)  then 
Write('0',secC:1) else Write(secC:2); 
   RestoreRoi; 
  end else begin 
 ResetTimer; 
 Timer; 
 end; 
end; 
 
 
procedure OpenShutter; 
begin 
  scion[4]:=0; 
  shopen:=true; 
end; 
 
 
macro 'Open Shutter [1]'; 
begin 
 OpenShutter; 
end; 
 
 
 
procedure CloseShutter; 
begin 
  scion[4]:=15; 
  shopen:=false; 
end; 
 
 
macro 'Close Shutter [2]'; 
begin 
 CloseShutter; 
end; 
 
 
 
macro'(-' begin end; {Menu divider} 
 
 
 
macro 'Reset Timer [R]'; 
begin 
     ResetTimer; 
end; 
 
 
macro 'Timer [T]'; 
begin 
     Timer; 
end; 
 
 
{ 
These two macros continuously integrate and display frames either off-
chip, using the Scion AG-5, or on-clip, using the 
Scion LG-3 and a Coho 4910 series camera. Press and 
hold the mouse button near the top of the Camera 
window to decrease the number of frames integrated. 
Press near the bottom to increase the number of 
frames integrated. Press above or to the left of the 
Camera window to stop integrating. 
} 
 
procedure Integrate (mode:string); 
var 
   x,y,delta:integer; 
begin 
   if n=0 then n:=6; 
   repeat     Appendix 
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      if button then begin 
        GetMouse(x,y); 
        if (x<0) or (y<0) then begin 
   closeShutter; 
   exit; 
 end; 
        delta:=round(0.333*n); 
         if delta<1 then delta:=1; 
         if y<220 then begin 
            n:=n-delta; 
            if n<1 then n:=1; 
         end else begin 
             n:=n+delta; 
             if n>127 then n:=127; 
         end; 
      end; 
      AverageFrames(mode, n); 
   until false; 
end; 
 
 
 
macro'(-' begin end; {Menu divider} 
 
 
 
macro 'Counter +1 [+]'; 
begin 
 name:=name+1; 
 ShowMessage('Counter:  ',name); 
end; 
 
 
 
macro 'Counter -1 [-]'; 
begin 
 name:=name-1; 
 ShowMessage('Counter:  ',name); 
end; 
 
 
 
macro 'Picture number +1 [B]'; 
begin 
 roundnumber:=roundnumber+1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
 
macro 'Picture number -1 [V]'; 
begin 
 roundnumber:=roundnumber-1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
 
macro'(-' begin end; {Menu divider} 
 
 
 
macro 'Antigen1 frames +1 [I]'; 
begin 
 nframes1:=nframes1+1; 
 ShowMessage('Antigen1:\Number  of 
frames\integrated: ',nframes1); 
end; 
 
 
 
macro 'Antigen1 frames -1 [J]'; 
begin 
 nframes1:=nframes1-1; 
 ShowMessage('Antigen1:\Number  of 
frames\integrated: ',nframes1); 
end; 
 
 
 
macro 'Antigen2 frames +1 [O]'; 
begin 
 nframes2:=nframes2+1; 
 ShowMessage('Antigen2:\Number  of 
frames\integrated: ',nframes2); 
end; 
 
 
 
macro 'Antigen2 frames -1 [K]'; 
begin 
 nframes2:=nframes2-1; 
 ShowMessage('Antigen2:\Number  of 
frames\integrated: ',nframes2); 
end; 
 
 
 
macro 'Antigen3 frames -1 [6]'; 
begin 
 nframes3:=nframes3-1; 
 ShowMessage('Antigen3:\Number  of 
frames\integrated: ',nframes3); 
end; 
 
 
 
macro 'Antigen3 frames +1 [7]'; 
begin 
 nframes3:=nframes3+1; 
 ShowMessage('Antigen3:\Number  of 
frames\integrated: ',nframes3); 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
procedure FluorescenceSettings; 
begin 
 NumberofStainings:=GetNumber('Enter Number of 
Stainings -1 to 3-:', NumberofStainings); 
    if NumberofStainings <> 1 then 
      if NumberofStainings <> 2 then 
      if  NumberofStainings 
<> 3 then 
    Exit('Only 1, 2 or 3 allowed!'); 
    if NumberofStainings=1 then Settings1:=true 
     else  Settings1:=false; 
    if NumberofStainings=2 then Settings2:=true 
     else  Settings2:=false; 
 
  antigen1:=GetString('Name of Staining 1 / Antigen 1:', 
antigen1); 
    if antigen1='Global String' then Exit('Please 
enter name!'); 
 wavelength1:=GetNumber('Excitation wavelength of 
Antigen 1 in nm:', wavelength1); 
  if (nframes1=0) then nframes1:=4; 
  nframes1:=GetNumber('Number of Fluorescence-
Frames (Antigen 1):', nframes1);   
    if Settings1=true then begin 
     settings  :=  true; 
     Exit; 
   end; 
 
  antigen2:=GetString('Name of Staining 2 / Antigen 2:', 
antigen2); 
    if antigen2='Global String' then Exit('Please 
enter name!'); 
 wavelength2:=GetNumber('Excitation wavelength of 
Antigen 2 in nm:', wavelength2); 
  if (nframes2=0) then nframes2:=4; 
  nframes2:=GetNumber('Number of Fluorescence-
Frames (Antigen 2):', nframes2); 
    if Settings2=true then begin 
     Settings1  :=  true; 
      Settings2 := true; {only necesary if 
number of stainings is changed later} 
      Settings := true; 
     exit; 
   end; 
 
  antigen3:=GetString('Name of Staining 3 / Antigen 3:', 
antigen3); 
    if antigen3='Global String' then Exit('Please 
enter name!'); 
 wavelength3:=GetNumber('Excitation wavelength of 
Antigen 3 in nm:', wavelength3); 
  if (nframes3=0) then nframes3:=4; 
  nframes3:=GetNumber('Number of Fluorescence-
Frames (Antigen 3):', nframes3); 
   Settings1  :=  true; 
   Settings2  :=  true; 
   Settings3  :=  true; 
    Settings := true; 
 exit; 
end; 
 
 
procedure Annotate; 
begin 
  if generalsettings=true then 
 begin 
 MoveTo(10,547); 
   SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
   write(annotation); 
 MoveTo(10,559); 
    write('Magnification:', magnification, 'x'); 
      if (nophase=true) then begin 
          write ('      
', antigen, '      ', wavelength, 'nm      ', nframes); 
       i f  
(nframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
       write('  ', 
framenumber); 
      end; 
      if (nophase=false) then begin write 
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       i f  
(pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
       write('  ', 
framenumber); 
      end; 
 MoveTo(665,547); 
   SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
   GetTime(year,month,day,hour,min,sec,DoW); 
    write('Date: ', year:4, '-'); 
      if (month<10) then write ('0', 
month:1, '-') else write (month:2, '-'); 
      if (day<10) then write ('0', day:1) 
else write (day:2); 
 MoveTo(665,559); 
   write('Time:  ',hour:2,':'); 
       if (min<10) then Write('0',min:1,':') 
else Write(min:2,':'); 
      if (sec<10) then Write('0',sec:1) 
else Write(sec:2); 
 end; 
end; 
 
 
macro 'Fluorescence Settings [N]'; 
begin 
 FluorescenceSettings; 
end; 
 
 
macro 'Phase contrast settings [M]'; 
begin 
  if (pframes=0) then pframes:=2; 
 pframes:=GetNumber('Number of Phase contrast-
Frames to integrate:', pframes); 
end; 
 
 
macro 'General settings [0]'; 
begin 
 annotation:=GetString('Date and/or Type of 
experiment:', annotation); 
 magnification:=GetNumber('Magnification:', 
magnification); 
  ShowMessage('Date and/or Type\of experiment:\', 
annotation, '\\Magnification:', magnification, 'x'); 
 generalsettings:=true; 
end; 
 
 
macro 'Annotation on/off [A]'; 
begin 
 annotateon2:=annotateon; 
  if (annotateon=true) then annotateon:=false; 
 if  (annotateon2=false)  then annotateon:=true; 
  if (annotateon=true) then begin 
   ShowMessage('Annotation  on'); 
  end else begin ShowMessage('Annotation off'); 
 end; 
end; 
 
 
macro 'Save As “Window Title.tif” [S]'; 
begin 
 SetSaveAs('TIFF'); 
 SaveAs; 
End; 
 
 
Macro 'Make Standard ROI [Q]' 
begin 
    MakeRoi(0,34,767,512); 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
macro 'Integrate Phase [P]'; 
begin; 
 nophase:=false; 
 GetTime(year,month,day,hour,minute,second,DoW); 
 StartCapturing; 
 StopCapturing; 
 StartCapturing; 
 name:=name+1; 
  if (pframes=0) then pframes:=2; 
 AverageFrames('Integrate',pframes); 
  
  if (annotateon=true) then Annotate; 
  if (pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  SetPicName(name:3, '_', roundnumber:2, '_1p_', 
year:4, '-', month:2, '-', day:2, '_', hour:2, '.', minute:2, 
'.', second:2, '_', pframes:1, framenumber); 
  duplicate(name:3, '_', roundnumber:2, '_1p_', year:4, '-
', month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', 
second:2, '_', pframes:1, framenumber); 
end; 
 
 
procedure IntegrateFluorescent; 
begin; 
  if (nframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  if (annotateon=true) then begin 
    if (settings=false) then FluorescenceSettings; 
    if (nframes<1) then FluorescenceSettings; 
   nophase:=true; 
 
 GetTime(year,month,day,hour,minute,second,D
oW); 
   StartCapturing; 
   StopCapturing; 
   StartCapturing; 
   OpenShutter; 
   AverageFrames('Integrate On-chip',nframes); 
     Annotate; 
     SetPicName(name:3,  '_', 
roundnumber:2, '_2f_',  antigen, '_', nframes:1, 
framenumber, '_', year:4, '-', month:2, '-', day:2, '_', 
hour:2, '.', minute:2, '.', second:2); 
   CloseShutter; 
    duplicate(name:3, '_', roundnumber:2, '_2f_',  
antigen, '_', nframes:1, framenumber, '_', year:4, '-', 
month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', 
second:2); 
   nophase:=false; 
  end else begin 
    if (nframes<1) then nframes:=1; 
 
 GetTime(year,month,day,hour,minute,second,D
oW); 
   StartCapturing; 
   StopCapturing; 
   StartCapturing; 
   OpenShutter; 
   AverageFrames('Integrate On-chip',nframes); 
   SetPicName(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-
',day:2,'_',hour:2,'.',minute:2,'.', second:2, '_', 
nframes:1, framenumber); 
   CloseShutter; 
   duplicate(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-
',day:2,'_',hour:2,'.',minute:2,'.', second:2, '_', 
nframes:1, framenumber); 
   end;     
end; 
  
 
macro 'Integrate Fluorescent (Antigen 1) [F]'; 
begin 
 settings:=settings1; 
 antigen:=antigen1; 
 wavelength:=wavelength1; 
 nframes:=nframes1; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate Fluorescent (Antigen 2) [G]'; 
begin 
 settings:=settings2; 
 antigen:=antigen2; 
 wavelength:=wavelength2; 
 nframes:=nframes2; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate Fluorescent (Antigen 3) [H]'; 
begin 
 settings:=settings3; 
 antigen:=antigen3; 
 wavelength:=wavelength3; 
 nframes:=nframes3; 
 IntegrateFluorescent; 
end; 
 
macro 'Integrate On-chip Using Cohu [C]'; 
begin 
 StartCapturing; 
   OpenShutter; 
   Integrate('integrate  on-chip'); 
 CloseShutter; 
end;     Appendix 
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7.2  Intensity or ratio 
measurements 
{global variables} 
var 
 n,mean,mode,min,max:integer; 
 left,top,width,height:integer; 
 left2,top2,width2,height2:integer; 
  x, y, xcorrection, ycorrection, leftRoi, topRoi:integer; 
 total:integer; 
 
 
macro 'Synchronize mouse and window coordinates [W]'; 
begin 
  MoveWindow (100, 90); 
 {getmouse(x,  y); 
  showmessage('X: ', x, '  Y: ', y);} 
end; 
 
 
 
procedure PositionROI; 
begin 
 GetMouse(x,y); 
  if (width2=0) then width2:=5; 
 leftRoi:=x+xcorrection-(width2/2);   
    {xcorrection needed as the mouse position 
    ScionImage considers x=0 depends on the 
position 
    of the picture window for unknown reasons} 
  left2:=leftRoi; 
  if (height2=0) then height2:=5; 
 topRoi:=y+ycorrection-(height2/2); 
    {ycorrection needed as the mouse position 
    ScionImage considers y=0 depends on the 
position 
    of the picture window for unknown reasons} 
  top2:=topRoi; 
 MakeRoi(leftRoi,topRoi,width2,height2);   
end; 
 
 
procedure OvalROI; 
begin 
 GetMouse(x,y); 
  if (width2=0) then width2:=5; 
 leftRoi:=x+xcorrection-(width2/2);   
    {xcorrection needed as the mouse position 
    ScionImage considers x=0 depends on the 
position 
    of the picture window for unknown reasons} 
  left2:=leftRoi; 
  if (height2=0) then height2:=5; 
 topRoi:=y+ycorrection-(height2/2); 
    {ycorrection needed as the mouse position 
    ScionImage considers y=0 depends on the 
position 
    of the picture window for unknown reasons} 
  top2:=topRoi; 
 MakeOvalRoi(leftRoi,topRoi,width2,height2);   
end; 
 
 
 
 
macro 'Define Size of rectangular Region of Interest (ROI) by keyboard 
[N]'; 
begin 
  if (width2=0) then width2:=5; 
  if (height2=0) then height2:=5; 
 width2:=GetNumber('Width:',  width2); 
 height2:=GetNumber('Height:', height2); 
 PositionROI; 
end; 
 
 
macro 'Define ROI by mouse [D]'; 
begin 
 GetRoi(left,top,width,height); 
  left2:=left; top2:=top; width2:=width; height2:=height; 
 KillRoi; 
 RestoreRoi; 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
macro 'Position Oval ROI at mouse position (no zoom) [K]'; 
begin 
 xcorrection:=100; 
 ycorrection:=64; 
 OvalROI; 
end; 
 
 
 
macro 'Position ROI at mouse position (no zoom) [P]'; 
begin 
 xcorrection:=100; 
 ycorrection:=64; 
 PositionROI; 
end; 
 
 
macro 'Position ROI at mouse position (2:1 zoom) [6]'; 
begin 
 xcorrection:=49; 
 ycorrection:=32; 
 PositionROI; 
end; 
 
 
macro 'Position ROI at mouse position (3:1 zoom) [7]'; 
begin 
 xcorrection:=32; 
 ycorrection:=20; 
 PositionROI; 
end; 
 
 
macro 'Position ROI at mouse position (4:1 zoom) [8]'; 
begin 
 xcorrection:=24; 
 ycorrection:=15; 
 PositionROI; 
end; 
 
 
macro 'Position ROI at mouse position (8:1 zoom) [9]'; 
begin 
 xcorrection:=12; 
 ycorrection:=7; 
 PositionROI; 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
macro 'Restore ROI [R]'; 
begin 
 RestoreRoi; 
end; 
 
 
macro 'Total and Average density of selection [T]'; 
begin 
 GetRoi(left,top,width,height); 
 measure; 
 GetResults(n,mean,mode,min,max); 
 total:=n*mean; 
  ShowMessage('Total density of selection: ', total, 
'\Average:', mean, '\Pixels:', n); 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
macro 'Display Mouse Position [M]'; 
begin 
 GetMouse(x,y); 
  ShowMessage('x: ', x, ' ', 'y: ', y); 
end; 
 
 
macro 'Correct X-Y coordinates manually [C]'; 
begin 
 GetMouse(x,y); 
 xcorrection:=GetNumber('Correction of x-coordinates:', 
xcorrection); 
 ycorrection:=GetNumber('Correction of y-coordinates:', 
ycorrection); 
end; 
 
 
macro 'Convert to Binary Image [V]'; 
begin 
 MakeBinary; 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
macro 'Invert Picture [I]'; 
begin 
 MakeRoi(0,34,767,512); 
 Invert; 
 KillROI; 
end; 
 
 
procedure CheckForStack; 
begin     Appendix 
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   if nPics=0 then begin 
     PutMessage('This macro requires a stack!'); 
     exit; 
   end; 
   if nSlices=0 then begin 
     PutMessage('This window is not a stack!'); 
     exit; 
   end; 
end; 
 
 
macro 'Invert Stack [O]'; 
var 
 i:integer; 
begin 
 CheckForStack; 
  for i:= 1 to nSlices do begin 
  SelectSlice(i); 
  MakeRoi(0,34,767,512); 
  I n v e r t ;  
 end; 
 SelectSlice(1); 
 KillROI; 
end; 
 
 
Macro 'Make Standard ROI [Q]'; 
begin 
    MakeRoi(0,34,767,512); 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
macro 'Move ROI 1 Pixel left [G]'; 
begin 
 MoveRoi(-1,0); 
  {MoveRoi(dx,dy); Moves ROI right dx pixels and down dy 
pixels.} 
end; 
 
 
macro 'Move ROI 1 Pixel right [H]'; 
begin 
 MoveRoi(1,0); 
end; 
 
 
macro 'Move ROI 1 Pixel up [Z]'; 
begin 
 MoveRoi(0,-1); 
end; 
 
 
macro 'Move ROI 1 Pixel down [B]'; 
begin 
 MoveRoi(0,1); 
end; 
 
 
{ macro '(-' begin end; {Menu divider} } 
 
 
macro 'GoTo Slice Number... [G]'; 
var 
 j:integer; 
begin 
 CheckForStack; 
  j:=GetNumber('Go to slice number...', j); 
 SelectSlice(j); 
end; 
 
 
macro 'Slice Number -5 [K]'; 
begin 
 CheckForStack; 
  If (SliceNumber-5>0) then SelectSlice(SliceNumber-5) 
 Else 
 SelectSlice(1); 
end; 
 
 
macro 'Slice Number +5 [L]'; 
begin 
 CheckForStack; 
  If (SliceNumber+5<nSlices) then SelectSlice(SliceNumber+5) 
 Else 
 SelectSlice(nSlices); 
end;     Appendix 
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7.3  Shutter control during 
uncaging experiments 
{ Global variables } 
var 
mag,  barlength:  real;  { objective magnification, size of scale bar to 
use (µm) } 
camerapid: integer;  { PID of camera window } 
bgpid: integer;    { background window } 
bgsub: boolean;    { whether to subtract background } 
tsoff: boolean;    { whether to omit timestamp from 
captured images } 
asoff:  boolean;    { whether the AutoShutter feature 
is off } 
PhaseOpen, FluorescOpen: boolean;   { whether we think the 
shutter is open } 
tlperiod: real;    { timelapse period } 
n:integer;  {Global variable used by integration macros} 
houri,mini,seci, ticksuncaging1, ticksuncaging2:integer; 
 
frequency, duration, WaitBetweenPics: integer; {Uncaging parameters} 
xcoord, ycoord : integer; {coordinates of uncaged area} 
UncagingSet, Uncaging, AimSet: Boolean; 
left,top,width,height: integer;  {parameters of fluorescence iris ROI} 
 
extension:string; {variable for extension of window title} 
 
timeron:boolean; 
nframes, nframes1, nframes2, nframes3, pframes, pframes2, 
tlframes:integer; 
name, wavelength, wavelength1, wavelength2:integer; 
antigen, antigen1, antigen2, annotation, annotation2, annotation3, 
framenumber: string; 
Settings, Settings1, Settings2, generalsettings, nophase: boolean; 
NumberofStainings, magnification: integer; 
TimelapseSet, annotateon, annotateon2: boolean; 
year,month,day,hour,min,sec,minute,second,DoW:integer; 
roundnumber: integer; 
 
 
 
{ Error(s) issues the error message S and terminates the macro. } 
procedure Error(s:string); 
begin 
  PutMessage(s); exit; 
end; 
 
 
 
procedure ResetTimer 
var 
   
 year,month,day,hour,min,sec,DoW:integer; 
begin 
   
 GetTime(year,month,day,hour,min,sec,DoW); 
    timeron:=True; 
     houri:=hour; 
     mini:=min; 
     seci:=sec; 
end; 
 
procedure Timer; 
var 
 year,month,day,hour,min,sec,hourC,minC,secC,DoW:integer
; 
 year2,month2,day2,hour2,min2,sec2,hourC2,minC2,secC2,D
oW2:integer; 
 l,t,w,h:integer; 
begin 
 GetRoi(l,t,w,h); 
  If (w=0) then Error('Select an ROI First'); 
  If timeron then begin 
  GetTime(year,month,day,hour,min,sec,DoW);   
    if (sec>=secI) then secC:=sec-secI else begin 
   secC:=(sec+60)-secI; 
   min:=min-1; 
   e n d ;  
    if (min>=mini) then minC:=min-mini else begin 
   minC:=min+60-mini; 
   hour:=hour-1; 
   e n d ;  
   hourC:=hour-houri; 
  MoveTo(665,559); 
   SetForegroundColor(0); 
SetFont('Helvetica');SetFontSize(14); 
  
 GetTime(year2,month2,day2,hour2,min2,sec2,DoW2); 
   write('Time:  ',hour2:2,':'); 
    if  (min2<10)  then 
Write('0',min2:1,':') else Write(min2:2,':'); 
    if  (sec2<10)  then 
Write('0',sec2:1) else Write(sec2:2); 
  MoveTo(665,  547); 
   write('Date:  ',  year:4,  '-'); 
    if  (month<10)  then 
write ('0', month:1, '-') else write (month:2, '-');   
     
  if (day<10) then write ('0', day:1) else write (day:2); 
  MoveTo(560,547); 
      Write('Timer:  ',hourC:2,':'); 
       if  (minC  <10)  then 
Write('0',minC:1,':') else Write(minC:2,':'); 
    if  (secC<10)  then 
Write('0',secC:1) else Write(secC:2); 
  RestoreRoi; 
  end else begin 
 ResetTimer; 
 Timer; 
 end; 
end; 
 
 
procedure OpenFluorescenceShutter; 
begin 
  {Uniblitz Shutters are routinely set to active-low, i.e. an input 
signal means no output, no input signal means output} 
  if (PhaseOpen=true) then scion[4]:= 12 {shutter 0 & 1 open} 
else 
    scion[4]:=13; {Shutter 0 closed & 1 open} 
 FluorescOpen:=true; 
end; 
 
 
 
procedure CloseFluorescenceShutter; 
begin 
  if (PhaseOpen=false) then scion[4]:= 15 {all shutters closed} 
else 
    scion[4]:=14;    {Shutter 0 closed & 1 
open} 
 FluorescOpen:=false; 
end; 
 
 
 
procedure OpenPhaseShutter; 
begin 
  if (FluorescOpen=true) then scion[4]:= 12 {shutter 0 & 1 
open} else 
    scion[4]:=14;    {Shutter 0 open & 1 
closed} 
 PhaseOpen:=true; 
end; 
 
 
 
procedure ClosePhaseShutter; 
begin 
  if (FluorescOpen=false) then scion[4]:= 15 {all shutters 
closed} else 
    scion[4]:=13;    {Shutter 0 closed & 1 
open} 
 PhaseOpen:=false; 
end; 
 
 
macro 'Open Fluorescence Shutter [1]'; 
begin 
 OpenFluorescenceShutter; 
end; 
 
 
 
macro 'Close Fluorescence Shutter [2]'; 
begin 
 CloseFluorescenceShutter; 
end; 
 
 
 
macro 'Open Phase Shutter [3]'; 
begin 
 OpenPhaseShutter; 
end; 
 
 
 
macro 'Close Phase Shutter [4]'; 
begin 
 ClosePhaseShutter; 
end; 
 
 
 
macro'(-' begin end; {Menu divider} 
 
 
 
macro 'Reset Timer [R]'; 
begin 
     ResetTimer; 
end; 
 
 
macro 'Timer [T]';     Appendix 
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begin 
     Timer; 
end; 
 
 
{ 
These two macros continuously integrate and display frames either off-
chip, using the Scion AG-5, or on-clip, using the Scion LG-3 and a Coho 
4910 series camera. Press and hold the mouse button near the top of the 
Camera window to decrease the number of frames integrated. Press near 
the bottom to increase the number of frames integrated. Press above or 
to the left of the Camera window to stop integrating. 
} 
 
procedure Integrate (mode:string); 
var 
   x,y,delta:integer; 
begin 
   if n=0 then n:=6; 
   repeat 
      if button then begin 
        GetMouse(x,y); 
        if (x<0) or (y<0) then begin 
  CloseFluorescenceShutter; 
  exit; 
 end; 
        delta:=round(0.333*n); 
         if delta<1 then delta:=1; 
         if y<220 then begin 
            n:=n-delta; 
            if n<1 then n:=1; 
         end else begin 
             n:=n+delta; 
             if n>127 then n:=127; 
         end; 
      end; 
      AverageFrames(mode, n); 
   until false; 
end; 
 
 
 
macro 'Counter +1 [+]'; 
begin 
 name:=name+1; 
 ShowMessage('Counter:  ',name); 
end; 
 
macro 'Counter -1 [-]'; 
begin 
 name:=name-1; 
 ShowMessage('Counter:  ',name); 
end; 
 
 
macro 'Picture number +1 [B]'; 
begin 
 roundnumber:=roundnumber+1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
macro 'Picture number -1 [V]'; 
begin 
 roundnumber:=roundnumber-1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
macro 'Antigen1 frames +1 [I]'; 
begin 
 nframes1:=nframes1+1; 
 ShowMessage('Antigen1:\Number  of  frames\integrated: 
',nframes1); 
end; 
 
 
macro 'Antigen1 frames -1 [J]'; 
begin 
 nframes1:=nframes1-1; 
 ShowMessage('Antigen1:\Number  of  frames\integrated: 
',nframes1); 
end; 
 
 
macro 'Antigen2 frames +1 [O]'; 
begin 
 nframes2:=nframes2+1; 
 ShowMessage('Antigen2:\Number  of  frames\integrated: 
',nframes2); 
end; 
 
 
macro 'Antigen2 frames -1 [K]'; 
begin 
 nframes2:=nframes2-1; 
 ShowMessage('Antigen2:\Number  of  frames\integrated: 
',nframes2); 
 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
procedure FluorescenceSettings; 
begin 
 NumberofStainings:=GetNumber('Enter Number of Stainings 
-1 or 2-:', NumberofStainings); 
    if NumberofStainings <> 1 then 
      if NumberofStainings <> 2 then 
    Exit('Only 1 or 2 allowed!'); 
    if NumberofStainings=1 then Settings1:=true 
   else  Settings1:=false; 
 
  antigen1:=GetString('Name of Staining 1 / Antigen 1:', 
antigen1); 
    if antigen1='Global String' then Exit('Please 
enter name!'); 
 wavelength1:=GetNumber('Excitation wavelength of Antigen 
1 in nm:', wavelength1); 
  if (nframes1=0) then nframes1:=4; 
 nframes1:=GetNumber('Number of Fluorescence-Frames 
(Antigen 1):', nframes1);   
    if Settings1=true then begin 
   settings  :=  true; 
   E x i t ;  
  end; 
 
  antigen2:=GetString('Name of Staining 2 / Antigen 2:', 
antigen2); 
    if antigen2='Global String' then Exit('Please 
enter name!'); 
 wavelength2:=GetNumber('Excitation wavelength of Antigen 
2 in nm:', wavelength2); 
  if (nframes2=0) then nframes2:=4; 
 nframes2:=GetNumber('Number of Fluorescence-Frames 
(Antigen 2):', nframes2); 
  Settings1  :=  true; 
  Settings2  :=  true; 
  Settings  :=  true; 
 exit; 
end; 
 
 
procedure Annotate; 
begin 
  if generalsettings=true then 
 begin 
 MoveTo(10,547); 
  SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
  write(annotation); 
 MoveTo(10,559); 
  write('Magnification:',  magnification,  'x'); 
   if  (nophase=true)  then  begin 
     write  ('           
', antigen, '      ', wavelength, 'nm      ', nframes); 
     i f  
(nframes>1) then framenumber:='frames' else framenumber:='frame'; 
     write('  ', 
framenumber); 
    e n d ;  
   if  (nophase=false)  then  begin  write 
('      Phase contrast      ', pframes); 
     i f  
(pframes>1) then framenumber:='frames' else framenumber:='frame'; 
     write('  ', 
framenumber); 
    e n d ;  
 MoveTo(665,547); 
  SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
  GetTime(year,month,day,hour,min,sec,DoW); 
    write('Date: ', year:4, '-'); 
   if  (month<10)  then  write  ('0', 
month:1, '-') else write (month:2, '-'); 
      if (day<10) then write ('0', day:1) 
else write (day:2); 
 MoveTo(665,559); 
  write('Time:  ',hour:2,':'); 
        if (min<10) then Write('0',min:1,':') 
else Write(min:2,':'); 
   if  (sec<10)  then  Write('0',sec:1) 
else Write(sec:2); 
 end; 
end; 
 
 
macro 'Fluorescence Settings [N]'; 
begin 
 FluorescenceSettings; 
end; 
 
 
macro 'Phase contrast settings [M]'; 
begin 
  if (pframes=0) then pframes:=2; 
  pframes:=GetNumber('Number of Phase contrast-Frames to 
integrate:', pframes); 
end; 
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macro 'General settings [0]'; 
begin 
 annotation:=GetString('Annotation 1: Date and/or Type of 
experiment:', annotation); 
 annotation2:=GetString('Annotation 2: Date and/or Type of 
experiment:', annotation2); 
 magnification:=GetNumber('Magnification:',  magnification); 
  ShowMessage('Date and/or Type\of experiment:\', 
annotation, '\\Magnification:', magnification, 'x'); 
 generalsettings:=true; 
end; 
 
 
macro 'Annotation on/off [A]'; 
begin 
 annotateon2:=annotateon; 
  if (annotateon=true) then annotateon:=false; 
 if  (annotateon2=false)  then annotateon:=true; 
  if (annotateon=true) then begin 
  ShowMessage('Annotation  on'); 
  end else begin ShowMessage('Annotation off'); 
 end; 
end; 
 
 
 
macro 'Toggle annotation'; 
begin 
 annotation3:=annotation; 
 annotation:=annotation2; 
 annotation2:=annotation3; 
 ShowMessage('Annotations  switched'); 
end; 
 
 
 
Procedure SaveAsTitle; 
begin 
 SetSaveAs('TIFF'); 
 SaveAs; 
End; 
 
 
macro 'Save As “Window Title.tif” [S]'; 
begin 
 SaveAsTitle; 
End; 
 
 
 
Macro 'Make Standard ROI [Q]'; 
begin 
    MakeRoi(0,34,767,512); 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
Macro 'Make Standard Fluorescence Iris ROI [D]'; 
begin 
    MakeOvalRoi(335,235,80,80); 
end; 
 
 
 
macro 'Correct Aim [W]'; 
var 
a, b, c, d: integer; 
begin 
 GetROI(a,b,c,d);  {a=left;  b=top; c=width; d=height} 
  If (c<>0) then begin 
  KillROI; 
  StartCapturing; 
  Exit; 
  end; 
  If (c=0) then StopCapturing; 
  If (AimSet = true) then begin 
  MakeOvalRoi(xcoord,  ycoord,  width,  height); 
  end else begin 
  MakeOvalRoi(335,235,80,80); 
 end; 
end; 
 
 
 
macro 'Set Iris ROI [E]'; 
var 
a, b, c, d: integer; 
begin 
  GetRoi(a, b, c, d); {a=left; b=top; c=width; d=height} 
  If (c = 0) then begin 
    Exit('Please use "Correct Aim [W]" or define Iris 
ROI first!'); 
  end; 
  xcoord := a; {values of local position variables are copied to 
global position variables} 
  ycoord := b; {without local variables, there is no ROI any 
more after setting the Iris ROI} 
  width := c;  {when nothing is selected, even if an error is 
displayed} 
  height := d; 
  AimSet := true; 
end; 
 
 
procedure DisplayIris; 
begin 
  MakeOvalRoi(xcoord, ycoord, width, height); 
 SetLineWidth(2); 
 DrawBoundary; 
 KillRoi; 
end; 
 
 
 
macro 'Display Iris ROI [X]'; 
begin 
  If (AimSet = false) then Exit('Please set Iris ROI using "Set 
Iris ROI [E]" first!'); 
 DisplayIris; 
end; 
 
 
macro 'Show Iris Parameters [5]'; 
begin 
  PutMessage('X-coord.: ', xcoord, '   Y-coord.: ', ycoord, '     
Width: ', width, '   Height: ', height); 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
procedure SetUncagingParameters; 
begin 
  frequency := GetNumber('Time between pulses in seconds 
(fractions allowed):', frequency); 
  duration := GetNumber('Duration of pulses in seconds 
(fractions allowed):', duration); 
  If duration >= frequency then Exit('Duration too long for this 
frequency!'); 
 UncagingSet  :=  true; 
end; 
 
 
macro 'Set Uncaging parameters [Z]'; 
begin 
 SetUncagingParameters; 
end; 
 
 
 
procedure IntegratePhase; 
begin; 
 nophase:=false; 
 GetTime(year,month,day,hour,minute,second,DoW); 
  If (Uncaging=false) then begin 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  end; 
 roundnumber:=roundnumber+1; 
  if (pframes=0) then pframes:=1; 
 AverageFrames('Integrate',pframes); 
  
  if (annotateon=true) then Annotate; 
  if (pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  SetPicName(name:3, '_', roundnumber:2, '_1p_', year:4, '-', 
month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2, '_', pframes:1, 
framenumber); 
end; 
 
 
 
 
macro 'Start uncaging [Y]'; 
var 
  i, StartTick, StopTick, NoROI, WithROI:integer; 
begin 
  If UncagingSet=false then SetUncagingParameters; 
  PutMessage('To stop, press "Esc" or hold down "Shift" until 
pulsing ceases!'); 
 i:=0; 
 wait(2); 
 repeat 
  OpenFluorescenceShutter; 
  wait(duration); 
  CloseFluorescenceShutter; 
  Wait(frequency-duration); 
  until KeyDown ('Shift'); 
end; 
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macro 'Check ROI during uncaging[]'; 
var 
 NoROI,  WithROI:integer; 
begin 
 IntegratePhase; 
 SetPicName(windowtitle, '_during uncaging'); 
 SaveAsTitle; 
 NoROI:=PidNumber; 
 duplicate(windowtitle,  '_ROI'); 
 WithROI:=PidNumber; 
 DisplayIris; 
 SaveAsTitle; 
 SelectPic(NoROI); 
 Dispose; 
 SelectPic(WithROI); 
end; 
 
 
 
{macro 'Test'; in principal a macro to test how long a process takes 
var 
  i, NoROI, WithROI, a, b, duration:integer; 
begin 
 a:=TickCount; 
 OpenPhaseShutter; 
 IntegratePhase; 
 ClosePhaseShutter; 
 SaveAs; 
 NoROI:=PidNumber; 
 duplicate(windowtitle,  '_ROI'); 
 WithROI:=PidNumber; 
 DisplayIris; 
 SaveAs; 
 ChoosePic(NoROI); 
 Dispose; 
 b:=TickCount; 
 duration:=(b-a)/60; 
 SetPrecision(3); 
  ShowMessage(a,'\',b,'\Duration in sec: ',duration); 
end;} 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
macro 'Integrate Phase [P]'; 
begin 
 IntegratePhase; 
 duplicate(windowtitle); 
end; 
 
 
 
procedure IntegrateFluorescent; 
begin; 
  if (nframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  if (annotateon=true) then begin 
    if (settings=false) then FluorescenceSettings; 
    if (nframes<1) then FluorescenceSettings; 
  nophase:=true; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
   Annotate; 
   SetPicName(name:3,  '_', 
roundnumber:2, '_2f_',  antigen, '_', nframes:1, framenumber, '_', year:4, 
'-', month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2); 
  CloseFluorescenceShutter; 
    duplicate(name:3, '_', roundnumber:2, '_2f_',   
antigen, '_', nframes:1, framenumber, '_', year:4, '-', month:2, '-', day:2, '_', 
hour:2, '.', minute:2, '.', second:2); 
  nophase:=false; 
  end else begin 
    if (nframes<1) then nframes:=1; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
  SetPicName(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-',day:2,'_',hour:2,'.',minute:2,'.', 
second:2, '_', nframes:1, framenumber); 
  CloseFluorescenceShutter; 
  duplicate(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-',day:2,'_',hour:2,'.',minute:2,'.', 
second:2, '_', nframes:1, framenumber); 
  end;    
end; 
  
 
macro 'Integrate Fluorescent (Antigen 1) [F]'; 
begin 
 settings:=settings1; 
 antigen:=antigen1; 
 wavelength:=wavelength1; 
 nframes:=nframes1; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate Fluorescent (Antigen 2) [G]'; 
begin 
 settings:=settings2; 
 antigen:=antigen2; 
 wavelength:=wavelength2; 
 nframes:=nframes2; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate On-chip Using Cohu [C]'; 
begin 
 StartCapturing; 
  OpenFluorescenceShutter; 
  Integrate('integrate  on-chip'); 
 CloseFluorescenceShutter; 
end; 
 
 
 
macro 'Integrate InvertedÉ'; 
{ 
Inverts captured video to allow more than 128 frames to be 
integrated without overflow. For example, the sum of 256 pixels 
with an average value of 200(very dark) is 51,200, which is 
greater than the 32,767 maximum, but the sum of 256 pixels 
with and average value of 55(200 inverted) is 14,080. 
} 
begin 
  nframes:=GetNumber('Number of Frames:', 200); 
  SetVideo('Invert'); 
  AverageFrames('Integrate', nframes); 
  SetVideo(''); {Don't invert} 
  Invert; 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
procedure SetTimelapse; 
begin 
  if (tlperiod=0) then tlperiod:=20; 
  tlperiod:=GetNumber('Seconds between pictures:',tlperiod); 
  PutMessage ('Your current integration settings for phase 
will be used for the time lapse.'); 
 TimelapseSet:=true; 
end; 
 
macro 'Set Phase-Timelapse'; 
begin 
 SetTimelapse; 
end; 
 
 
 
procedure TimelapsePhase; 
begin; 
 nophase:=false; 
 GetTime(year,month,day,hour,minute,second,DoW); 
 StartCapturing; 
 OpenPhaseShutter; 
 roundnumber:=roundnumber+1; 
  if (pframes=0) then pframes:=1; 
 AverageFrames('Integrate',pframes); 
 ClosePhaseShutter; 
  if (annotateon=true) then Annotate; 
  if (pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  SetPicName(name:3, '_', roundnumber:2, '_1p_', year:4, '-', 
month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2, '_', pframes:1, 
framenumber, '_before uncaging'); 
end; 
 
 
 
macro 'Phase-Timelapse'; 
var 
  l,t,w,h:integer; 
  year,month,day,hour,minute,second,DoW:integer; 
  time,next,last:real; 
begin 
  if (WindowTitle<>'Camera') then Startcapturing; 
  if TimelapseSet=false then 
  SetTimelapse; 
  GetROI(l,t,w,h); 
  if (w=0) then SelectAll; 
  KillROI; RestoreROI;    { save ROI for future RestoreROIs } 
 
  StopCapturing;    { in case we're live } 
  if (tlperiod=0) then tlperiod:=20;     Appendix 
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  { start at the next multiple of tlperiod } 
  GetTime(year,month,day,hour,minute,second,DoW); 
  time:=second+60*(minute+60*hour); 
  if (tlperiod<60) then next:=time+tlperiod 
    else next:=time+(60-second); 
  last:=time; 
   
  while true do begin 
    while (time<next) do begin 
      GetTime(year,month,day,hour,minute,second,DoW); 
      time:=second+60*(minute+60*hour); 
      if (time>last) then begin 
        ShowMessage(hour:2,':',minute:2,':',second:2,'\',next-time); 
        last:=time; 
      end; 
    end; 
{take phase picture} 
 TimelapsePhase; 
 
    GetTime(year,month,day,hour,minute,second,DoW); 
    RestoreROI; 
 Timer; 
    RestoreROI; 
 
{save phase image} 
 SetSaveAs('TIFF'); 
 SaveAs; 
 
    if (w>0) then begin 
      SetLineWidth(1); 
      DrawBoundary; 
    end; 
    RestoreROI; 
    next:=next+tlperiod; 
  end; 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
procedure ExtendWindowtitle; 
begin 
 duplicate(windowtitle); 
 SetPicName(windowtitle,  extension); 
end; 
 
 
 
macro 'Add "_before uncaging" to window title [6]'; 
begin 
 extension:='_before  uncaging'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Add "_after uncaging" to window title [7]'; 
begin 
 extension:='_after  uncaging'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Add "_ROI" to window title [8]'; 
begin 
 extension:='_ROI'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Shorten window title by one character [9]'; 
var 
 picnamelength:  integer; 
 picname:  string; 
begin 
 picname:=windowtitle; 
 picnamelength:=length(windowtitle); 
  Delete(picname, picnamelength, 1); {removes last character 
from picture name} 
 SetPicName(picname); 
end; 
 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
macro 'Add "_1 day recovery" to window title [3]'; 
begin 
  extension:='_1 day recovery'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Add "_2 days recovery" to window title [4]'; 
begin 
  extension:='_2 days recovery'; 
 ExtendWindowtitle; 
end; 
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7.4  Time lapse imaging 
{ Global variables } 
var 
mag,  barlength:  real;  { objective magnification, size of scale bar to 
use (µm) } 
camerapid: integer;  { PID of camera window } 
bgpid: integer;    { background window } 
bgsub: boolean;    { whether to subtract background } 
tsoff: boolean;    { whether to omit timestamp from 
captured images } 
asoff:  boolean;    { whether the AutoShutter feature 
is off } 
PhaseOpen, FluorescOpen: boolean; { whether we think the shutters are 
open } 
tlperiod: real;    { timelapse period } 
n:integer;  {Global variable used by integration macros} 
houri,mini,seci:integer; 
timeron:boolean; 
nframes, nframes1, nframes2, nframes3, pframes, pframes2:integer; 
name, wavelength, wavelength1, wavelength2:integer; 
antigen, antigen1, antigen2, annotation, annotation2, annotation3, 
framenumber: string; 
Settings, Settings1, Settings2, generalsettings, nophase: boolean; 
NumberofStainings, magnification: integer; 
TimelapseSet, annotateon, annotateon2: boolean; 
KindOfTimelapse: integer; 
year,month,day,hour,min,sec,minute,second,DoW:integer; 
roundnumber: integer; 
 
 
 
{ Error(s) issues the error message S and terminates the macro. } 
procedure Error(s:string); 
begin 
  PutMessage(s); exit; 
end; 
 
 
 
procedure ResetTimer 
var 
   
 year,month,day,hour,min,sec,DoW:integer; 
begin 
   
 GetTime(year,month,day,hour,min,sec,DoW); 
    timeron:=True; 
     houri:=hour; 
     mini:=min; 
     seci:=sec; 
end; 
 
procedure Timer; 
var 
 year,month,day,hour,min,sec,hourC,minC,secC,DoW:integer
; 
 year2,month2,day2,hour2,min2,sec2,hourC2,minC2,secC2,D
oW2:integer; 
 l,t,w,h:integer; 
begin 
 GetRoi(l,t,w,h); 
  If (w=0) then Error('Select an ROI First'); 
  If timeron then begin 
  GetTime(year,month,day,hour,min,sec,DoW);   
    if (sec>=secI) then secC:=sec-secI else begin 
   secC:=(sec+60)-secI; 
   min:=min-1; 
   e n d ;  
    if (min>=mini) then minC:=min-mini else begin 
   minC:=min+60-mini; 
   hour:=hour-1; 
   e n d ;  
   hourC:=hour-houri; 
  MoveTo(665,559); 
   SetForegroundColor(0); 
SetFont('Helvetica');SetFontSize(14); 
  
 GetTime(year2,month2,day2,hour2,min2,sec2,DoW2); 
   write('Time:  ',hour2:2,':'); 
    if  (min2<10)  then 
Write('0',min2:1,':') else Write(min2:2,':'); 
    if  (sec2<10)  then 
Write('0',sec2:1) else Write(sec2:2); 
  MoveTo(665,  547); 
   write('Date:  ',  year:4,  '-'); 
    if  (month<10)  then 
write ('0', month:1, '-') else write (month:2, '-');   
     
  if (day<10) then write ('0', day:1) else write (day:2); 
  MoveTo(580,559); 
      Write('Timer:  ',hourC:2,':'); 
       if  (minC  <10)  then 
Write('0',minC:1,':') else Write(minC:2,':'); 
    if  (secC<10)  then 
Write('0',secC:1) else Write(secC:2); 
  RestoreRoi; 
  end else begin 
 ResetTimer; 
 Timer; 
 end; 
end; 
 
 
procedure OpenFluorescenceShutter; 
begin 
  {Uniblitz Shutters are routinely set to active-low, i.e. an input 
signal means no output, no input signal means output} 
  if (PhaseOpen=true) then scion[4]:= 12 {shutter 0 & 1 open} 
else 
    scion[4]:=13; {Shutter 0 closed & 1 open} 
 FluorescOpen:=true; 
end; 
 
 
 
procedure CloseFluorescenceShutter; 
begin 
  if (PhaseOpen=false) then scion[4]:= 15 {all shutters closed} 
else 
    scion[4]:=14;    {Shutter 0 closed & 1 
open} 
 FluorescOpen:=false; 
end; 
 
 
 
procedure OpenPhaseShutter; 
begin 
  if (FluorescOpen=true) then scion[4]:= 12 {shutter 0 & 1 
open} else 
    scion[4]:=14;    {Shutter 0 open & 1 
closed} 
 PhaseOpen:=true; 
end; 
 
 
 
procedure ClosePhaseShutter; 
begin 
  if (FluorescOpen=false) then scion[4]:= 15 {all shutters 
closed} else 
    scion[4]:=13;    {Shutter 0 closed & 1 
open} 
 PhaseOpen:=false; 
end; 
 
 
macro 'Open Fluorescence Shutter [1]'; 
begin 
 OpenFluorescenceShutter; 
end; 
 
 
 
macro 'Close Fluorescence Shutter [2]'; 
begin 
 CloseFluorescenceShutter; 
end; 
 
 
 
macro 'Open Phase Shutter [3]'; 
begin 
 OpenPhaseShutter; 
end; 
 
 
 
macro 'Close Phase Shutter [4]'; 
begin 
 ClosePhaseShutter; 
end; 
 
 
 
macro'(-' begin end; {Menu divider} 
 
 
 
macro 'Reset Timer [R]'; 
begin 
     ResetTimer; 
end; 
 
 
macro 'Timer [T]'; 
begin 
     Timer; 
end; 
 
 
{ 
These two macros continuously integrate and display frames either off-
chip, using the Scion AG-5, or on-clip, using the Scion LG-3 and a Coho     Appendix 
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4910 series camera. Press and hold the mouse button near the top of the 
Camera window to decrease the number of frames integrated. Press near 
the bottom to increase the number of frames integrated. Press above or 
to the left of the Camera window to stop integrating. 
} 
 
procedure Integrate (mode:string); 
var 
   x,y,delta:integer; 
begin 
   if n=0 then n:=6; 
   repeat 
      if button then begin 
        GetMouse(x,y); 
        if (x<0) or (y<0) then begin 
  closeFluorescenceShutter; 
  exit; 
 end; 
        delta:=round(0.333*n); 
         if delta<1 then delta:=1; 
         if y<220 then begin 
            n:=n-delta; 
            if n<1 then n:=1; 
         end else begin 
             n:=n+delta; 
             if n>127 then n:=127; 
         end; 
      end; 
      AverageFrames(mode, n); 
   until false; 
end; 
 
 
 
macro 'Counter +1 [+]'; 
begin 
 name:=name+1; 
 ShowMessage('Counter:  ',name); 
end; 
 
macro 'Counter -1 [-]'; 
begin 
 name:=name-1; 
 ShowMessage('Counter:  ',name); 
end; 
 
 
macro 'Picture number +1 [B]'; 
begin 
 roundnumber:=roundnumber+1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
macro 'Picture number -1 [V]'; 
begin 
 roundnumber:=roundnumber-1; 
 ShowMessage('Picture  number:\',roundnumber); 
end; 
 
 
macro 'Antigen1 frames +1 [I]'; 
begin 
 nframes1:=nframes1+1; 
 ShowMessage('Antigen1:\Number  of  frames\integrated: 
',nframes1); 
end; 
 
 
macro 'Antigen1 frames -1 [J]'; 
begin 
 nframes1:=nframes1-1; 
 ShowMessage('Antigen1:\Number  of  frames\integrated: 
',nframes1); 
end; 
 
 
macro 'Antigen2 frames +1 [O]'; 
begin 
 nframes2:=nframes2+1; 
 ShowMessage('Antigen2:\Number  of  frames\integrated: 
',nframes2); 
end; 
 
 
macro 'Antigen2 frames -1 [K]'; 
begin 
 nframes2:=nframes2-1; 
 ShowMessage('Antigen2:\Number  of  frames\integrated: 
',nframes2); 
 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
procedure FluorescenceSettings; 
begin 
 NumberofStainings:=GetNumber('Enter Number of Stainings 
-1 or 2-:', NumberofStainings); 
    if NumberofStainings <> 1 then 
      if NumberofStainings <> 2 then 
    Exit('Only 1 or 2 allowed!'); 
    if NumberofStainings=1 then Settings1:=true 
   else  Settings1:=false; 
 
  antigen1:=GetString('Name of Staining 1 / Antigen 1:', 
antigen1); 
    if antigen1='Global String' then Exit('Please 
enter name!'); 
 wavelength1:=GetNumber('Excitation wavelength of Antigen 
1 in nm:', wavelength1); 
  if (nframes1=0) then nframes1:=4; 
 nframes1:=GetNumber('Number of Fluorescence-Frames 
(Antigen 1):', nframes1);   
    if Settings1=true then begin 
   settings  :=  true; 
   E x i t ;  
  end; 
 
  antigen2:=GetString('Name of Staining 2 / Antigen 2:', 
antigen2); 
    if antigen2='Global String' then Exit('Please 
enter name!'); 
 wavelength2:=GetNumber('Excitation wavelength of Antigen 
2 in nm:', wavelength2); 
  if (nframes2=0) then nframes2:=4; 
 nframes2:=GetNumber('Number of Fluorescence-Frames 
(Antigen 2):', nframes2); 
  Settings1  :=  true; 
  Settings2  :=  true; 
  Settings  :=  true; 
 exit; 
end; 
 
 
procedure Annotate; 
begin 
  if generalsettings=true then 
 begin 
 MoveTo(10,547); 
  SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
  write(annotation); 
 MoveTo(10,559); 
  write('Magnification:',  magnification,  'x'); 
   if  (nophase=true)  then  begin 
     write  ('           
', antigen, '      ', wavelength, 'nm      ', nframes); 
     i f  
(nframes>1) then framenumber:='frames' else framenumber:='frame'; 
     write('  ', 
framenumber); 
    e n d ;  
   if  (nophase=false)  then  begin  write 
('      Phase contrast      ', pframes); 
     i f  
(pframes>1) then framenumber:='frames' else framenumber:='frame'; 
     write('  ', 
framenumber); 
    e n d ;  
 MoveTo(665,547); 
  SetForegroundColor(0); SetFont('Helvetica'); 
SetFontSize(14); 
  GetTime(year,month,day,hour,min,sec,DoW); 
    write('Date: ', year:4, '-'); 
   if  (month<10)  then  write  ('0', 
month:1, '-') else write (month:2, '-'); 
      if (day<10) then write ('0', day:1) 
else write (day:2); 
 MoveTo(665,559); 
  write('Time:  ',hour:2,':'); 
        if (min<10) then Write('0',min:1,':') 
else Write(min:2,':'); 
   if  (sec<10)  then  Write('0',sec:1) 
else Write(sec:2); 
 end; 
end; 
 
 
macro 'Fluorescence Settings [N]'; 
begin 
 FluorescenceSettings; 
end; 
 
 
macro 'Phase contrast settings [M]'; 
begin 
  if (pframes=0) then pframes:=1; 
  pframes:=GetNumber('Number of Phase contrast-Frames to 
integrate:', pframes); 
end; 
 
 
macro 'General settings [0]'; 
begin 
 annotation:=GetString('Annotation 1: Date and/or Type of 
experiment:', annotation); 
 annotation2:=GetString('Annotation 2: Date and/or Type of 
experiment:', annotation2); 
 magnification:=GetNumber('Magnification:', magnification);     Appendix 
Ph.D. Thesis Harald Witte   115 
  ShowMessage('Date and/or Type\of experiment:\', 
annotation, '\\Magnification:', magnification, 'x'); 
 generalsettings:=true; 
end; 
 
 
macro 'Annotation on/off [A]'; 
begin 
 annotateon2:=annotateon; 
  if (annotateon=true) then annotateon:=false; 
 if  (annotateon2=false)  then annotateon:=true; 
  if (annotateon=true) then begin 
  ShowMessage('Annotation  on'); 
  end else begin ShowMessage('Annotation off'); 
 end; 
end; 
 
 
 
macro 'Toggle annotation [7]'; 
begin 
 annotation3:=annotation; 
 annotation:=annotation2; 
 annotation2:=annotation3; 
 ShowMessage('Annotations  switched'); 
end; 
 
 
 
macro 'Save As “Window Title.tif” [S]'; 
begin 
 SetSaveAs('TIFF'); 
 SaveAs; 
End; 
 
 
Macro 'Make Standard ROI [Q]' 
begin 
    MakeRoi(0,34,767,512); 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
 
macro 'Integrate Phase [P]'; 
begin; 
 nophase:=false; 
 GetTime(year,month,day,hour,minute,second,DoW); 
 StartCapturing; 
 StopCapturing; 
 StartCapturing; 
 name:=name+1; 
  if (pframes=0) then pframes:=2; 
 AverageFrames('Integrate',pframes); 
  
  if (annotateon=true) then Annotate; 
  if (pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  SetPicName(name:3, '_', roundnumber:2, '_1p_', year:4, '-', 
month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2, '_', pframes:1, 
framenumber); 
 duplicate(windowtitle); 
end; 
 
 
procedure IntegrateFluorescent; 
begin; 
  if (nframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  if (annotateon=true) then begin 
    if (settings=false) then FluorescenceSettings; 
    if (nframes<1) then FluorescenceSettings; 
  nophase:=true; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
   Annotate; 
   SetPicName(name:3,  '_', 
roundnumber:2, '_2f_',  antigen, '_', nframes:1, framenumber, '_', year:4, 
'-', month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2); 
  closeFluorescenceShutter; 
    duplicate(name:3, '_', roundnumber:2, '_2f_',   
antigen, '_', nframes:1, framenumber, '_', year:4, '-', month:2, '-', day:2, '_', 
hour:2, '.', minute:2, '.', second:2); 
  nophase:=false; 
  end else begin 
    if (nframes<1) then nframes:=1; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
  SetPicName(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-',day:2,'_',hour:2,'.',minute:2,'.', 
second:2, '_', nframes:1, framenumber); 
  closeFluorescenceShutter; 
  duplicate(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-',day:2,'_',hour:2,'.',minute:2,'.', 
second:2, '_', nframes:1, framenumber); 
  end;    
end; 
  
 
macro 'Integrate Fluorescent (Antigen 1) [F]'; 
begin 
 settings:=settings1; 
 antigen:=antigen1; 
 wavelength:=wavelength1; 
 nframes:=nframes1; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate Fluorescent (Antigen 2) [G]'; 
begin 
 settings:=settings2; 
 antigen:=antigen2; 
 wavelength:=wavelength2; 
 nframes:=nframes2; 
 IntegrateFluorescent; 
end; 
 
 
macro 'Integrate On-chip Using Cohu [C]'; 
begin 
 StartCapturing; 
  OpenFluorescenceShutter; 
  Integrate('integrate  on-chip'); 
 closeFluorescenceShutter; 
end; 
 
 
 
macro 'Integrate InvertedÉ'; 
{ 
Inverts captured video to allow more than 128 frames to be 
integrated without overflow. For example, the sum of 256 pixels 
with an average value of 200(very dark) is 51,200, which is 
greater than the 32,767 maximum, but the sum of 256 pixels 
with and average value of 55(200 inverted) is 14,080. 
} 
begin 
  nframes:=GetNumber('Number of Frames:', 200); 
  SetVideo('Invert'); 
  AverageFrames('Integrate', nframes); 
  SetVideo(''); {Don't invert} 
  Invert; 
end; 
 
 
macro '(-' begin end; {Menu divider} 
 
 
procedure SetTimelapse; 
begin 
  if (tlperiod=0) then tlperiod:=5; 
  tlperiod:=GetNumber('Seconds between pictures:',tlperiod); 
  KindOfTimelapse:= GetNumber('Timelapse: 1=Phase; 2= 
Fluorescence; 3=both', KindOfTimelapse); 
  If  ((KindOfTimelapse<>1)  AND 
(KindOfTimelapse<>2) AND (KindOfTimelapse<>3)) then Exit('Only 1, 2 
or 3 allowed!'); 
  PutMessage ('Your current integration settings for phase 
and fluorescence will be used for the time lapse.'); 
 TimelapseSet:=true; 
end; 
 
macro 'Set Timelapse [8]'; 
begin 
 SetTimelapse; 
end; 
 
 
 
{Timelapse starts taking a timelapse series of pictures, every tlperiod 
seconds (use Set Timelapse to set this period). Use command-period to 
abort the series. 
 
Note: the timing loop doesn't handle the transition over midnight.} 
 
 
 
procedure TimelapsePhase; 
begin 
 nophase:=false; 
 GetTime(year,month,day,hour,minute,second,DoW); 
 StartCapturing; 
 OpenPhaseShutter; 
 name:=name+1; 
  if (pframes=0) then pframes:=1; 
 AverageFrames('Integrate',pframes); 
 ClosePhaseShutter; 
  if (annotateon=true) then Annotate;     Appendix 
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  if (pframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  SetPicName(name:3, '_', roundnumber:2, '_1p_', year:4, '-', 
month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2, '_', pframes:1, 
framenumber); 
end; 
 
 
 
procedure InsertTimer; 
begin 
 GetTime(year,month,day,hour,minute,second,DoW); 
 RestoreROI; 
 Timer; 
 RestoreROI; 
end; 
 
 
 
procedure TimelapseFluorescent; 
begin; 
  if (nframes>1) then framenumber:='frames' else 
framenumber:='frame'; 
  if (annotateon=true) then begin 
    if (settings=false) then FluorescenceSettings; 
    if (nframes<1) then FluorescenceSettings; 
  nophase:=true; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
   Annotate; 
   SetPicName(name:3,  '_', 
roundnumber:2, '_2f_',  antigen, '_', nframes:1, framenumber, '_', year:4, 
'-', month:2, '-', day:2, '_', hour:2, '.', minute:2, '.', second:2); 
  closeFluorescenceShutter; 
  nophase:=false; 
  end else begin 
    if (nframes<1) then nframes:=1; 
 
 GetTime(year,month,day,hour,minute,second,DoW); 
  StartCapturing; 
  StopCapturing; 
  StartCapturing; 
  OpenFluorescenceShutter; 
  AverageFrames('Integrate  On-chip',nframes); 
  SetPicName(name:3,  '_', 
roundnumber:2,'_',year:4,'-',month:2,'-',day:2,'_',hour:2,'.',minute:2,'.', 
second:2, '_', nframes:1, framenumber); 
  closeFluorescenceShutter; 
  end;    
end; 
 
 
 
procedure AcquireImages; 
begin 
  if (KindOfTimelapse<>2) then begin  { KindOfTimelapse<>2 
means 'NOT "fluorescence only", but phase (1) or phase/fluorescence 
(3)' } 
    TimelapsePhase;  { take phase picture } 
  InsertTimer; 
    { save phase image } 
  SetSaveAs('TIFF'); 
  S a v e A s ;  
 end; 
 
  if (KindOfTimelapse<>1) then begin  { 'KindOfTimelapse<>1 
means NOT "phase only", but fluorescence (2) or phase/fluorescence (3)' 
} 
    TimelapseFluorescent;  { take fluorescence 
picture } 
  InsertTimer; 
    { save fluorescence image } 
  SetSaveAs('TIFF'); 
  S a v e A s ;  
  end; 
 
end; 
 
 
 
macro 'Timelapse [9]'; 
var 
  l, t, w, h, round1: integer; 
  year, month, day, hour, minute, second, DoW: integer; 
  time, time2, next,last:real; 
 
begin 
  if (WindowTitle<>'Camera') then Startcapturing; 
  if TimelapseSet=false then 
  SetTimelapse; 
 
  if (KindOfTimelapse<>1) then begin   { settings for 
fluorescence (2) or phase/fluorescence (3) timelapse } 
  settings:=settings1; 
  antigen:=antigen1; 
  wavelength:=wavelength1; 
  nframes:=nframes1; 
 end; 
 
  {wait(1);} { to avoid instant start } 
 
 GetROI(l,t,w,h); 
  if (w=0) then SelectAll; 
 KillROI; 
  RestoreROI; { save ROI for future RestoreROIs } 
  StopCapturing;    { in case we're live } 
  if (tlperiod=0) then tlperiod:=5; 
 
  AcquireImages; {First image is acquired "outside" the while 
loop to allow instant start} 
 
  { start at the next multiple of tlperiod } 
 GetTime(year,month,day,hour,minute,second,DoW); 
 time:=second+60*(minute+60*hour); { time is converted into 
seconds } 
  if (tlperiod<60) then next:=time+tlperiod 
  else  next:=time+(60-second); 
 last:=time; 
 
  while true do begin 
    while (time<next) do begin 
  
 GetTime(year,month,day,hour,minute,second,DoW); 
  
 time:=second+60*(minute+60*hour); 
   if  (time>last)  then  begin 
   
 ShowMessage(hour:2,':',minute:2,':',second:2,'\',next-time); 
    l a s t : = t i m e ;  
   e n d ;  
  end; 
 
  AcquireImages; 
 
    if (w>0) then begin 
   SetLineWidth(1); 
   DrawBoundary; 
  end; 
 
  RestoreROI; 
  next:=next+tlperiod; 
 end; 
end; 
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7.5  Kymograph building and 
analysis 
{global variables} 
var 
i, bigger, BiggerStack, OldStack, OldStackSize: integer; 
angle, magnif, picscale, number, i, SourceWindow, intermediate, root: 
integer; 
a, b, c, d, left, top, width, height, FirstSlice, LastSlice: integer; 
AngleSet, MagnifSet, StackPresent, ProcSelect, ProcSelect2, SelectSet: 
boolean; 
Stack, Stack2, Kymograph, Stacksize, Stack2Size: integer; 
timescalepix, timescalesec, picscale, measurecount: integer; 
xfix, yfix, down, right, xy, SecondSelect, ROIwidth: integer; 
PicScaleSet, TimeScaleSet, ROISet, AnchorDef, FirstSliceAdded, 
SecondSlice, SecondSlice2: boolean; 
extension, custextensio: string; 
 
 
macro 'Set rotation angle [1]'; 
begin 
  If (angleset=false) then angle:=90; 
  angle:=Getnumber('Please enter rotation angle (-180 <= x <= 
180):', angle, 0); 
  if (angle>=-180) then 
  if  (angle<=180)  then 
   AngleSet:=true 
  else Exit('Not a valid angle!');   
end; 
 
 
 
macro 'Set magnification [2]'; 
begin 
  If (MagnifSet=false) then magnif:=1; 
  magnif:=Getnumber('Enter magnification (0.05 <= scale <= 
25.0):', magnif); 
  if (magnif>=0.05) then 
  if  (magnif<=25)  then 
   MagnifSet:=true 
  else Exit('Not a valid Scale!'); 
end; 
 
 
 
macro 'Set Slice Selection [3]'; 
begin 
  FirstSlice:=GetNumber('Enter number of first slice to be 
processed:', FirstSlice, 0); 
  LastSlice:=GetNumber('Enter number of last slice to be 
processed:', LastSlice, 0); 
 SelectSet:=true; 
end; 
 
 
macro 'Process Slice Selection only on/off [4]'; 
begin 
 ProcSelect2:=ProcSelect; 
  if (ProcSelect=true) then ProcSelect:=false; 
  if (ProcSelect2=false) then ProcSelect:=true; 
  if (ProcSelect=true) then begin 
  ShowMessage('Slice  Selection  active'); 
  end else begin ShowMessage('Slice Selection inactive'); 
 end; 
end; 
 
 
 
procedure SetPicScale; 
begin 
  If picscale=0 then picscale:=3.856; 
  picscale:=GetNumber('Please enter scale (pixel/µm):', 
picscale, 3); 
 SetScale(picscale,'µm'); 
 PicScaleSet:=true;   
end; 
 
macro 'Set picture scale (pixel/µm) [5]'; 
begin 
 SetPicScale; 
end; 
 
 
 
procedure SetTimeScale; 
begin 
  If TimeScaleSec=0 then TimeScaleSec:=5; 
  If TimeScalePix=0 then TimeScalePix:=4; 
  
  timescalesec:=GetNumber('Please enter seconds between 
frames:', timescalesec, 0); 
  timescalepix:=GetNumber('Pixel width of 1 frame in the 
kymograph:', timescalepix, 0); 
 TimeScaleSet:=true;   
end; 
 
macro 'Set time scale [6]'; 
begin 
 SetTimeScale; 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
Macro 'Make Standard ROI [Q]' 
var 
a,b,c,d: integer; 
begin 
 SelectAll; 
  GetROI(a,b,c,d);  {a=left, b=top, c=width, d=height} 
  if (c=768) then begin 
  MakeRoi(0,34,767,512) 
  end else begin 
  MakeROI(100,  100,  768,  576); 
 end; 
end; 
 
 
 
Macro 'Set width of ROI [C]'; 
var 
 a,b,c,d:  integer; 
begin 
 GetROI(a,b,c,d); 
  if (c=0) then exit; 
  if (ROIWidth=0) then ROIWidth:=c; 
  ROIWidth:=GetNumber('Enter width of ROI:', ROIWidth, 0); 
 MakeROI(a,b,ROIWidth,  d); 
end; 
 
 
 
macro 'Define ROI [D]'; 
begin 
  GetROI(a, b, c, d); {a=left, b=top, c=width, d=height} 
  If (c=0) then Exit('Please define ROI first!'); 
 ROISet:=true; 
end; 
 
 
 
macro 'Show defined ROI [F]'; 
begin 
  if (ROISet=false) then Exit('Define ROI first!'); 
 MakeROI(a,b,c,d); 
end; 
 
 
 
macro 'Rotate ROI [R]'; 
var 
RotatedPic: integer; 
 
begin 
 SourceWindow:=PidNumber; 
 KillROI; 
 RestoreROI; 
 GetROI(left,top,width,height); 
 Copy; 
 Root:=Sqrt(width*width+height*height); 
 SetNewSize(Root,Root); 
 MakeNewWindow('Intermediate'); 
 Intermediate:=PidNumber; 
 Paste; 
 SelectAll; 
 SetScaling('Bilinear,  New  Window'); 
  if (MagnifSet=false) then Magnif:=1; 
  if (AngleSet=false) then Angle:=90; 
 ScaleAndRotate(Magnif,Magnif,angle); 
 RotatedPic:=PidNumber; 
 SelectPic(Intermediate); 
 Dispose; 
 SelectPic(RotatedPic); 
 SetForegroundColor(0); 
 MakeROI(root/2-50,0,  100,  14); 
 Fill; 
 MoveTo(root/2-42,0); 
 SetForegroundColor(255); 
  Write(Angle, ' degree turned'); 
  MakeROI(root/2-2, 30, 4, 100); 
end; 
 
 
 
macro 'Rotate ROI with various angles [V]'; 
var 
RotatedPic, FlexAngle, AngleStack: integer;     Appendix 
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begin 
 SourceWindow:=PidNumber; 
 KillROI; 
 RestoreROI; 
 GetROI(left,top,width,height); 
 Copy; 
 SetForegroundColor(255); 
SetFont('Helvetica');SetFontSize(14); 
 Root:=Sqrt(width*width+height*height); 
 SetNewSize(Root,Root); 
 MakeNewStack('Tested  angles'); 
 AngleStack:=PidNumber; 
 SetScaling('Bilinear,  New  Window'); 
  if (MagnifSet=false) then Magnif:=1; 
  if (AngleSet=false) then Angle:=90; 
  for i:=0 to 10 do begin 
  SelectPic(SourceWindow); 
  C o p y ;  
  MakeNewWindow('Intermediate'); 
  Intermediate:=PidNumber; 
  Paste; 
  SelectAll; 
  FlexAngle:=angle-10+i*2; 
  ScaleAndRotate(Magnif,Magnif,FlexAngle); 
  RotatedPic:=PidNumber; 
  SelectAll; 
  C o p y ;  
  Dispose; 
  SelectPic(Intermediate); 
  Dispose; 
  SelectPic(AngleStack); 
  Paste; 
  MoveTo(0,0); 
    Write(FlexAngle, ' degree turned'); 
  If  (i<10)  then  AddSlice; 
  SelectPic(SourceWindow); 
  MakeROI(left,top,width,height); 
  C o p y ;  
  Paste; 
 end; 
 SelectPic(AngleStack); 
  MakeROI(root/2-2, 30, 4, 100); 
end; 
 
 
 
macro 'Dispose window [+]'; 
begin 
 Dispose; 
end; 
 
 
 
procedure CheckStack1; 
begin 
 StackPresent:=false; 
  if nPics=0 then begin 
    PutMessage('This macro requires a stack.'); 
  exit; 
 end; 
  if nSlices=0 then begin 
    PutMessage('This window is not a stack.'); 
  exit; 
 end; 
 StackPresent:=true; 
end; 
 
 
 
procedure CheckStack2; 
begin 
  if nSlices=0 then StackPresent:=false 
 else  StackPresent:=true; 
end; 
 
 
 
macro 'Rotate ROI in stack [T]'; 
var 
FirstSlice2: integer; 
 
begin 
 CheckStack1; 
 SetScaling('Bilinear,  New  Window'); 
  if (MagnifSet=false) then Magnif:=1; 
  if (AngleSet=false) then Angle:=90; 
 Stack:=PidNumber; 
 StackSize:=nslices; 
    if (ProcSelect=true) then begin 
   if  LastSlice<Stacksize  then 
StackSize:=LastSlice; 
   FirstSlice2:=FirstSlice; 
  end  else  begin 
   F i r s t S l i c e 2 : = 1 ;  
  end; 
 GetRoi(left,top,width,height); 
  if width=0 then begin 
   SelectAll; 
   GetRoi(left,top,width,height); 
  end; 
 Root:=Sqrt(width*width+height*height); 
 SetNewSize(Root,Root); 
 MakeNewStack('Stack2'); 
 Stack2:=PidNumber; 
 ChoosePic(Stack); 
  for i:=FirstSlice2 to StackSize do begin 
  ChoosePic(Stack); 
  ChooseSlice(i); 
  C o p y ;  
  MakeNewWindow('Intermediate'); 
  Intermediate:=PidNumber; 
  Paste; 
  SelectAll; 
  ScaleAndRotate(Magnif,Magnif,angle); 
  SelectAll; 
  C o p y ;  
  Dispose; 
  ChoosePic(Intermediate); 
  Dispose; 
  ChoosePic(Stack2); 
  ChooseSlice(i); 
  Paste; 
  If  (i<StackSize)  then  AddSlice; 
 end; 
 SelectSlice(1); 
 SetForegroundColor(0); 
 MakeROI(root/2-50,0,  100,  14); 
 Fill; 
 MoveTo(root/2-42,0); 
 SetForegroundColor(255); 
  Write(Angle, ' degree turned'); 
  MakeROI(root/2-2, 30, 4, 100); 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
procedure Measurement; 
var 
left2,top2,width2,height2: integer; 
duration, distance: integer; 
 
begin 
 GetRoi(left2,top2,width2,height2); 
  If (width2=0) then exit; 
  If (PicScaleSet=false) then SetPicScale; 
  If (TimeScaleSet=false) then SetTimeScale; 
 SetOptions('User1;  User2'); 
 SetPrecision(2); 
 SetUser1Label('time_sec'); 
 SetUser2Label('dist_µm'); 
 duration:=trunc(width2/timescalepix+1.6)*timescalesec; 
    {'duration' is a good estimation for the number 
of frames which are 
    crossed by the line selection. '+1.6' 
compensates that one measures 
    from roughly the middle of one frame to 
roughly the middle of another, 
    thereby missing more or less the width of one 
frame (namely the first 
    half of the first and the second half of the last 
frame). In addition 
    it compensates for the truncation of the 
number.} 
 distance:=height2/PicScale; 
  rUser1[rcount+1]:=duration; 
  rUser2[rcount+1]:=distance; 
 Measure; 
{ SetForegroundColor(120);} 
 Setlinewidth(2); 
 DrawBoundary; 
end; 
 
 
macro 'Measure [A]'; 
begin 
 Measurement; 
end; 
 
 
macro 'Redo last measurement [L]'; 
begin 
 SetCounter(rcount-1); 
 Measurement; 
end; 
 
 
 
macro 'Reset measurement counter [0]'; 
begin 
 ResetCounter; 
end; 
 
 
 
macro '(-'; {Menu divider}     Appendix 
Ph.D. Thesis Harald Witte   119 
begin  
end; 
 
 
 
macro 'Make Kymograph [Y]'; 
begin 
 CheckStack1; 
 GetRoi(left,top,width,height); 
 KillROI; 
 RestoreROI; 
  If (width=0) then Exit('Select ROI first!'); 
 Stack:=PidNumber; 
 StackSize:=nslices; 
 SetNewSize(Stacksize*width,height); 
 MakeNewWindow('Kymograph'); 
 Kymograph:=PidNumber; 
  for i:=1 to StackSize do begin 
  SelectPic(Stack); 
  SelectSlice(i); 
  C o p y ;  
  SelectPic(Kymograph); 
  MakeROI(((i-1)*width),0,width,  height); 
  Paste; 
 end; 
 KillRoi; 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
macro 'Crop area outside ROI'; 
var 
name: string; 
FirstSlice2: integer; 
 
begin 
 CheckStack2; 
 GetRoi(left,top,width,height); 
 name:=windowtitle; 
 SetNewSize(width,height); 
  If (StackPresent=false) then begin   
  C o p y ;  
  MakeNewWindow(name); 
  Paste; 
  end else begin 
  Stack:=PidNumber; 
  StackSize:=nslices; 
   if  (ProcSelect=true)  then  begin 
    if  LastSlice<Stacksize 
then StackSize:=LastSlice; 
   
 FirstSlice2:=FirstSlice; 
   end  else  begin 
    F i r s t S l i c e 2 : = 1 ;  
   e n d ;  
  MakeNewStack(name); 
  Stack2:=PidNumber; 
    for i:=FirstSlice2 to StackSize do begin 
   SelectPic(Stack); 
   SelectSlice(i); 
   C o p y ;  
   SelectPic(Stack2); 
   P a s t e ;  
   If  (i<StackSize)  then  AddSlice; 
  end; 
 SelectSlice(1); 
 end; 
 KillROI; 
end; 
 
 
 
macro 'Outline ROI [O]'; 
begin 
 SetForegroundColor(120); 
 Setlinewidth(2); 
 DrawBoundary; 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
macro 'Save As “Window Title.tif” [S]'; 
begin 
 SetSaveAs('TIFF'); 
 SaveAs; 
End; 
 
 
 
procedure ExtendWindowtitle; 
begin 
 duplicate(windowtitle); 
 SetPicName(windowtitle,  extension); 
end; 
 
 
 
macro 'Add custom extension to window title [N]'; 
begin 
  if (custextensio='Global String') then 
custextensio:='_o´clock'; 
 custextensio:=GetString('Enter custom file name 
extension:', custextensio); 
 extension:=custextensio; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Add "_anterograde" to window title'; 
begin 
 extension:='_anterograde'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Add "_retrograde" to window title'; 
begin 
 extension:='_retrograde'; 
 ExtendWindowtitle; 
end; 
 
 
 
macro 'Shorten window title by one character [-]'; 
var 
 picnamelength:  integer; 
 picname:  string; 
begin 
 picname:=windowtitle; 
 picnamelength:=length(windowtitle); 
  Delete(picname, picnamelength, 1); {removes last character 
from picture name} 
 SetPicName(picname); 
end; 
 
 
 
macro '(-'; {Menu divider} 
begin  
end;  
 
 
 
macro 'Define anchor point [7]'; 
begin 
 GetMouse  (xfix,  yfix); 
  showmessage('Anchorpoint defined:\X: ', xfix, '   Y: ', yfix); 
 rUser1[1]:=xfix; 
 rUser2[1]:=yfix; 
 SetCounter(rcount+1); 
 AnchorDef:=true; 
end; 
 
 
 
macro 'Switch process all slices/every second slice'; 
begin 
 SecondSlice2:=SecondSlice; 
  if (SecondSlice=true) then SecondSlice:=false; 
 if  (SecondSlice2=false)  then SecondSlice:=true; 
  if (SecondSlice=true) then begin 
    ShowMessage('Every second slice\will be 
processed'); 
  end else begin ShowMessage('Every slice\will be 
processed'); 
 end; 
end; 
SecondSelect 
 
 
procedure MoveImage; 
var 
 xfix2,  yfix2:  integer; 
begin 
  if (AnchorDef=false) then Exit('Please define anchor point 
first!'); 
  if (ROISet=false) then Exit('Please define ROI first!'); 
 getMouse  (xfix2,  yfix2); 
  MakeROI(a, b, c, d); 
 Copy; 
 {DrawBoundary;} 
  MoveROI(xfix-xfix2, yfix-yfix2); {MoveRoi(dx,dy) Moves ROI 
right dx pixels and down dy pixels.} 
 Paste; 
 {DrawBoundary;} 
end; 
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Macro 'Move image according to anchor point [8]'; 
begin 
 SetForegroundColor(125); 
 SetLineWidth(2); 
 MoveImage; 
end; 
 
 
 
Macro 'Move remaining slices according to anchor point [X]'; 
var 
i, Current, Last: integer; 
 
begin 
  for i:=SliceNumber to nSlices do begin 
  SelectSlice(i); 
  M o v e I m a g e ;  
 end; 
end; 
 
 
 
macro '(-'; {Menu divider} 
begin  
end;  
 
 
procedure ROIStackMove; 
begin 
 CheckStack1; 
 xy:=SliceNumber; 
 i:=SliceNumber; 
  if (SecondSlice=true) then SecondSelect:=2 else 
SecondSelect:=1; 
  while i<=nslices do begin 
  SelectSlice(i); 
  MakeROI(80,  80,  808,  616); 
  C o p y ;  
    MoveRoi(down, right);  {MoveRoi(dx,dy) Moves 
ROI right dx pixels and down dy pixels.} 
  Paste; 
  i:=i+SecondSelect; 
 end; 
 SelectSlice(xy); 
end; 
 
 
macro 'Move content of ROI in whole stack 1 pixel to the left [G]'; 
begin 
 down:=-1; 
 right:=0; 
 ROIStackMove; 
end; 
 
 
 
macro 'Move content of ROI in whole stack 1 pixel to the right [H]'; 
begin 
 down:=1; 
 right:=0; 
 ROIStackMove; 
end; 
 
 
 
macro 'Move content of ROI in whole stack 1 pixel up [Z]'; 
var 
xy: integer; 
begin 
 down:=0; 
 right:=-1; 
 ROIStackMove; 
end; 
 
 
 
macro 'Move content of ROI in whole stack 1 pixel down [B]'; 
begin 
 down:=0; 
 right:=1; 
 ROIStackMove; 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
procedure ROIMove; 
begin 
{  GetROI(a, b, c, d);} {a=left, b=top, c=width, d=height} 
{  If (c=0) then Exit('Please make ROI first!');} 
  MakeROI(70, 80, 808, 616); 
 Copy; 
  MoveRoi(down, right);  {MoveRoi(dx,dy) Moves ROI right dx 
pixels and down dy pixels.} 
 Paste; 
{    MakeROI(a, b, c, d);} 
end; 
 
 
macro 'Move content of ROI 1 pixel to the left [J]'; 
begin 
 down:=-1; 
 right:=0; 
 ROIMove; 
end; 
 
 
 
macro 'Move content of ROI 1 pixel to the right [K]'; 
begin 
 down:=1; 
 right:=0; 
 ROIMove; 
end; 
 
 
 
macro 'Move content of ROI 1 pixel up [I]'; 
var 
xy: integer; 
begin 
 down:=0; 
 right:=-1; 
 ROIMove; 
end; 
 
 
 
macro 'Move content of ROI 1 pixel down [M]'; 
begin 
 down:=0; 
 right:=1; 
 ROIMove; 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
macro 'Transfer Stack to bigger window'; 
begin 
 SetNewSize(968,  776); 
 OldStack:=PidNumber; 
 OldStackSize:=nslices; 
 MakeNewStack('Bigger  Stack'); 
 BiggerStack:=PidNumber; 
  for i:=1 to OldStackSize do begin 
  SelectPic(OldStack); 
  SelectSlice(i); 
  SelectAll; 
  C o p y ;  
  SelectPic(BiggerStack); 
  SelectSlice(i); 
  MakeROI(100,  100,  768,  576); 
  Paste; 
  if  (i<OldStackSize)  then  AddSlice; 
 end; 
end; 
 
 
 
macro 'Select Image in Bigger Stack [P]'; 
begin 
  MakeROI(100, 100, 768, 576); 
end; 
 
 
 
macro 'Add first slice after every slice'; 
begin 
 CheckStack1; 
 SelectSlice(1); 
 SelectAll; 
 Copy; 
 i:=0; 
  while i<nslices-2 do begin 
  SelectSlice(i+2); 
  AddSlice; 
  SelectAll; 
  Paste; 
  i:=i+2; 
 end; 
 FirstSliceAdded:=true; 
 SecondSlice:=true; 
 SelectSlice(1); 
end; 
 
 
 
macro 'Remove added first slices'; 
begin 
 CheckStack1;     Appendix 
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{  If FirstSliceAdded=false then Exit('No slices have been 
added to this stack.');} 
 i:=1; 
  while i<nslices-1 do begin 
  SelectSlice(i+2); 
  DeleteSlice; 
  i:=i+1; 
 end; 
 FirstSliceAdded:=false; 
 SecondSlice:=false; 
 SelectSlice(1); 
end; 
 
 
 
macro '(-'; {menu divider} 
begin 
end; 
 
 
 
macro 'Goto first slice [W]'; 
begin 
 CheckStack1; 
 SelectSlice(1); 
end; 
 
 
 
macro 'Goto last slice [E]'; 
begin 
 CheckStack1; 
 SelectSlice(nslices); 
end;     Appendix 
122   Ph.D. Thesis Harald Witte 
  
Ph.D. Thesis Harald Witte   123 
8. Acknowledgements 
First, I wish to thank my supervisor Dr. Frank Bradke for giving me the opportunity to 
do my PhD in his lab, for his support, his encouragement and his training in 
presentation and writing skills. The excellent working atmosphere in his lab has 
always made it a nice place to go to. Especially, I would like to express my gratitude 
to Dr. Bradke for his support not only in good but also more difficult times. 
 
I am very grateful to Dr. Rüdiger Klein and Dr. Damian Brunner (EMBL) as members 
of my thesis committee for their efforts, their precious time and suggestions. 
 
I am indebted to Dr.  Joshua Sanes for providing SAD  A/B knockout mice, 
Dr. Magdalena Götz for GFP-expressing mice, Drs. Anna Akhmanova and Vic Small 
for the EB3-GFP expression plasmid and Drs. Susanne Nagel and Erich Nigg for the 
Tubulin-GFP construct. I am very grateful to Dr. Michael Schleicher for kindly sharing 
the antibody against tyrosinated tubulin. I am also indebted to Ralf Zenke for help 
with setting up the FRAP experiments. 
 
I am very grateful to Jonathan Mackinnon for critically reading and proof-reading this 
thesis. Thanks a lot! 
 
Especially, the members of the fabulous Bradke lab deserve my deep gratitude for 
their support and friendship. 
In particular, Liane Meyn, for help with neuronal cultures, for keeping lab and kitchen 
tidy, and for many delicious cakes. Susana Gomis-Rüth, my “little (PhD) sister”, for 
Salsa music, GFP-expressing neurons, for cheering me up and introducing me to the 
world of Jorge Cham’s PhD-comics, and for mutual understanding. Boyan Garvalov, 
for great support and good music, his excellent dry sense of humor, and for patiently 
reading my paper manuscript over and over again, giving priceless input. Ali Ertürk, 
for Borma, friendship, Cinema Clubs, and the best trip to the USA I have ever had – 
“Thanks, man!”. Farida Hellal, for discussions, guidance and encouragement on both 
a scientific and personal level, many smiles and invaluable help to shape my paper to 
be accepted. Joana Enes, for her unbreakable optimism, her cheerful nature, and her 
unmatched skills at preparing DRG neurons. Keep going! Sabina Tahirovic, for 
sharing reagents and equipment at the “socialistic bench”, moral support and true 
appreciation of gentlemen. Bhavna Ylera, for her calm nature, her initial 
recommendation to Frank, and her excellent working morale. Dorothee ‘Dodo’ 
Neukirchen, for joining me to ‘X-Ray World’, for friendship and support, for simply 
listening, and for countless smiles and jokes. Michael Stiess, for supply with all kinds 
of music, for keeping the stocks of sweets filled, and for many Kalauer and 
Schenkelklopfer. Finally, Frank, for his support, encouragement and patience, his     Acknowledgements 
124   Ph.D. Thesis Harald Witte 
cheerful personality, and for carefully selecting all these wonderful people to become 
part of his lab. I would also like to thank some of the transient lab members, Andres 
Hortado and Kevin Flynn, and one of the best neighbors our lab ever had, Harry 
Schnürch, for bringing out the best in us. 
 
I would also like to express my gratitude to the members of the animal facilities and 
the MPI workshops, our EDV group, and the members of the Photolab for continued 
support. 
 
On a personal level, I would like to thank Sabine Seidel, Max Mühlhaus, and the 
members of the “Gentlemen’s Club”, Matthias Dax, Florian Kiesl and Sascha Kampf, 
for continued encouragement, inspiration and friendship over the years. I am also 
deeply indebted to S. Stallone for the “Rocky” series and Bill Conti for the respective 
soundtrack. 
 
Annette Dell`Aere danke ich ganz besoders herzlich für ihre Unterstützung, ihre 
große Geduld und die vielen Aufmunterungen, womit sie im Speziellen zum Gelingen 
dieser Arbeit beigetragen hat. 
 
Meinen Eltern und Großeltern gilt ebenfalls mein besonderer Dank. Während des 
Studiums und der Promotion konnte ich immer auf sie zählen und ihrer Unterstützung 
gewiß sein. Danke dafür und für so vieles mehr!  
Ph.D. Thesis Harald Witte   125 
9. Curriculum vitae 
Personal details   
Name:  Harald Witte 
Date of birth:  July 3
rd, 1976 
Place of birth:  Munich, Germany 
Citizenship:  German 
   
Education  
July 2003 to 
July 2008 
Ph.D. thesis in the laboratory for „Axonal Growth and 
Regeneration“ of Dr. Frank Bradke at the Max-Planck-Institute of 
Neurobiology, Martinsried 
Title: “The role of microtubules in initial neuronal polarization“ 
March 2002 – 
Feb. 2003 
Diploma thesis in the laboratory of Prof. Rudolf Grosschedl at the 
Gene Center, Munich 
Title: “Identification of ’Matrix Attachment Region’-binding proteins and 
cofactors in a Yeast-One-Hybrid screen“ 
Nov. 1997 – 
Feb. 2002 
Diploma in Biology, Ludwig-Maximilians-Universität, Munich 
Final grade: 1.1 
Major subject:  Genetics 
Minor subjects:  Biochemistry, Physiological Botany and Cell Biology 
Additional subject:  Informatics 
Oct. 1996 – 
Nov. 1997 
Civil service 
1983 – 1996  Primary and Secondary Education 
May 1996 University-entrance diploma (Abitur; final grade: 1.1) 
   
Scientific communications and publications  
•  Witte, H., and F. Bradke. 2008. The Establishment of Neuronal Polarity. Curr Opin 
Neurobiol. (in preparation) 
•  Witte, H., D. Neukirchen, and F. Bradke. 2008. Microtubule stabilization specifies 
initial neuronal polarization. J Cell Biol. 180:619-32. 
•  Platform presentation (talk) at Cold Spring Harbor Laboratory meeting 
„Axon Guidance, Synaptogenesis & Neural Plasticity“, Sept. 2006 
 
 
 
     Curriculum vitae 
 
126   Ph.D. Thesis Harald Witte 
•  Witte, H., and F. Bradke. 2005. Guidance of Axons to Targets in Development and in 
Disease. In Peripheral Neuropathy. Vol. 1. P.J. Dyck and P.K. Thomas, editors. 
Elsevier Inc., Philadelphia. 447-481. 
•  International Patent: Bradke, F., Witte, H., Ertürk, A. Use of microtubule stabilizing 
compounds for the treatment of lesions of CNS axons (WO/2006/094811). 
Filed March 9
th, 2004 / March 9
th, 2006 
 